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Uncovering the mechanisms underlying ageing of the central nervous system (CNS) is 
crucial to identify therapeutic targets to promote healthy ageing. Although the CNS is 
considered predominantly post-mitotic, it has been suggested that telomerase, mostly known 
for its role in cell division through maintenance of telomere length, has a protective role 
against cellular senescence. However, the mechanisms underlying this remain unclear. Here, 
I aimed to determine telomerase-dependent mechanisms of ageing in the CNS, particularly in 
the retina and the brain. To do so, I used wild-type zebrafish alongside with the telomerase-
mutant (tert-/-) zebrafish model. 
This study shows that zebrafish display retina degeneration and visual impairment with 
ageing, and that these occur in a telomerase independent manner. Despite preserving its 
regenerative capacity in response to acute damage until old ages, rather than regeneration, 
the aged zebrafish retina undergoes gliosis, like in humans. This highlights zebrafish as a 
suitable model to explore relevant mechanisms to neurodegeneration in the human retina, 
during ageing, pointing to gliosis as a key target to explore endogenous regeneration 
mechanisms. 
When looking at the brain, this study shows an accumulation of senescence markers, 
specifically in the diencephalon and cerebellum. Contrasting with the retina, in the brain, 
these hallmarks were accelerated in the tert-/- model, suggesting that TERT exerts a protective 
role against accumulation of senescence in the aged brain. Here, I also identify a set of genes 
potentially involved in TERT-dependent senescence in the ageing brain, but further 
investigation is required to test whether the expression of these genes delay accumulation of 
senescence in the aged zebrafish brain. 
Together, this opens new lines of investigation on telomerase-dependent and independent 
mechanisms of ageing, pointing to zebrafish as a valuable model to further explore potential 
therapeutic targets aiming to ameliorate retina and brain degeneration with ageing.  
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1.1  Ageing 
People are now living longer than ever before, as life expectancy has been increasing. In 
the European Union, life expectancy increased almost 10 years in the past 5 decades and it is 
predicted to increase another 7 years until 2060, reaching the 84 years of age in man and the 
89 years of age in women (European Commission Directorate-General for Economic and 
Financial Affairs, 2015). In the United Kingdom (UK), the lifespan increase of the past decades 
has stalled since 2010. Whilst from 1980 to 2010 life expectancy in the UK increased 1 year 
every 6 years, nowadays it takes on average 21.5 years (15 in man and 28 in women) to 
increase life expectancy by 1 year (Michael et al., 2020). If this rate is to be maintained, then 
it is expected that life expectancy in the UK will increase by 2.8 years for man and 1.5 year for 
women, reaching the 82.4 and 84.7 years of age, respectively, by 2060. 
The drawback of an increased life expectancy is that with ageing comes disease and 
therefore people are now living longer with the burden of age-associated diseases. Indeed, 
ageing can be defined as a gradual accumulation of damage that leads to a functional decline 
of the organism (López-Otín et al., 2013), increasing vulnerability to chronic diseases and 
probability of death (Barnett et al., 2012; Cutler & Mattson, 2006; Marengoni et al., 2014). In 
particular after the age of 65, the incidence of chronic diseases such as hypertension, 
dementia, arthritis, heart diseases, and visual impairments, increases dramatically 
(Alessandra et al., 2009; Partnership for Solution, 2004). Importantly, the percentage of over 
65’s with multimorbidity, i.e. co-occurrence of more than 1 disease (Fortin et al., 2004), 
reaches about 60% (Barnett et al., 2012; Vogeli et al., 2007). Chronic disease refers to a 
permanent, non-reversible condition that affects a person both physically and mentally, 
leading to an increased risk of disability and hampering the daily-life activities (Partnership 
for Solution, 2004). Hence, age-associated chronic diseases have a strong negative impact in 
the quality of life as well as in the medical care costs of the elderly. In fact, the European 
average of care expenditure per capita by age doubles between 65 and 90 years old 
(European Commission Directorate-General for Economic and Financial Affairs, 2015). 
Similarly, in the UK, it is estimated that the NHS care costs increase from ca.£1,000 to 
ca.£2,000-2,500, between the age groups of 65 and >85 (Angele, 2018). 
Considering this, it is urgent to prevent age-related diseases in order to promote health in 
ageing, so that people may live healthier for longer (‘healthspan’) (Tinetti et al. 2012). Longer 
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healthspan would reduce the age-associated negative impact on people’s quality of life and 
on the socio-medical economy. To achieve this, it is essential to understand the mechanisms 
underlying the ageing process and that predispose people to multiple chronic diseases of 
ageing. Highlighting this urge, the Corporate Plan 2014-2015 of the UK Department of Health 
set research into “ageing well” as one of the top-3 priorities (Unit & Health, 2014) and the 
Horizon 2020 (Work plan 2018-2020) framework is aiming to develop research and 
techniques to promote healthy ageing (Commission, 2018). 
 
1.2 Hallmarks of ageing 
With ageing, cells and tissues undergo several molecular alterations that contribute to the 
impairment of tissue homeostasis, leading to progressive tissue degeneration. These 
alterations include genome instability, epigenetic modifications, loss of proteostasis, and 
telomere shortening, known as primary hallmarks of ageing (López-Otín et al., 2013). 
Accordingly, premature ageing syndromes (progerias) are underlined by accumulation of DNA 
damage and impairment of DNA repair (Burtner & Kennedy, 2010; Mostoslavsky et al., 2006), 
aberrant DNA methylation (Heyn et al., 2013), loss of proteostasis (Alupei et al., 2018; Gabriel 
et al., 2016) and telomere dysfunction (Armanios et al. 2009; Zhong et al. 2011). 
The primary hallmarks of ageing do not occur isolated and are instead known to interact 
with and affect each other in multiple ways. For example, the exposure to cellular extrinsic 
factors such as radiation and chemicals, as well as cellular intrinsic factors such as Reactive 
Oxygen Species (ROS) and DNA replication errors, threat genomic and mitochondrial DNA, 
contributing to accumulation of DNA damage and consequent genome instability (López-Otín 
et al., 2013; Moskalev et al., 2013; Ovadya & Krizhanovsky, 2014). Indeed, mutations in genes 
encoding for key enzymes involved in DNA repair and DNA maintenance cause progeroid 
syndromes such as Werner Syndrome (WRM), Bloom Syndrome (BLM), Cockayne Syndrome 
(CK) and Dyskeratosis congenita (DKC) (Burtner & Kennedy, 2010). 
With ageing, there are also epigenetic alterations, including changes in DNA methylation 
patterns and chromatin remodelling (Talens et al., 2012), which contribute to structural and 
functional alterations in the genome, reinforcing this DNA damage cycle (Zhang et al. 2016; 
Moskalev et al. 2013). Moreover, with ageing, there is deterioration of the ability to regulate 
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protein homeostasis (proteostasis), which can either lead to a loss of function or gain of toxic 
function, affecting cell function and causing disease (Koga et al., 2012; Powers et al., 2009). 
De-regulated proteostasis may impair the DNA-repair machinery, promoting genomic 
instability and contributing to DNA damage accumulation (Jackson & Bartek, 2010). 
Importantly, due to its G-rich regions, telomeres are favoured sites for accumulation of DNA 
damage where, contrary to other DNA regions, DNA damage is not efficiently repaired (Hewitt 
et al., 2012). This means that ROS-induced DNA damage can cause telomere damage and 
rapid telomere attrition, contributing, in turn, to more DNA-damage responses (DDR). This 
can therefore create a positive feedback loop generating more genomic instability (Kim et al., 
2016; Rossiello et al., 2014). Adding to this telomere damage, it is well described that 
telomeres shorten with age (Allsopp et al., 1995; Heidinger et al., 2012; Moyzis et al., 1988), 
which will be detailed in section 1.2.1. 
 
1.2.1 Telomeres and telomerase: structure and function 
Telomeres are specialised structures that constitute the tips of linear chromosomes in 
eukaryotes, comprising repetitive TTAGGG sequences of DNA (Moyzis et al., 1988). In humans, 
telomeres consist of 2-30 kilobase (kb)-long double-stranded DNA repeats, presenting a 
single-stranded 100-200 nucleotide-long 3’ overhang, termed 3’ Guanine- or G-overhang 
(Lange, 2004) (Fig 1.1A, left). Telomeres are associated with a protein complex, known as 
Shelterin, essential for telomere protection and function. This protein complex is organised 
in 6 distinct subunits, including telomere repeat binding 1 (TRF1), telomere repeat binding 2 
(TRF2, or TRFA in zebrafish), protection of telomere 1 (POT1), repressor/activator protein 1 
(RAP1), TRF1 and TRF2 interacting nuclear protein 2 (TIN2) and adrenocortical dysplasia 
protein homolog (TPP1) (Palm & Lange, 2008; Wagner et al., 2017) (Fig 1.1A, left). The 
Shelterin complex is highly conserved among vertebrates. Likewise, zebrafish present the 






Fig 1.1. Diagram illustrating the structure of telomeres, the associated Shelterin complex, and 
telomerase. (A) Structure of telomeres, constituted by repetitive DNA sequences (TTAGGG), and 
associated protein complex, called Shelterin. TRF1: telomere repeat binding 1; TRF2: telomere repeat 
binding 2; TIN2: TRF1 and TRF2 interacting nuclear protein 2; POT1: protection of telomere 1; TPP1: 
adrenocortical dysplasia protein homolog; RAP1: repressor/activator protein 1. (B) Representation 
of telomerase constituted by TERT and TERC components. DKC1: dyskeratosis congenita 1; NHP2: 
nucleolar protein family A member 2; NOP10: NOP10 ribonucleoprotein; GAR1: GAR1 
ribonucleoprotein. Image made in Biorender (https://biorender.com) and adapted from 
(Maciejowski & Lange, 2017). 
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Together with Shelterin, the 3’ G-overhang form a loop-like structure at telomeres (termed 
T-loop), creating a protective “cap”. This protective “cap” “hides” the end of linear 
chromosomes, preventing their recognition as DNA Double-Strand Breaks (DSBs) (Carneiro et 
al., 2010; Sullivan & Karlseder, 2010). However, because DNA polymerases are unable to 
complete DNA replication at the termini of the lagging strand (3’ end), known as the ‘end-
replication-problem’, telomeres shorten with each cell division (Levy et al., 1992). It is 
estimated that there is a loss of around 50-200 base-pairs (bp) in each cell division (Levy et 
al., 1992), at least in cell culture. As telomeres do not comprise any protein-encoding gene, 
telomere shortening offers a buffering-like system, protecting the protein-coding DNA against 
erosion with each cell division. Importantly, when telomeres become too short, they become 
“uncapped” (Ferreira et al., 2004), and this exposure of the DNA double strand end, leads to 
activation of DDRs (Levy et al., 1992; Sahin & Depinho, 2010).  
Telomerase is the only known enzyme capable of counteracting telomere erosion, by 
elongating telomeres. Nonetheless, in humans, telomerase expression is restricted in most 
somatic cells. Telomerase is mainly expressed, albeit at limited levels, in stem cells, germ cells 
(Wright et al., 1996), cancer cells (Kim et al., 1994) and some activated immune cells (Gizard 
et al., 2011; Hiyama et al., 1995). Therefore, despite telomerase’s ability to elongate 
telomeres, its limited expression in most cells is not sufficient to prevent telomere shortening 
over-time (Greider & Blackburn, 1985).  
Telomerase is a ribonucleoprotein formed by a telomere-specific reverse transcriptase 
(TERT) and an RNA template (TERC) (Greider & Blackburn, 1985). The TERT component of 
telomerase uses the RNA template, TERC, to synthetize de novo telomeric tandem repeats at 
the 3’ end of telomeres (Greider & Blackburn, 1985). This occurs in association with a core of 
4 telomerase-associated proteins, including dyskeratosis congenita 1 (DKC1), nucleolar 
protein family A member 2 (NHP2), NOP10 ribonucleoprotein (NOP10), and GAR1 
ribonucleoprotein (GAR1) (Armanios, 2010; Dey & Chakrabarti, 2018; Egan & Collins, 2012) 
(Fig 1.1B). These four proteins are known to interact with a box H/ACA domain, which 
resembles a H/ACA small nucleolar RNA (snoRNA), and is located at the 3’-terminal of TERC 
(Mitchell et al., 1999). The interaction between the H/ACA box and the four above mentioned 
telomerase-associated proteins is important to regulate RNA stability, maturation and 
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location, and it is therefore essential for telomere lengthening (Armanios, 2010; Mitchell et 
al., 2000).  
Furthermore, the TERT component of telomerase has a complex structure, containing an 
RNA binding domain (or TERC binding domain) localised at the N-terminal, a reverse 
transcriptase (RT) domain localised at the C-terminal and a C-terminal extension (Armbruster 
et al., 2001; Lai et al., 2001). Both RNA binding and RT domains are required for telomere 
elongation (Lai et al., 2001). The C-terminus of TERT was also shown to be essential for 
telomere elongation, as the addition of an epitope tag at this site blocked its ability to prevent 
telomere shortening in human fibroblasts (Counter et al., 1998). 
Therefore, telomerase is a complex protein and the correct assembly of its holoenzyme 
complex involves a multistep process that is crucial for telomerase activity at elongating 
telomeres.  
 
1.2.1.1 Telomerase functions: canonical versus non-canonical 
Although telomere biogenesis is the most well-characterised function of telomerase (i.e. 
canonical functions), this ribonucleoprotein has been reported to have important functions 
that are independent of telomeres (i.e. non-canonical functions) (e.g. Goodman & Jain, 2011; 
Romaniuk et al., 2019; Ségal-bendirdjian & Geli, 2019; Sung, Ali, & Lee, 2014). These non-
canonical functions of telomerase have been suggested to occur at the nucleus, cytoplasm 
and mitochondria. Despite this, work so far has been unable to discern which part of 
telomerase is responsible for which non-canonical function. It may be that they cannot be 
completely separated (Mukherjee et al., 2011). Further work genetically modulating different 
parts of telomerase in model organisms should help clarifying this. Modulating TERC or TERT 
components separately, or even modulating specific parts of the TERT component of 
telomerase (e.g. RNA-binding domain or reverse transcriptase), would help to dissect which 
components of telomerase are required for the different functions of telomerase. 
At the nucleus, telomerase seems to have an important role on transcriptional regulation. 
By recognising the sequence ACCACCC, human TERC has been shown to interact with 2,198 
sites of the genome, including with the MYC promoter and several genes from the Wnt 
pathway (Chu et al., 2012). Apart from these direct interactions, modulation of TERC has been 
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suggested to alter the expression of other important genes. For example, inhibition of TERT 
(using shRNA) in human induced pluripotent stem cells has been shown to reduce the 
differentiation of hematopoietic stem cells (HSCs), without affecting telomere length (Jose et 
al., 2018). Similarly, depletion of TERC (using a morpholino antisense oligonucleotide model) 
in zebrafish embryos was shown to lead to impairment of myelopoiesis. The authors showed 
that this occur independently of telomerase activity as TERT-knockout morpholino did not 
display any alteration in myelopoiesis (Alcaraz-pe et al., 2014). This evidence show that the 
telomerase role in HSCs differentiation and myelopoiesis is independent of its functions at 
telomeres (Alcaraz-pe et al., 2014; Jose et al., 2018). Although the mechanisms underlying 
this remain generally unclear, Alcaraz-pe et al. (2014) showed that the role of TERC in 
myelopoiesis may involve modulation of transcription factor PU.1 (SPI1) and GATA-binding 
factor 1 (GATA1) by TERC (Alcaraz-pe et al., 2014). Together, this suggest that the TERC 
component of telomerase can play roles independent of telomeres, possibly by modulating 
the expression of key transcription factors.  
Apart from TERC functions at the nucleus, recently it was shown that this component of 
telomerase can also translocate to the mitochondria, where it is processed giving rise to a 
shorter form, TERC-53. This shorter form is then translocated to the cytoplasm where it can 
play roles independently of telomeres or telomerase activity (Cheng et al., 2018). In vitro, 
overexpression of TERC-53 in mouse embryonic fibroblasts (MEFs) was reported to accelerate 
cellular senescence, without affecting telomere length. Additionally, TERC-53 overexpression 
in mice led to reduced proliferation in the hippocampus and this was associated with 
accelerated cognitive decline (Zheng et al., 2019). The authors proposed that these functions 
of TERC-53 might be associated with regulation of gene expression at the nucleus; however, 
the mechanisms underlying these functions remain largely unknown (Zheng et al., 2019). 
Like TERC, the TERT component of telomerase has also been reported to interact with 
several gene promoters, including promoters of genes associated with the Wnt pathway. 
Accordingly, TERT expression was shown to be essential for the development of the anterior-
posterior axis in Xenopus laevis, through direct modulation of Wnt/β-catenin signalling 
pathway (Park et al., 2015). Moreover, the TERT component of telomerase can modulate the 
expression of other genes, through which TERT has been shown to play several other roles. 
Within those roles, TERT expression has been shown to be essential for cell proliferation and 
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cell survival. More specifically, TERT expression has been shown to promote proliferation in 
the mouse skin, particularly in keratinocytes and hair follicle stem cells. Importantly, this does 
not require TERC expression or catalytic telomerase activity, suggesting that this function of 
telomerase is independent of its activities at telomeres (Choi et al., 2008; Sarin et al., 2005). 
Accordingly, lack of TERT (using a morpholino model) was reported to lead to reduced 
haematopoiesis in zebrafish embryos, without affecting telomeres. Deficient haematopoiesis 
was rescued by the expression of the RNA-binding domain of TERT, but not by its RT domain 
(Imamura et al., 2008). This suggests that the function of TERT in haematopoiesis, in zebrafish, 
only requires specific domains of telomerase and does not require TERT functions at 
telomeres. Furthermore, TERT expression was also reported to protect human cells against 
p53-induced apoptosis, independently of telomerase activity or telomere length (Cao et al., 
2002; Rahman et al., 2005).  
Apart from its functions in cell proliferation and cell survival, TERT was shown to induce 
transcription of inflammatory-associated genes, including nuclear factor kappa B (NFkB) and 
tumour necrosis factor alpha (TNFα) (Deacon & Knox, 2018; Ghosh et al., 2012; Mattiussi et 
al., 2012). Additionally, increasing TERT expression in both nucleus and cytoplasm has shown 
to exert a protective effect against excitotoxicity in the mammalian brain, contributing to cell 
survival (Eitan et al., 2012). However, the mechanisms underlying this remain unclear. 
Interestingly, TERT can translocate from the nucleus to the mitochondria site (Ahmed et 
al., 2008). Santos et al. have reported that TERT at the mitochondria promotes mitochondrial 
DNA damage and increased levels of apoptosis in several human cell lines (e.g. fibroblasts, 
breast epithelial cells and HeLa cells). The authors proposed that TERT disturbs the integrity 
of mitochondrial DNA, either by inducing DNA damage or by affecting DNA repair (Hertzog 
Santos et al., 2006; Hettzog Santos et al., 2004). However, more recent evidence has shown 
opposite results, by showing that TERT expression at the mitochondria has a protective role 
against DNA damage and oxidative stress, in human umbilical vein endothelial cells (HUVECs) 
and human fibroblasts (Ahmed et al., 2008; Haendeler et al., 2009). Ahmed et al. reported 
that TERT at the mitochondria leads to better function of the mitochondria and integrity of 
mitochondria DNA, reducing production of mitochondria superoxide and ROS (Ahmed et al., 
2008). Supporting this evidence, mitochondria from TERT-deficient mice displays decreased 
respiratory chain activity, suggesting that TERT expression is important for mitochondria 
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function (Haendeler et al., 2009). Haendeler et al., (2009) identified that TERT can bind to 
mitochondrial DNA, particularly to ND1 and ND2 genes, hypothesising that this mechanism 
could contribute to reduced ROS production (Haendeler et al., 2009). However, the 
mechanisms underlying the potential protective role of telomerase against oxidative stress 
are still largely unknown. 
In summary, telomerase has been proposed to have multiple functions, which seem to vary 
depending on its location, presence of the different components of telomerase, telomerase 
activity and possibly, cellular, and organismal context. Telomerase non-canonical functions 
have been revealed to be quite intricate and complex, and therefore the mechanisms 
associated with these functions are still largely unknown. Despite this, continuous efforts 
have been made to uncover the complex mechanisms underlying telomerase. 
 
1.3 Cellular senescence 
Most of the primary mechanisms driving ageing mentioned in section 1.2 have in common 
the accumulation of DNA damage. In response to DNA damage accumulation, the machinery 
of DNA damage response is activated, promoting mechanisms of repair (Ovadya & 
Krizhanovsky, 2014; Sahin & Depinho, 2010). These mechanisms are thought to trigger a 
cascade of events that culminate in p53-mediated activation of p21 or, when persistent, 
p16INK4a activation. p21 and p16INK4a are two major cyclin-dependent kinase (CDK) inhibitors 
(encoded by CDKN1A and CDKN2A, respectively) that act by repressing target genes required 
for S-phase onset, leading to cell-cycle arrest (van Deursen, 2014). When a cell loses its 
division capacity in response to DNA damage, it can either enter apoptosis (programmed cell-
death), mediated by P53 upregulated modulator of apoptosis (PUMA; Roos & Kaina 2006), or 
enter a senescence state, through a still not fully understood process mediated by p53, P21 
and p16INK4a (e.g. Xue et al. 2007; Coppé et al. 2008; for review, see: van Deursen 2014). 
The term senescence and, more specifically, “replicative senescence”, was first introduced 
by Hayflick when it was described that in vitro cultured human fibroblasts undergo a finite 
number of cell divisions (about 50 replications), after which they enter a non-proliferative 
state (Hayflick, 1965; Hayflick & Moorhead, 1961). Later, Bodnar and colleagues determined 
that replicative senescence is associated with telomere shortening (Bodnar et al., 1998). It is 
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thought that when telomeres reach a certain limit (established as 12.8 repeats of TTAGGG in 
human cells, Capper et al. 2007) termed the Hayflick limit, DDRs are elicited, leading to cell-
cycle arrest. Depending on the cell type and model organismal, this may lead to senescence 
(Allsopp & Harley, 1995). Nonetheless, apart from telomere dysfunction that can lead to 
replicative senescence, there are other stimuli capable of inducing cellular senescence. For 
example, high levels of DNA damage and/or ROS can lead to stress-induced senescence and 
activated oncogenes can trigger oncogene-induced senescence (Campisi & d’Adda di Fagagna, 
2007; van Deursen, 2014) (Fig 1.2A). 
Today, senescent cells are known as non-proliferative but metabolically active cells (Coppé 
et al., 2008), that are resistant to apoptosis (Ryu et al., 2007). Additionally, senescent cells 
have been described to release the so-called senescence-associated secretory phenotype 
(SASP) (Coppé et al., 2008), which includes multiple pro-inflammatory cytokines, such as 
Interleukin-6 (IL-6); chemokines, such as Interleukin-8 (IL-8), Monocyte Chemoattractant 
Protein-2 (MCP-2), and Macrophage Inflammatory Protein-3 (MIP-3a); growth factors, such 
as Growth Regulated Oncogene (GRO), Hepatocyte Growth Factor (HGF) and Insulin-like 
Growth Factor-Binding Protein (IGFBP); and tissue remodelling factors such as matrix 
metalloproteinases (MMP-1, -3, -12) (Coppé et al. 2008; Campisi & d’Adda di Fagagna 2007; 
Ohtani & Hara 2013) (Fig 1.2B). Importantly, the presence of elevated levels of SASP, released 
by senescent cells themselves, can induce cellular senescence in the surrounding cells, by 
paracrine senescence (Acosta et al., 2013). 
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A) Causes B) Consequences 
 
 
Fig 1.2. Diagram illustrating putative causes and consequences of DNA damage accumulation with 
ageing. a) Both exogenous (i.e. radiation and chemicals) and endogenous (i.e. DNA damage, 
telomere dysfunction, and ROS) stresses lead to an accumulation of DNA damage that triggers DNA 
damage responses. b) DNA damage responses activate a cascade of events that culminate in p53-
mediated activation p21 and activation of p16INK4a and promote cell-cycle arrest. When a cell loses 
its proliferative ability, it can either enter in apoptosis, through p53-mediated PUMA activation, or 
enter in a senescent state, mediated by p53-p21 and p16INK4a. Senescent cells secrete several 
cytokines, chemokines, and growth factors (SASP), which impairs tissue homeostasis, promotes 
inflammation and contributes to tissue degeneration.  
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Giving senescent cells’ inability to proliferate, they were first considered to be a protective 
mechanism, by acting as tumour suppressors (Serrano et al., 1997). However, more recently 
it has been shown that, probably due to the different characteristics of the SASP phenotype 
(Coppé et al., 2010; Pérez-Mancera et al., 2014), accumulation of senescent cells can also 
contribute to tissue degeneration (Ovadya & Krizhanovsky, 2014). 
 
1.3.1 From cellular senescence to inflammageing 
Senescent cells play important roles in tissue repair (Krizhanovsky et al., 2008), wound 
healing (Demaria et al., 2014) and tumour suppression (Serrano et al., 1997). For example, 
hepatic stellate cells proliferate in response to liver damage (fibrosis) and eventually enter 
senescence, locating along the fibrotic scar. Senescence in these cells triggers a mechanism 
of immune clearance, part of the immunosurveillance phenomenon, recruiting natural killer 
cells which eliminate the senescent cells and contribute to tissue repair (Krizhanovsky et al., 
2008). Additionally, the presence of senescent cells at the wound site seems to be important 
for fin regeneration after amputation, in adult zebrafish (Da et al., 2019). Demaria et al. (2014) 
have also described a transient increase in senescent cells in wound healing, particularly at 
the wound site, in the days following an injury, in mice (Demaria et al., 2014). In this context, 
the SASP factor Platelet-derived growth factor-AA (PDGF-AA) was identified to be crucial to 
promote the repair mechanism which, in turn, is delayed in the absence of senescent cells 
(Demaria et al., 2014). Furthermore, senescent pre-malignant hepatocytes secrete 
chemokines and cytokines that can recruit immune cells and promote their clearance from 
the tissue, through a T-cell mediated process (Kang et al., 2011), which was shown to play an 
important role in tumour suppression (Sagiv & Krizhanovsky, 2013). There is also evidence 
suggesting that a similar tumour suppression mechanism can also occur in liver carcinoma in 
both mice (Xue et al. 2007) and humans (Kang et al., 2011).  
These studies suggest that, at least some types of senescent cells, in some contexts, can 
be cleared by the immune system, contributing to tissue repair and homeostasis. However, 
senescent cells have been reported to accumulate with ageing in different tissues of different 
organisms, including humans (Dimri et al., 1995), primates (Jeyapalan, 2007), rodents (Wang 
et al., 2009) and zebrafish (Carneiro et al., 2016; Henriques et al., 2013). On one hand, this 
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accumulation of senescence in old organisms suggests that there is a greater number of cells 
that are becoming senescent with ageing, possibly due to defects in DNA repair and/or SASP-
factors released by surrounding cells. On the other hand, accumulation of senescent cells with 
ageing may also suggest that they are not being efficiently cleared from aged tissues. This is 
important because persistent accumulation of senescent cells with ageing can contribute to 
tissue degeneration and disease in at least two manners: (1) in a cell autonomous manner, by 
hampering cell proliferation, which contributes to the impairment of tissue homeostasis; and 
(2) in a non-cell-autonomous manner, through SASP, by contributing to a sterile, low-level 
inflammatory state, termed ‘inflammageing’ (Franceschi & Campisi, 2014; Tchkonia et al. 
2013; Freund et al. 2010; Campisi & d’Adda di Fagagna 2007). Inflammageing characterises 
aged tissues and underlies multiple diseases of ageing (Ovadya & Krizhanovsky, 2014; van 
Deursen, 2014) (Fig 1.2B). 
Accordingly, the accumulation of senescent cells seems to be associated with many age-
related diseases. In humans, senescent cells’ accumulation has been identified in patients 
with cataracts, osteoporosis, cancer (Ovadya & Krizhanovsky, 2014), type 2 diabetes, 
glaucoma (Jeck et al., 2012), idiopathic pulmonary fibrosis (IPF) (Schafer et al., 2017), 
atherosclerosis (Childs et al., 2016), liver cirrhosis (Wiemann et al., 2019), Alzheimer’s disease 
(AD) (Lukens et al., 2009) and Amyotrophic Lateral Sclerosis (ALS) (Salech et al., 2017). This is 
not human specific, as animal models also show an association between accumulation of 
cellular senescence and disease. For example, in mice, accumulation of senescent cells is 
associated with cachexia, lipodystrophy, kidney and cardiac dysfunction, cancer (Baker et al., 
2016), tau-hyperphosphorylation in the brain and cognitive impairment (Bussian et al., 2018). 
In zebrafish, telomere dysfunction-induced senescence has been associated with sarcopenia, 
cachexia, infection, cancer and infertility (Carneiro et al., 2016; Henriques et al., 2013). 
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Importantly, recent ground-breaking studies in mice showed that clearance of senescent 
cells (by inducing apoptosis specifically in p16-expressing cells) ameliorates multiple 
age-related phenotypes and increases lifespan. More specifically, clearance of senescent cells 
in mice attenuated the appearance of lipodystrophy, glomerulosclerosis, kidney deterioration, 
cardiomyocyte hypertrophy and locomotion impairment, typically observed in aged mice 
(Baker et al., 2008, 2016; Bussian et al., 2018). This provided the first proof-principle evidence 
that senescent cells can cause disease, highlighting senescence as an important therapeutic 
target for multiple chronic diseases of ageing. Reinforcing this, initial phases of clinical trials 
now show that clearance of senescent cells in humans, using senolytics (drugs that selectively 
destroy senescent cells by promoting apoptosis of senescent cells), may also have positive 
effects. Treatment with Dasatinib and Quercetin (DQ) (3 days/week for 3 weeks) in a cohort 
of 14 patients with idiopathic pulmonary fibrosis (IPF) significantly ameliorated the physical 
function of the patients, improving their walking distance, pacing speed and chair-stands 
capacity (Justice et al., 2019). Moreover, a 3-day treatment with DQ in 9 patients with diabetic 
kidney disease, led to decreased number of macrophages and crown-like structures in 
adipose tissue, characteristics of patients with diabetes and obesity (Hickson et al., 2019). 
Despite these benefits, possible side effects of these treatments are still being explored. This 
is important, not only due to safety and toxicity issues but also because oral treatments are 
likely to affect non-target tissues as well, with unknown consequences. For example, Justice 
et al. (2019) reported that during treatment patients often presented cough, tiredness, 
nausea and headaches (Justice et al., 2019). Therefore, it is important to better understand 
the potential side effects of senolytic treatments and to explore alternative, more targeted 
therapies, to prevent or alleviate the accumulation of cellular senescence with ageing. 
 
1.3.2 Markers of cellular senescence 
Given the complex and heterogeneous profile of senescent cells, there is not a universal 
marker that can identify senescent cells. Because of this, cellular senescence is usually 
identified by a combination of markers.  
SA-β-Gal is the most widely used marker of cellular senescence and it is defined as 
Senescence Associated β-galactosidase (SA-β-Gal) activity detected specifically at suboptimal 
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pH 6.0  (Dimri et al., 1995). SA-β-Gal activity is thought to result from increased lysosomal β-
D-galactosidase expression, encoded by the GLB1 gene. Although β-D-galactosidase 
expression is normally detected at optimal pH 4 – 4.5 in non-senescent cells, its activity can 
be detected at suboptimal pH 6.0 (called SA-β-Gal) specifically in senescent cells (Lee et al., 
2006). Increased SA-β-Gal activity in senescent cells is therefore likely due to an enlargement 
of the lysosomal compartment or increased lysosomal activity (Lee et al., 2006). However, SA-
β-Gal staining presents some limitations as it can also be detected in other conditions, 
including in quiescent cells, immortalised cells, cells exposed to hydrogen peroxide (H2O2), 
and cells under serum starvation (Severino et al., 2000; Yang & Hu, 2005). Additionally, SA-β-
Gal activity can also be transiently expressed by activated immune cells, particularly by pro-
inflammatory macrophages, which can lead to a false-positive signal (Hall et al., 2017). Hence, 
SA-β-Gal activity should only be used as a marker of cellular senescence when in combination 
with other markers.  
Other markers of senescence include accumulation of DNA damage, commonly assessed 
by γH2AX foci (H2A histone family member X phosphorylated at serine 139), and consequent 
DDRs. DDR can include increased expression of p53, p21, and/or p16, together with hypo-
phosphorylated retinoblastoma protein (RB) and hyper-phosphorylated ataxia telangiectasia 
mutated (ATM) (Hernandez-Segura et al., 2017; Hernandez-Segura et al., 2018). Being non-
proliferative cells, resistant to apoptosis, senescent cells are also identified by the absence of 
proliferative (i.e. 5-BRomoDeoxyUridine, BrdU, and/or Proliferating Cell Nuclear Antigen, 
PCNA) and apoptosis markers (i.e. PUMA). Being metabolically active, senescent cells may 
also be detected by the presence of SASP-associated cytokines, chemokines, and growth 
factors. These can include IL6, IL8, MCP-2, MMP-1, MMP-3, MMP-12, IGFBP, among others 
(Coppé et al. 2008; Campisi & d’Adda di Fagagna 2007; Ohtani & Hara 2013). Furthermore, 
senescent cells have shown to suffer morphological alterations, including enlarged size, loss 
of LaminB1, appearance of cytoplasmatic chromatin fragments, changes in plasma 
membrane’s composition and increased production of ROS (Hernandez-Segura et al., 2017, 
2018). Thus, in an ideal scenario, these are additional markers that should be used to 
characterise cellular senescence. 
However, it is important to note that not all senescent cells will express all the markers 
above mentioned. This depends on the type of senescence (i.e. replicative senescence, stress-
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induced senescence, oncogene-induced senescence) as well as on the type of cells (i.e. 
fibroblasts, melanocytes). It is therefore important to stress that cellular senescence should 
be assessed by using a combination of markers. Nonetheless, it is often technically challenging 
or impossible to test all these markers in the same cell. 
 
1.4 Accumulation of senescence with ageing in high versus low proliferative tissues 
Interestingly, it has been reported that senescent cells accumulate with ageing in a time- 
and tissue-dependent manner (Carneiro et al., 2016; Henriques et al., 2013; Krishnamurthy 
et al., 2004). In rodents, it was shown that the duodenum, the kidney and the gonads are the 
tissues accumulating higher levels of senescence with ageing, assessed by p16 mRNA 
expression (from 2.5 to 26 months of age) (Krishnamurthy et al., 2004). Apart from the 
intestine and kidney, a more recent study also showed high accumulation of senescence in 
inguinal fat, liver, pancreas and spleen of aged mice (>30 months of age), characterised by 
elevated levels of p21 and p16 (Yousefzadeh et al., 2020). Similarly, zebrafish was reported to 
accumulate higher levels of cellular senescence, assessed by γH2AX and SA-β-Gal expression, 
in the kidney marrow, gut and gonads (from 3 to 24 months of age) (Carneiro et al., 2016).  
Note that these are mainly high proliferative tissues. As tissues with high cell turnover 
present accelerated telomere erosion (Bodnar et al., 1998; Lee et al., 1998), they are more 
likely to accumulate replicative senescence over-time. Indeed, using the zebrafish premature 
ageing model tert-/-, Henriques et al. (2013) showed that accumulation of senescence in the 
kidney marrow, gut and gonads occurs earlier and in greater level than in the muscle, a low 
proliferative tissue (3-6 compared with 12 months of age) (Henriques et al., 2013). Thus, this 
time- and tissue-dependent accumulation of senescent cells with ageing is likely influenced 
by the proliferative rates of the tissues, given that cell turnover leads to telomere shortening.  
 
1.4.1 Accumulation of senescence in the aged gut 
Early accumulation of critically short telomeres have been identified in high proliferative 
tissues such as the gut, in a tert knockout mice model (Lee et al., 1998). In agreement with 
this, more recent studies in zebrafish have reported that the gut is one of the first organs to 
accumulate extremely short telomeres, senescent cells and inflammation, with ageing 
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(Carneiro et al., 2016). Like in mice (Lee et al., 1998), this accumulation in zebrafish is 
anticipated and exacerbated in the absence of telomerase (Henriques et al., 2013), suggesting 
that telomerase restriction and consequent telomere shortening (an already mentioned 
hallmark of ageing) are important mechanisms driving this process. Since accumulation of 
senescence was shown to be associated with telomere shortening, aggravated in the absence 
of telomerase, this is likely to be replicative senescence.  
These observations are in accordance with the concept of the gut as a ‘motor’ for multiple 
organ failure, first suggested in the late eighties. This hypothesis proposed that changes in 
the microbiota and/or the translocation of organisms through the gut barrier can contribute 
to the development of systemic infection (Marshall et al., 1988). Nowadays, there is evidence 
suggesting that the gut plays an important role in the pathogenesis and progression of 
systemic inflammation, which can lead to multiple organ failure and eventually death (de Jong 
et al., 2016). Accordingly, gut barrier permeability has been shown to increase with ageing in 
drosophila and zebrafish, and to be a good predictor of mortality, surpassing chronological 
age (Dambroise et al., 2016; Rera et al., 2012).  
 
1.4.2 Accumulation of senescence in the aged central nervous system (CNS) 
Despite being considered a predominantly non-dividing, post-mitotic tissue, growing 
evidence now shows that the CNS also accumulates cellular senescence with ageing. Indeed, 
some markers of senescence have been identified in the ageing brain and eye, in both  mice 
and zebrafish (Arslan-Ergul et al. 2016; Baker et al., 2008; Jurk et al., 2012; Kishi et al., 2008; 
Van Houcke et al., 2019). Moreover, this phenomenon does not seem to be limited to the 
brain or the eye, as cellular senescence has also been reported in the mice peripheral nervous 
system (Jurk et al., 2012) and in the zebrafish spinal cord, with ageing (Kishi et al., 2008).  
However, most of these studies did not assess multiple markers of senescence. Particularly 
Van et al. (2019) and Kishi et al. (2008), only measured SA-β-Gal in the zebrafish retina and 
spinal cord (Kishi et al., 2008; Van Houcke et al., 2019). Therefore, the knowledge about the 




1.4.2.1 Senescence in the aged retina 
Markers of senescence have been detected in the eye, with ageing. More specifically, 
increased expression of p16 has been reported in the eye of the progeroid mouse model 
(bubr1-/-) (Baker et al., 2008), and increased SA-β-Gal expression has been identified in the 
retina of old zebrafish (Van Houcke et al., 2019). 
It has been suggested that a specific region of the retina accumulates senescence with 
ageing – the retinal pigment epithelium (RPE). In culture, human RPE cells from a child donor 
underwent senescence over-time, displaying decreased cell proliferation and increased levels 
of SA-β-Gal (Matsunaga et al., 1999). Adult RPE cells (ARPE-19 line), in culture, were also 
shown to acquire elevated levels of DNA damage when exposed to concentrated N-
retinylidene-N-retinylethanolamine (A2E) (Wang et al., 2018), a well-described constituent of 
lipofuscin in the RPE (Sparrow et al., 2003). Supporting the idea that cellular senescence may 
also occur in vivo, a 40 years old study has reported elevated levels of lipofuscin with ageing, 
in the human RPE (Wing et al., 1978). Studies in animal models also corroborate this idea, 
since A2E and lipofuscin have been reported to increase with ageing in the RPE of mice (Boyer 
et al., 2012), and accumulation of SA-β-Gal has been detected in the RPE of old primates 
(Mishima et al., 1999). Similarly, it was recently shown accumulation of SA-β-Gal in the aged 
zebrafish retina, particularly in the RPE (Van Houcke et al., 2019). 
RPE is a layer of epithelial cells that, among other functions, has a crucial role in 
maintaining the integrity of the photoreceptors (J. Marshall, 1987; Nian & Lo, 2019; Salvi et 
al., 2006). Nonetheless, these cells are known to undergo degeneration with ageing, 
displaying morphological alterations and increased apoptosis, in both mice and humans (Majji 
et al., 2000; Priore et al., 2002). It is now thought that accumulation of cellular senescence in 
the RPE can lead to degeneration of these cells, which in turn affect the integrity of the 
photoreceptors (Holz et al., 2001). As degeneration of the RPE is a hallmark of age-related 
macular disease (AMD), a retinal disease that can lead to vision impairment or even vision 
loss, it has been postulated that accumulation of senescence in the RPE can be part of the 
etiology of this disease (Holz et al., 2001; Kozlowski, 2012; Blasiak, 2020). Nonetheless, further 
investigation is required to confirm whether accumulation of senescence with ageing can lead 
to visual impairment and/ or AMD. 
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Furthermore, other parts of the retina are known to undergo degeneration with ageing. 
Indeed, human retinal ageing affects several cell populations, being characterised by overall 
thinning of the retina (Eriksson & Alm, 2009), degeneration and death of photoreceptors 
(Nian & Lo, 2019), as well as neuronal loss (Aggarwal et al., 2007; Gao & Hollyfield, 1992; Nian 
& Lo, 2019). It remains unknown whether other cell populations of the retina, apart from the 
RPE, undergo senescence over-time and whether it contributes to overall retina degeneration 
and visual impairment with ageing. 
 
1.4.2.2 Senescence in the aged brain 
With ageing, elevated levels of DNA damage (Baltanás et al., 2011; S. Zhu & Coffman, 2017) 
and SA-β-Gal (Arslan-Ergul et al., 2016; Jurk et al., 2012) have been identified in the mice and 
zebrafish brains. In addition, increased expression of CDKi, such as p21 and p16, and SASP 
factors, such as Insulin-like growth factor 1 (IGF1) and IL6, have been observed in the mice 
aged brain (Jurk et al., 2012). Importantly, this is not limited to animal models, as senescence-
associated markers have also been reported in human neurodegenerative diseases. In 
particular, increased levels of DNA damage checkpoints such as p53, p21 and p16, as well as 
SASP factors have been observed in the spinal cord and brain of patients with ALS (De Felice 
et al., 2014) and AD (Bhat et al., 2012), respectively. Hence, the literature shows that despite 
being a low proliferative tissue, the CNS accumulates senescence, and that this may be 
associated with brain diseases of ageing. Causality between senescence and 
neurodegenerative diseases has not yet been established in human. However, mice models 
where senescent cells have been cleared (Bussian et al., 2018) show an improve of the 
cognitive decline in aged mice, suggesting that senescence can actively contribute to it. It 
remains to be determined which cell populations undergo senescence in natural ageing, in 
the CNS, and what type of senescence this is, i.e. replicative, telomere-dependent or stress-
induced senescence. 
It has been reported that several cell populations in the CNS can undergo senescence, 
depending on the context. Neural stem cells (NSCs) and neural progenitor cells (NPCs) have 
been shown to undergo stress-induced senescence when exposed to ionized radiation, 
characterised by increased SA-β-Gal (Mason, 2012) and p16 expression (Le et al., 2018). 
Endothelial cells and pericytes, two major components of the blood brain barrier (BBB), have 
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also been reported to undergo senescence with ageing in mice, in vitro and in vivo, expressing 
elevated levels of p16, p21 and SA-β-Gal (Yamazaki et al., 2016).  
Microglia, specialised immune cells of the CNS, seem to undergo replicative senescence, 
in vitro and in vivo (Flanary & Streit, 2004; Raj et al., 2015). In vivo, this was demonstrated in 
a progeroid mice model where microglia displays short telomeres and modest increased 
expression of p21 and SASP-factors (Raj et al., 2015). Moreover, a mouse model of tau-
dependent neurodegenerative disease (MAPTP301SPS19) was shown to display senescence-
associated markers, in comparison with age matched WT (Bussian et al., 2018), suggesting 
that senescence in aged microglia might be associated with tau-associated disease. Astrocytes, 
the most abundant glial cell in the CNS, also seem to undergo stress-induced senescence, in 
humans (Crowe et al., 2016; Mason, 2012), exhibiting high levels of SASP factors when 
exposed to irradiation (Mason, 2012), as well as SA-β-gal activity, increased expression of DNA 
damage checkpoints (Bitto et al., 2010) and SASP-factors (Crowe et al., 2016), when exposed 
to H2O2. However, in vitro studies have reported controversial results regarding whether 
these cells also undergo replicative senescence. Whilst Flanary & Streit (2004) did not identify 
replicative senescence in rat astrocytes (Flanary & Streit, 2004), another two studies reported 
that astrocytes from humans (Evans et al., 2003), mice and rats undergo replicative 
senescence (Evans et al., 2003). Oligodendrocytes are the glial cells responsible for producing 
the sheath of myelin around the neuronal axons. Post-mortem studies have reported 
increased DNA damage in the white matter, together with oxidative damage and SA-β-Gal in 
this cell population (Nasrabady et al., 2018).  
Surprisingly, neurons, considered largely non-proliferative cells, have also been reported 
to undergo senescence. Le et al. showed increased expression of p16 in the hippocampus, 
sub-ventricular zone (SVZ) and cortex of mice, after irradiation (Le et al., 2018).  Similarly, 
cortical neurons and Purkinje neurons of aged mice present DNA damage, SA-β-Gal and SASP 
factors. Curiously, myenteric ganglia also undergoes senescence in the aged mice, presenting 
DNA damage, together with activated P38MAPK p38 mitogen-activated protein kinases 
(p38MAPK), SA-β-Gal and ROS (Jurk et al., 2012). 
Together, the literature shows that great part of the cell populations in the CNS undergoes 
senescence and, despite being a low-proliferative tissue, some of them even undergo 
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replicative senescence. This raises the question of whether there is evidence for telomere 
shortening and/or telomerase deficiency in the ageing CNS. 
 
1.4.3 Potential association between cellular senescence, telomere shortening and 
decreased telomerase expression in the ageing CNS 
1.4.3.1 Telomerase, telomere shortening and senescence in the aged retina 
RPE cells display the shortest telomeres within the cell populations occupying the neural 
retina (Desgarnier et al., 2016). However, it is still unclear whether this is due to a higher cell 
turnover or due to stress-induced damage that can lead to fast telomere erosion.  
Cells from the RPE have been shown to undergo replicative senescence, at least in culture. 
After 57-58 passages, RPE cells from a 1-year old donor displayed critically short telomeres 
and elevated expression of SA-β-Gal (Matsunaga et al., 1999). It is important to note that 
these observations were from cells derived from one single donor, and therefore may not be 
representative of the population. Despite the limitations, these observations might be 
surprising as RPE cells are generally considered to be quiescent. Actually, it is thought that 
the mammalian retina lacks proliferative capacity (Jadhav et al., 2009; Ooto et al., 2004). 
Despite this, a few studies have suggested that there is a population of peripheral RPE cells, 
in mice, that retain their proliferative capacity throughout life and that are able to migrate to 
the central retina (Kokkinopoulos et al., 2011). Additionally, Salero et al. (2012) reported the 
existence of RPE stem cells (RPESCs), capable of dividing and differentiating, in human cell 
cultures (Salero et al., 2012). However, it is still unclear whether peripheral RPE cells and/ or 
RPESCs are able to replace dying RPE in the central retina. Moreover, it remains unclear 
whether a subpopulation of dividing RPE cells undergo replicative senescence with ageing, in 
vivo. 
Furthermore, RPE cells have been reported to undergo stress-induced senescence. For 
example, exposure to cigarette smoke was shown to lead to increased ROS and accumulation 
of senescence (increased DNA damage, SA-β-Gal, p21, p16, and SASP factors), in a human RPE 
cell line (ARPE-19). The same cell line displayed increased levels of IL6, IL8 and vascular 
endothelial growth factor (VEGF) after exposure to H2O2. (Marazita et al., 2016). Additionally, 
in a cell culture of human RPE cells, photosensitisation to A2E was shown to lead to 
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accumulation of senescence, characterised by increased levels d DNA damage, accompanied 
by telomere shortening (Sparrow et al., 2003). Interestingly, a parallel study has showed that 
telomerase over-expression rescued A2E-induced cellular senescence in human RPE cells 
(Wang et al., 2018). This suggests that somehow telomerase may play a protective role 
against accumulation of senescence in the RPE layer of the retina. It remains unclear whether 
this potential protective role is associated with telomerase canonical or non-canonical 
functions. 
One of the functions of the RPE cells is to phagocytose the discs of the photoreceptors’ 
outer segment, when they start detaching. However, with ageing, the ability of degrading cell 
debris decreases and therefore the RPE cells tend to accumulate phagosome contents over-
time. This is thought to lead to the accumulation of lipofuscin and oxidative stress in this cell 
population (Marshall, 1987; Nian & Lo, 2019; Salvi et al., 2006). Since there is accumulation 
of A2E and lipofuscin in the ageing mammalian RPE (Wing et al., 1978; Boyer et al., 2012) and 
that increased levels of A2E can contribute to accumulation of senescence (Sparrow et al., 
2003), it is plausible to hypothesise that accumulation of lipofuscin and oxidative stress in the 
RPE cells, with ageing, can lead to cellular senescence. 
Hence, it is still unclear whether accumulation of senescence in the aged retina is 
associated with increased lipofuscin and oxidative stress (i.e stress-induced senescence) or 
whether telomere shortening can also contribute for it (i.e. replicative senescence). 
Independently of this, telomerase may be important to prevent accumulation of cellular 
senescence in the ageing retina, as its over-expression was shown to reduce senescence in 
response to A2E (Wang et al., 2018). Supporting this, clinical trials have shown that 
telomerase reactivation alleviates the symptoms of AMD (Dow & Harley, 2016; Rowe-
Rendleman & Randolph, 2004). This suggests that expression of telomerase may play a 
protective role against retina degeneration. Accordingly, the telomerase mutant zebrafish 
model (tert-/-) has been reported to present accelerated retina thinning, in comparison to WT 
siblings (Anchelin et al., 2013). Therefore, telomerase seems to be important to maintain 
retina’s health; however, the mechanisms underlying this remain unclear. 
This encourages additional study to test whether telomerase expression has a protective 
effect against retina degeneration with ageing and consequent visual impairment, and what 
functions of telomerase (i.e. canonical versus non-canonical) are involved on this. This is 
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important because uncovering the mechanisms underlying retina degeneration would allow 
to find new therapeutic targets to prevent and/or delay vision impairment with ageing.  
 
1.4.3.2 Telomerase, telomere shortening and senescence in the aged brain 
Telomere shortening has been identified in the brain, in human ageing, particularly in the 
cerebral white matter after the age of 60 (Nakamura et al., 2007). Similarly, there is telomere 
shortening with ageing in the mice (at 26 months) (Ain et al., 2018) and zebrafish brains (at 
26-32.5 months) (Arslan-Ergul et al., 2016). As expected, telomere shortening with ageing 
occurs in an environment with really low levels of telomerase, which are not enough to 
prevent telomere erosion. In mice, there is a dramatic decrease in telomerase activity after 
the first postnatal week, being its activity in adulthood almost restricted to the SVZ and 
olfactory bulb (OB) (Caporaso et al., 2003). In zebrafish, there is an increase in telomerase 
expression in the brain and eye until 6-months of age, followed by a dramatic decrease until 
30-months of age (Anchelin et al., 2011).  
In humans, contrary to rodents and fish (Caporaso et al., 2003; Anchelin et al., 2011), 
telomerase expression in the brain does not seem to decrease with ageing (Allsopp et al., 
1995). Nonetheless, it is important to take into account that the levels of telomerase are 
already very low from birth (Allsopp et al., 1995), and therefore any further changes in the 
levels of telomerase may be under the limits of detection. Nonetheless, it was shown that 
patients with ALS display lower telomerase expression when compared with age-matched 
controls (De Felice et al., 2014), suggesting once again that low expression of telomerase may 
be associated with age-associated brain disorders. Importantly, low expression of telomerase 
has reported to be associated with accumulation of senescent-associated markers, as patients 
with ALS present higher levels of p53 and p21 in the spinal cord when compared with healthy 
age-matched controls (De Felice et al., 2014). Hence, low levels of telomerase and consequent 
telomere shortening may contribute to age-associated brain disorders by promoting 
senescence. Nonetheless, it remains unknown whether the potential impact of telomerase 
on aged-associated brain diseases is telomere-dependent, since patients with Parkinson’s 
disease (PD) (Hudson et al., 2011), ALS (Linkus et al., 2016) and AD (Lukens et al., 2009) do 




Importantly, growing evidence in animal models now support that telomerase may play a 
protective role against senescence accumulation in the aged brain. This evidence comes 
mainly from telomerase-deficient animal models. For example, 4th generation (G4) of 
telomerase-deficient mice models lacking specifically the TERC component of telomerase 
(Terc-/-), display accelerated telomere shortening and increased levels of senescence-
associated markers in Purkinje neurons, cortical neurons (Jurk et al., 2012) and microglia (Raj 
et al., 2015), when compared with Terc+/+  siblings.  Furthermore, an ALS mouse model that 
lacks expression of TERC (Terc-/-; SOD1G93A) has accelerated onset of ALS phenotypes and 
dies prematurely (Linkus et al., 2016). These studies suggest that the TERC component of 
telomerase can exert a protective role against accumulation of senescence in the aged brain 
and, possibly, a protective role against neurodegenerative diseases. It remains unknown 
whether this is a specific function of TERC or whether lack of TERT would also accelerate 
senescence accumulation in ageing. Jaskelioff et al., (2011) has shown that the G4 TERT-ER 
mouse model (in a Tert-/- background), lacking specifically the TERT component of telomerase, 
displays decreased levels of proliferation and increased expression of p53 when compared to 
Tert+/+ siblings. This is a knock-in mouse model that reactivates ectopic TERT expression in the 
whole body, upon addition of 4-hydroxytamoxifen (4-OHT). After TERT reactivation, 
proliferative capacity is rescued and levels of p53 decrease, reinforcing the idea that TERT 
plays an important role in the brain (Jaskelioff et al., 2011). Further supporting evidence 
comes from showing that transient TERT activation is sufficient to delay the onset and 
progression of ALS disease in a mouse model. This was observed in the SOD1 transgenic 
mouse model, a model that has a mutation in the Cu/Zn Superoxide Dismutase 1 gene, like 
around 20% of the cases of familial ALS (Eitan et al., 2012). Together, these studies suggest 
TERT may have important functions in the brain, by promoting cell proliferation and survival, 
and by delaying neurodegenerative diseases.  
This encourages further investigation to determine TERT expression can prevent and/or 
delay senescence accumulation in the brain and, if so, which mechanisms are responsible for 
this. More specifically, it would be important to test whether protective functions of TERT are 
telomere dependent (i.e. canonical functions) or telomere independent (i.e. non-canonical 
function), and whether lack of TERT can drive brain diseases of ageing. It is relevant to test 
this because understanding the mechanisms underlying brain ageing would open new lines 
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of investigation aiming to find therapeutic approaches to promote healthy ageing and 
ameliorate quality of life in the elderly. 
 
1.5 Zebrafish as a research model of ageing 
Zebrafish (Danio rerio) is a freshwater teleost fish from the Cyprinidae family (Spence et 
al., 2008), originally from South Asia (Sterba, 1962). In the wild, zebrafish abundantly inhabits 
ditches, ponds and shallow lakes (Spence et al., 2006), with warm (26-31 ºC), clear (visibility 
up to 30 cm), shallow (1-100 cm depth), slow-moving waters (Spence et al., 2006). Zebrafish 
is also described as a gregarious species, living in shoals of <12 to >300 fish in its natural 
environment (Suriyampola et al., 2016).  
Since George Streisinger brought, for the first time, zebrafish into the laboratory in the 70’s 
(reported in Clarck, 1981), this species has become a popular research model. This is mainly 
due to their favourable embryologic and genetic features. Zebrafish have large number of 
offspring (>100 eggs) and can reproduce all year round. Danio rerio present a fast growth, as 
it is close to full development by the 5th day post-fertilisation (dpf) and reaches adulthood 
(sexual maturity) at 3 months of age. This, together with their small size (2-4cm long), makes 
them a cost-effective species to house. Additionally, the zebrafish genome has been entirely 
mapped and it presents a great similarity with human genome – 71% of the protein-coding 
human genes have orthologs in the zebrafish genome (Howe et al., 2013; Sassen & Köster, 
2015), and there are now several sophisticated genetic tools available to zebrafish. Moreover, 
besides external embryo development, the zebrafish larvae are transparent until the 5th day 
post-fertilization, making it an exceptional model for live imaging.  
Regarding the mechanisms of ageing, zebrafish was shown to present human-like 
telomeres size (6-15 bk) and to require telomerase expression to maintain a healthy lifespan 
(Anchelin et al., 2013; Carneiro et al., 2016; Henriques et al., 2013). G1 telomerase-deficient 
zebrafish is reported to develop age-related phenotypes and die prematurely, with a half-life 
3x shorter (c.12 months) than WT siblings (c.30 months) (Anchelin et al., 2013; Carneiro et al., 
2016; Henriques et al., 2013). This contrasts with the most commonly used laboratory mice 
(BALB/c or C57BL/6) that have 5- to 10-times longer telomeres (around 40-60 kb) than 
humans (Hemann & Greider, 2000) and require several consecutive inbred generations of 
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telomerase-deficient models, normally G4 to G6, until displaying accelerated development of 
age-related phenotypes and shorter lifespan (Ferron et al., 2009). Zebrafish is therefore an 
appropriate model to study telomere- and telomerase-dependent features of ageing. 
In this project, apart from the WT zebrafish, I also used the tert-/- model, a model of 
premature ageing (Henriques et al. 2013). Apart from the shorter lifespan already mentioned, 
this model develops a progressive accumulation of critically short telomeres, cellular 
senescence and inflammation over a relatively short period of time compared with the 
naturally ageing WT (3-6 months in the tert-/- versus 12-18 months in the WT) (Carneiro et al. 
2016). Hence, using the prematurely aged tert-/- model alongside with WT siblings provides a 
faster temporal analysis throughout the life course of the animal, allowing, at the same time, 
to uncover telomerase-dependent mechanisms. 
Importantly, and relevant for this project, accumulation of senescence in the ageing 
zebrafish does not seem to be confined to peripheric tissues, as the zebrafish retina and brain 
also seem to accumulate senescent-associated markers over-time. Moreover, SA-β-Gal 
expression was also reported in the aged zebrafish telencephalon, accompanied by telomere 
shortening and decreased proliferation levels (Arslan-Ergul et al., 2016), suggesting that the 
zebrafish brain may undergo replicative senescence with ageing. It remains unknown whether 
limited expression of telomerase plays a role in accumulation of senescence in the aged 
zebrafish brain and, if so, which mechanisms are associated with this.  
It is important to mention that the zebrafish retina presents a high regenerative capacity 
upon acute damage (Cameron, 2000; Richardson et al., 2017; Stenkamp, 2015). Nonetheless, 
it remains unclear what is the impact of this regenerative ability on ageing. If the zebrafish 
retina can regenerate until old age, then I would not expect that the zebrafish retina to 
degenerate with ageing. However, it was recently shown that the zebrafish retina undergoes 
neurodegeneration with ageing (Van Houcke et al., 2019). It remains unknown whether this 
degeneration is due to an impairment of its regenerative ability and whether telomerase, 
known to be essential for regeneration, is required to prevent and/or delay degeneration in 
the zebrafish retina. 
Together, this suggest that zebrafish is a useful model to further explore the role of 




1.6 Hypothesis and Aims 
In this project I aimed to test the following hypotheses:  
 
Hypothesis 1. “The zebrafish retina does not undergo degeneration with ageing due to Müller 
glia regenerative capacity, and this requires telomerase expression”. 
In order to test this hypothesis, this project has the following aims: 
Aim 1. Determine whether the zebrafish retina undergoes age-associated degeneration 
and whether this is accelerated in the absence of telomerase. 
Aim 2. Determine whether Müller glia maintain their regenerative capacity throughout the 
zebrafish lifespan. 
 
Hypothesis 2. “There is accumulation of cellular senescence with ageing, in the zebrafish brain, 
in a TERT-dependent manner”. 
In order to test this hypothesis, this project has the following aims: 
▪ Aim 1. Determine whether there is accumulation of cellular senescence in the 
naturally aged zebrafish brain. 
 
▪ Aim 2. Determine whether lack of TERT expression leads to an accelerated 
accumulation of senescence in the ageing zebrafish brain. 
 
 
Hypothesis 3. “Accumulation of TERT-dependent senescence in the aged zebrafish brain is 
associated with inflammation and impairment of tissue homeostasis”. 
In order to test this hypothesis, this project has the following aims: 
▪ Aim 1. Determine whether accumulation of TERT-dependent senescence in the 





▪ Aim 2. Identify potential TERT-dependent mechanisms of ageing in the zebrafish 
brain that might be involved in accumulation of senescence. 
 
 
Hypothesis 4. “TERT-dependent accumulation of senescence and inflammation in the aged 
gut (high proliferative tissue) precedes the brain (low proliferative tissue)”. 
In order to test this hypothesis, this project has the following aim: 
▪ Aim 1. Determine whether there is accumulation of senescence and inflammation 
in the naturally aged zebrafish gut, and whether this is accelerated in the absence 
of TERT  
 
▪ Aim 2. Determine whether accumulation of cellular senescence in the gut precedes 
the brain. 
 
These two aims were tested in the same animals used to test Hypothesis 2 and 3, 









2.1 General experimental design 
In this project, different tissues from the same fish were collected and/or analysed in 
parallel, for most of the experiments performed. For example, using paraffin sections of the 
whole fish allowed me to analyse the expression of several age-associated markers, by IF, in 
the retina, brain and gut of the same fish (Fig 2.1, Group 1). For different sets of experiments, 
I collected the brain and the gut from the same fish and processed the tissues in the same 
way in order to analyse other age-associated markers in both tissues. From one group of fish, 
brain and gut tissues were fixed, cryopreserved and cryosectioned to perform the SA-β-Gal 
assay (Fig 2.1, Group 2). From another two groups, brain and gut tissues were collected from 
same individuals, followed by RNA or protein extraction, to perform RT-qPCR and RNA 
Sequencing or enzymatic assays, respectively (Fig 2.1, Group 3 and 4). 
This approached allowed me to directly compare ageing-associated phenotypes in 
different tissues, particularly low and high proliferative tissues, in the same animal. Ultimately, 
this enabled to assess whether the ageing-associated markers analysed in this project differ 
in a tissue-dependent manner and whether some tissues age earlier than others. This was 
one of the aims of Chapter 6. At the same time, this type of approach contributed to a lower 









Fig 2.1. Schematic figure showing the experimental design of most of the experiments performed 
in this project. In this project, different organs of the same animals (retina, brain and gut) were 
used to perform most of the experiments. Each ‘Group’ illustrated here represent a set of fish used 
for one group of experiments. Each ‘Group’ therefore includes several WT and tert-/- fish, from 





2.2 Zebrafish  
2.2.1 Adult zebrafish husbandry 
All the experimental procedures were carried out in accordance with the UK legislation – 
Animals (Scientific Procedures) Act 1986 – under the Project License 70/8681 held by Dr 
Catarina M. Henriques and the Personal License I1395945C held by Raquel Martins. All adult 
zebrafish were housed in aquaria at the Bateson Centre, University of Sheffield, and 
maintained with a 14h-light and 10h-dark cycles, at 27-28°C. All tests involving zebrafish 
manipulation were approved beforehand through the submission and respective approval (by 
the aquarium manager) of an Individual Study Plan (ISP).  
 
2.2.2 Zebrafish lines 
The telomerase mutant line (tert hu3430) is available at the ZFIN repository (ZFIN ID: ZDB-
GENO-100412-50) and was first described by Henriques et al. (2013). Briefly, it consists of a 
point mutation in the second exon of the tert gene that leads to an early stop codon, 
preventing RNA translation and consequent protein formation. This line was generated by N-
Ethyl-N-nitrosourea (ENU) mutagenesis. For simplicity, the tert hu3430 homozygous mutants 
will be referred to as tert-/-. Due to the reduced infertility of the tert-/- zebrafish (Anchelin et 
al., 2013; Henriques et al., 2013) the telomerase-mutants used in this project derived from 
tert+/- in-crosses and all the fish used in this study are F1 animals.  
The mpeg.mcherry.caax line is an immune reporter line where macrophages/microglia 
express a fluorescent protein (mcherry) and therefore can be easily identified (Ellett et al., 
2011). This line was used in some experiments of this project in order to identify 
macrophages/microglia cells. For that, tert+/; mpeg.mcherry  progeny were incrossed to 
generate both tert+/+; mpeg.mcherry and tert-/-; mpeg.mcherry fish.  
Whenever possible, when comparing tert+/- and tert-/-, age-matched siblings were used. 
However, due to the limitation in numbers of fish at specific ages, occasionally age-matched 
non-siblings were used instead, including tert+/+ and tert-/- reporter lines. Moreover, WT AB, 
non-mutant fish, were used for later ages (>30 months), due to unavailability of old tert+/+ 




2.3 Immunohistochemistry (IHC) 
IHC was used to detect the expression of target proteins and respective spatial distribution 
in the brain and gut, throughout the adult zebrafish life. More specifically, I used IHC to detect 
specific cell populations within each tissue and to detect several senescence- and 
inflammation-associated markers. 
 
2.3.1 Tissue fixation and processing: paraffin-embedded sections 
Fish were culled by immersion in concentrated tricaine mesylate (MS-222, SIGMA-ALDRICH, 
St. Louis, MO, USA). After terminal anaesthesia, the animals were fixed by immersion in 50ml 
of 4% paraformaldehyde buffered at pH 7.0 (PFA, SIGMA-ALDRICH) at 4°C for 48-72h, and 
decalcified in 50ml of 0.5M Ethylenediaminetetraacetic acid (EDTA, SIGMA-ALDRICH), pH 8.0, 
for additional 48-72h. Then, the whole fish was paraffin-embedded in a series of formalin and 
ethanol washes, as follows: formalin (SIGMA-ALDRICH) for 10min, formalin (SIGMA-ALDRICH) 
for 50min, ethanol 50% for 1h, ethanol 70% for 1h, ethanol 95%  for 1h 30min, ethanol 100% 
for 2h, ethanol 100% for 2h 30min, 50:50 of ethanol 100% : xilol for 1h 30min, xylene (SIGMA-
ALDRICH) for 3h, xylene (SIGMA-ALDRICH) for 3h, paraffin for 3h and paraffin for 4h 30min. 
To do this, absolute ethanol (Thermo Fisher Scientific, Waltham, MA, USA) diluted in distilled 
water (dH2O, VWR International) and paraffin histosec pastilles (Merck & Co, Kenilworth, NJ, 
USA) were used. Paraffin-embedded fish were sectioned by the histology staff at the SkeletAL 
lab, at the Medical School of the University of Sheffield (tUoS), using a Leica TP 1020 cryostat, 
and stored at room temperature (RT). Unless otherwise stated, the tissue sections were 
longitudinal (sagittal) 4μm-thick slices. 
 
2.3.2 Standard immunofluorescence (IF) protocol 
In order to perform IF, paraffin-embedded slices were deparaffinised and hydrated 
through the following sequence of washes: histoclear (Scientific Laboratory Supplies, Wilford, 
Nottingham, UK) 2x 5min, ethanol 100% 2x 5min, ethanol 90% 5min, ethanol 70% 5min, and 
dH2O 2x 5min. For this, absolute ethanol (Thermo Fisher Scientific) was diluted in dH2O. After 
antigen retrieval in 0.01M citrate buffer at pH 6.0, made with Trisodium citrate dihydrate 
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(SIGMA-ALDRICH) – sub-boiling at 800W in a microwave for 10min –, the tissue sections were 
permeabilised in phosphate buffered saline (PBS, SIGMA-ALDRICH) 0.5% Triton X-100 
(SIGMA-ALDRICH, for 10min) and blocked in blocking solution for 1h. The blocking solution 
consisted in 3% bovine serum albumin (BSA, SIGMA-ALDRICH), 5% Goat Serum (or Donkey 
Serum, both from SIGMA-ALDRICH), and 0.3% Tween-20 in PBS (SIGMA-ALDRICH). 
The slides were then incubated overnight (ON) at 4°C, with the primary antibody, in a 
humidified box. This incubation period was followed by washes in PBS 0.1% Tween-20 
(SIGMA-ALDRICH, 3x 10min) and secondary antibody incubation (1h at RT or ON at 4°C). All 
primary and secondary antibodies were diluted in blocking solution before incubation on the 
slides. Note that two primary antibodies can be added if both come from different species 
(e.g. a mouse monoclonal antibody with a rabbit polyclonal antibody) and if the secondary 
antibody is conjugated with different fluorophores (e.g. anti-mouse Alexa Fluor® 488 with 
anti-rabbit Alexa Fluor® 568). The primary and secondary antibodies used in this project are 
described in Table 2.1 and Table 2.2, respectively. 
Finally, the tissues were incubated in 1μg/ml of 4′,6-diamidino-2-phenylindole (DAPI, 
Thermo Fisher Scientific), a nuclear staining, diluted in PBS (SIGMA-ALDRICH), for 10min at RT. 
After 3x 10min washes in PBS 1x (SIGMA-ALDRICH), the slides were mounted with vectashield 
(an antifade mounting medium, from Vector Laboratories, Burlingame, CA, USA), covered 
with a coverslip (Scientific Laboratory Supplies), and sealed with clear nail varnish.   
The same IF protocol was used in cryosections, without the deparaffinisation step. LCP1 
was the only antibody used in cryosections (see section 2.4.1). LCP1 and all the other 
antibodies described in were used in paraffin sections.
36 
 
Table 2.1 Primary antibodies used for immunostaining. 
Antibody, 





Company, City, Country 
 




GTX127342; GeneTex, Irvine, CA, USA 
PCNA mouse monoclonal 1:500 
NB500-106; Novus Biologicals, Littleton, 
CO, USA 
PCNA rabbit 1:50 GTX124496; GeneTex, Irvine, CA, USA 
LCP1 (L-plastin) rabbit polyclonal 1:200 
GTX124420; Novus Biologicals, Littleton, 
CO, USA 




Table 2.2 Secondary antibodies used for immunostaining. 
Antibody,  




Company, City, Country 
 




A11008; Invitrogen, Carlsbad, CA, 
USA 
Goat anti-rabbit IgG Alexa Fluor® 568 1:500 
10032302; Thermo Fisher Scientific, 
Waltham, MA, USA 
Donkey anti-rabbit IgG Alexa Fluor® 647 1:500 
A31573; Thermo Fisher Scientific, 
Waltham, MA, USA 
Goat anti-mouse IgG Alexa Fluor® 568 1:500 
10348072; Thermo Fisher Scientific, 
Waltham, MA, USA 
Goat anti-mouse IgG Alexa Fluor® 647 1:500 
A21235; Thermo Fisher Scientific, 
Waltham, MA, USA 
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2.3.3 Telomere-fluorescence in situ hybridization (telo-FISH) 
Telo-FISH allows the detection of telomeres by probing TTAGGG sequences with a peptide 
nucleic acid (PNA) telomere oligonucleotide. Relative telomere length, in situ, can then be 
quantitatively measured by probe signal intensity (intensity value of the mean, in arbitrary 
units). 
This technique was performed in combination with IF, following the protocol described in 
section 2.3.2. After incubation with the secondary antibody and respective washes, the tissues 
were fixed in 4% PFA (SIGMA-ALDRICH) for 20min. Washes in PBS (SIGMA-ALDRICH, 3x 10min) 
were followed by a dehydration step consisting of washes with ice cold 70%, 90% and 100% 
ethanol (Thermo Fisher Scientific, 3min each). After this, the slides were left to dry for 45min 
to 1h. Once the slides were completely dried, 10μl of hybridisation solution (see Table 2.3) 
was pipetted on top of each tissue section and the slides were covered with a coverslip. The 
slides were incubated for 10min at 80°C for DNA denaturation, followed by incubation for 2h 
at RT, in the dark, to allow the probe to hybridise with the complementary DNA. After the 
incubation period, the coverslips were gently removed and the slides were washed for 10min 
in a solution made of 70% formamide (SIGMA-ALDRICH), 10% 2x saline-sodium citrate (SSC, 
SIGMA-ALDRICH) and 20% dH2O. This was followed by two more washes of 10min each, in 2x 
SSC (SIGMA-ALDRICH). SSC was diluted from a 20x stock solution consisting 88.3g of Tri-
sodium citrate dihydrate (SIGMA-ALDRICH) and 175.3g of NaCl (SIGMA-ALDRICH), diluted in 
dH2O to a total volume of 1L, adjusted to pH of 7.0 and autoclaved. Finally, the slides were 
washed in PBS (SIGMA-ALDRICH), incubated in DAPI (Thermo Fisher Scientific) for 10min and 
mounted as previously described in section 2.3.2.  
38 
 
Table 2.3 Components of hybridisation solution used in Telo-FISH. 
Reaction component 
Volume per 100μl of 
reaction solution (10 samples) 
Company 
MgCl2 buffer, pH 7.0 8.56μl Lab-made, see below 
Formamide 70μl Thermo Fisher Scientific 
1mM Tris, pH 7.5 1μl SIGMA-ALDRICH 
1x blocking buffer 5μl Lab-made, see below 
PNA probe  
(Telo-Cy3, zebrafish, 568) 
2μl 
Cambridge Research 
Biochemicals, Cleveland, UK 
Cent-Fam probe (488) 2μl Eurogentec, Liège, Belgium 




For the hybridisation solution, the following buffers were made. MgCl2 (magnesium 
chloride) buffer, consisting in 25mM magnesium chloride (SIGMA-ALDRICH), 9mM citric acid 
(SIGMA-ALDRICH) and 82mM sodium hydrogen phosphate (SIGMA-ALDRICH). Blocking buffer, 
consisting in 10x blocking reagent (Merck & Co.) diluted to 1x in maleic acid (SIGMA-ALDRICH). 
Note that the hybridisation solution contains both PNA (Telo-Cy3) and FAM-labelled 
centromere (Cent-FAM) probes, which allow the detection of telomeres and centromeres, 
respectively. Here, centromeres serve as the control for cell proliferation, as dividing cells 
present twice the number of telomeres and centromeres. Hybridisation solution without PNA 
and Cent-Fam probes was added in a few slides as a negative control, in order to control for 
unspecific binding and/or background. 
After imaging (see details in section 2.3.4), Telo-FISH staining was quantified by the 
intensity of the mean. For this, a line was drawn around each nucleus and the intensity of the 
mean was measured in each channel. Then, the ratio ‘telomeres/centromeres’ was calculated 
by dividing the intensity of the mean of telomeres (568 channel) by the intensity of the mean 
of centromeres (488 channel). Like this, the telomeric probe signal was normalised for the 
centromeric probe signal within individual cells.  
 
2.3.4  IF imaging  
The IF staining in paraffin-embedded sections was imaged using the DeltaVision 
epifluorescence microscope at the Light Microscopy Facility (LMF) at Department of 
Biomedical Science (BMS) of tUoS. In order to obtain images with good resolution, all images 
were taken using the 40x objective. For each animal, an average of 5 images was acquired 
from the gut and 20 from the brain (approximately 4 images per macroarea). Each image 
contains approximately 15 slices, of 0.2μm each, making up to a total of 3μm. All the images 
were taken in the different channels: 405 (DAPI), 488 (Fluorescein isothiocyanate, FITC), 568 
(RED) and 647 (Cy5). For the gut, images containing 2-3 entire villi were taken from the middle 
region of the gut. For the brain, the images were selected aiming to cover the maximum area 
of each macroarea possible. The selection of all images was made based on DAPI staining 




2.3.5 IF quantifications 
After the acquisition, a z-projection was made for each field of view (FOV) and the raw 
images were quantified. For most of the markers, quantifications were performed by manual 
counting using the ‘Cell Count’ tool of ImageJ Fiji (v. 1.51). For both gut and brain, the total 
number of cells (based on DAPI staining) and the positive cells (for each antibody) in each FOV 
were counted separately, and the percentage of positive cells was calculated. For the brain 
specifically, the weighted average of all macroareas (i.e. by normalising the positive cells by 
the average number of cells in each macroarea) was then used to estimate the % of positive 
cells in the whole brain. For the γH2Ax staining, cells containing >5 foci in the nucleus were 
considered positive.  
Finally, the images were processed with Adobe Illustrator 21.0.2 for display purposes. 
 
2.4 Senescence-associated β-Galactosidase (SA-β-Gal) staining assay 
SA-β-Gal activity was assessed to test whether there is an accumulation of senescent cells 
with ageing in the zebrafish brain and gut, and if so, in which regions of the tissues this 
accumulation occurs. Moreover, SA-β-Gal staining in cryosections was combined with IF in 
order to identify which cell populations are becoming senescent with ageing. 
 
2.4.1 Tissue fixation and processing: cryosections 
Fish were culled by immersion in concentrated MS-222 (Thermo Fisher scientific), followed 
by immediate decapitation (Schedule 1 method). The tissues were dissected, rinsed in cold 
L15 (Thermo Fisher Scientific) and fixed in neutral buffered formalin (SIGMA-ALDRICH) 
overnight at 4°C. Then, the tissues were washed in 3ml cold PBS (SIGMA-ALDRICH), and 
embedded in 3ml of 30% sucrose (in PBS, SIGMA-ALDRICH) overnight at 4°C for 
cryopreservation. Before embedding in mounting media (optimal cutting temperature, OCT, 
compound, VWR International), the tissues were immersed in a 50:50 solution of 30% sucrose : 
OCT for 30min at 4°C. Finally, the tissues were mounted in a base mould (Electron Microscopy 
Sciences, Hatfield, PA, USA), with OCT, snap-frozen in dry ice, and stored at -20°C. Prior to use, 
the tissues were sectioned in 13μm-thick coronal sections, using a Leica CM1860 cryostat.  
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2.4.2 SA-β-Gal assay 
The Senescence-Associated β-Galactosidase Staining Kit (Cell Signalling Technology, 
Danvers, MA, USA) was used to detect SA-β-Gal, following manufacturer’s instructions. This 
technique consists in staining the tissue with X-gal substrate, known to be cleavaged by 
galactosidase. The cleavage of X-gal results in a blue colouration and therefore the levels of 
galactosidase in the tissue can be assessed by measuring the blue staining.  
Briefly, after rinsing the cryosections in 1x PBS for 5min (SIGMA-ALDRICH), 200μl of β-Gal 
mix solution (see Table 2.4) was added in each slide. In parallel, β-Gal mix solution without 
the X-gal was added in some slides as a negative control. The slides were coverslipped and 
incubated at 37°C overnight in a humidified chamber box. On the next day, the slides were 
rinsed in 1x PBS (SIGMA, ALDRICH, 3x 1min) and mounted in glycergel mounting medium 
(Agilent, Santa Clara, CA, USA). 
In order to combine IF with SA-β-Gal Staining, the following steps were performed. After 
SA-β-Gal Staining, the slides were washed in 1x PBS (SIGMA-ALDRICH, 3x 10min) and fixed in 
neutral buffered formalin (SIGMA-ALDRICH) for 10min at RT. The fixative was then washed in 
1x PBS (SIGMA-ALDRICH) and the IF standard protocol was followed as described in section 
2.3.2 (antigen retrieval followed by permeabilisation, blocking and incubation with primary 
antibodies ON). After SA-β-Gal Staining, the secondary antibodies were incubated ON at 4°C 
instead of 1h at RT as in the standard IF protocol. This protocol was performed in order to 
detect SA-β-Gal staining and immune cells in the same sections, by using the LCP1 rabbit 
polyclonal primary antibody and the goat anti-rabbit IgG Alexa Fluor® 488 as the secondary 
antibody. The details of these antibodies and respective dilutions are described in Table 2.1 
and Table 2.2. 
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Table 2.4 Components of the Senescence-Associated β-Galactosidase Staining Kit. 
Reaction component Volume per 1ml of 
reaction solution (5 slides) 
 
1x staining solution (pH 6.0) 
 
930μl 
100x solution A 10μl 
100x solution B 10μl 






2.4.3 SA-β-Gal imaging 
The SA-β-Gal staining was imaged using the Olympus BX60 microscope or Leica DM6 
microscope. Random slices were imaged in both microscopes and quantifications were 
compared. No differences were identified between images taken in the different microscopes 
(data not shown).  
IF, when combined with SA-β-Gal staining, was imaged using an additional microscope, the 
Leica DM6 microscope, which allows the acquisition of images of the same FOV in different 
channels, simultaneously, including brightfield and fluorescent channels – DAPI, FITC and RED 
(Fluo-DAPI, Fluo-green fluorescent protein or GFP, and Fluo-Y3, respectively). Furthermore, 
Leica DM6 microscope has the option of generating an overlay image, combining the different 
staining in one single image. Alternatively, this overlay can be performed directly in ImageJ 
Fiji. This technique enabled the detection of the co-localisation of SA-β-Gal with immune cells. 
For the gut, approximately 4 images were taken per fish, containing at least 3 villi each. For 
the brain, approximately 6-9 images were taken per fish; 2-3 images from the anterior, middle 
and posterior part of the brain.  
 
2.4.4 SA-β-Gal quantification 
After capture, the raw images were analysed using ImageJ Fiji as follows. First, I defined 
the perimeter of the relevant section and measured its total area (Fig 2.2A). Then, the ‘Color 
Threshold’ tool was used to identify the SA-β-Gal-positive regions (or blue regions) within the 
perimeter, using the same set of settings across all images (hue: 116-192; saturation: 117-255; 
brightness: 0-255). The blue regions were selected, and their total area was measured (Fig 
2.2B, C). The blue density was finally estimated by comparing the blue area with the total area 
of the section, obtaining the percentage of blue area per section.  
As the different sections of the brain (anterior, middle and posterior) have different 
volumes, the weighted average of these 3 sections was calculated in order to have an 
approximate measure of the SA-β-Gal-positive area in the whole brain. This was done by 
normalising the blue area by the relative size of each brain section (anterior, middle and 
posterior). In order to analyse each macroarea individually, it was considered the arithmetic 




Fig 2.2. Representation of how the SA-β-Gal-positive area (blue stained area) was identified and 
measured. (A) First, the perimeter of the section was delimited, and the area of the section was 
measured. (B) Then, the blue areas were identified using the ‘Color Threshold’ tool in ImageJ Fiji 
(shown in red). (C) Finally, the SA-β-Gal-positive areas were delimited (shown by the yellow lines) 
and their area was measured.  
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2.5 Nucleic acid extraction and Quantitative Reverse Transcription Polymerase Chain 
Reaction (RT-qPCR) 
RT-qPCR was used in this project to quantify the relative amount of specific mRNA 
transcripts. More specifically, I used RT-qPCR to analyse the relative expression of 
senescence-associated markers in the brain and gut, throughout zebrafish life.  
All the RNA work was performed using nuclease-free plasticware and filter tips. 
 
2.5.1 RNA extraction 
Fish were culled by Schedule 1 method (as previously described in section 2.5.1). The 
tissues were rapidly dissected in cold PBS (SIGMA-ALDRICH), transferred to a microcentrifuge 
tube containing 100μl of Trizol (Thermo Fisher Scientific), snap-frozen in dry ice, and stored 
at -80°C until RNA extraction.  
To isolate the RNA, the tissue was homogenized with a mechanical homogenizer (VWR 
International) and a 1.5 pestle (Kimble Chase, Vineland, NJ, USA), after adding extra 50μl of 
fresh Trizol (Thermo Fisher Scientific). After 5min incubation at RT, 30μl of chloroform (1:5, 
VWR International) was added and the solution mixed. The samples were then incubated for 
further 3min at RT and centrifuged (at 13,000g for 30min at 4°C). The resulting upper aqueous 
phase was transferred to a new microcentrifuge tube, and isopropanol (Thermo Fisher 
Scientific) was added (approximately 83% of the amount of aqueous phase) and mixed with 
the sample. After an incubation of 10min at RT, the samples were centrifuged (13,000g for 
15min at 4°C) and the resulting supernatant was discarded. The pellet was twice washed in 
250μl of ice cold 75% ethanol and then left to air-dry. Once dried, the pellets were 
resuspended in 14μl of nuclease-free water (VWR International).  
All the samples were analysed on a Nanodrop 1000 Spectrophotometer in order to 
measure the concentration of RNA and to assess RNA purity. The RNA purity was analysed by 
the 260/230 and 260/280 ratios; samples with values >1.8 were considered acceptable while 
samples with values ≤1.8 were discarded. From each batch of RNA extracted, some of the 
samples with an acceptable RNA purity were further analysed in a bioanalyzer Agilent 2100 
(Agilent, Santa Clara, CA, USA), to assess RNA integrity. When RNA integrity number (RIN) >8 
46 
 
was observed, all samples from that batch were considered good to be further used (except 
the ones with not acceptable RNA purity, which were discarded). When these samples had a 
RIN ≤8, all the samples from that batch were analysed by bioanalyzer (Agilent) and only 
samples with RIN >8 were used. Finally, all the RNA samples were stored at -80°C until further 
use. 
 
2.5.2 Complementary DNA (cDNA) synthesis 
cDNA synthesis was performed using the SuperScript II RT Kit (Thermo Fisher Scientific), 
following the manufacturer’s instructions. Briefly, each RNA sample (300ng) was mixed with 
0.5μl of 500μg/ml random primers (Promega, Madison, WI, USA), 1μl of 10mM dNTP Mix (Life 
Technologies) and nuclease-free water up to 12μl, in a microcentrifuge tube. Afterwards, this 
mix was incubated at 65°C for 5min. After cooling on ice, 4μl of 5X First-Strand Buffer, 2μl of 
0.1M DTT, and 1μl of RNAse inhibitor (New England Biolabs Inc., Ipswich, MA, USA) were 
added and the contents were mixed. This was followed by a 2min incubation at 25°C, after 
which 1μl of SuperScript II RT was added. The samples were then incubated consecutively at 
25°C for 10min, 42°C for 50min and 70°C for 15min. Finally, the resulting cDNA was stored at 
-20°C until use.  
 
2.5.3 RT-qPCR 
Contrarily to standard PCRs, RT-qPCR enables the quantification of mRNA expression. This 
is performed by using a fluorescent dye (SYBR Green), which intercalates with the double-
stranded DNA. Therefore, the fluorescence intensity increases with the increasing number of 
gene copies, allowing a real-time quantification of the PCR product. The results are then 
analysed by the cycle threshold (Ct) values, where a Ct is defined as the number of cycles 
necessary to detect fluorescent signal (above the threshold, i.e. background). The primers 




Table 2.5 RT-qPCR primers used in this project. 
Gene 
 
Primer sequences References 
beta-actin 
forward – 5’ TTCACCACCACAGCCGAAAGA 3’ 
reverse – 5’ TACCGCAAGATTCCATACCCA 3’ 




forward – 5’ GGTGCTGAATGGACAACTGTGCT 3’ 
reverse – 5’ GCAACTGACCTTCCTGAGTCTCC 3’ 
 
(Henriques et al., 
2013) 
cdkn1α 
forward – 5’ ATGCAGCTCCAGACAGATGA 3’ 
reverse – 5’ CGCAAACAGACCAACATCAC 3’ 




forward – 5’ ATTATTTTAAGATATAATATTTTGATAAA 3’ 
reverse – 5’ CTACTACTATAATCA ATTCATCCTC 3’ 
 
(Farmen, Hultman, 
Anglès, & Erik, 2014) 
cyclin g1 
forward – 5’ GTGATGAAGATTCAGCCCAAGC 3’ 
reverse – 5’ CACTGGCCAGAGGGACATTTTTCT 3’ 





Prior to the primers use, each set of primers was optimised. Firstly, a range of cDNA 
concentrations was tested (1:10, 1:20, 1:40, 1:80, 1:160, 1:320, 1:640 and 1:1,280) using the 
same primer concentrations and, at least, 3 different melting temperatures (Tm). Secondly, a 
standard curve was designed, and the slope of the curve was analysed. A slope between −3 
and -3.9 was considered good. Thirdly, the dissociation curve of the RT-qPCR was analysed in 
order to ensure the existence of a single peak – multiple peaks might indicate non-specific 
binding and/or primer dimers. Once an optimal primer efficiency and dissociation curve were 
found, the lowest successful cDNA concentration falling within the linear range of standard 
curve (15-30 Cts), as well as the optimal Tm, were used in the subsequent reactions.  
To perform RT-qPCR, a 384-well plate (Greiner Bio-One, Kremsmünster, AT) was prepared 
with 6μl of SYBR Mix (PerfeCTa SYBR Green FastMix, ROX, from VWR International), 0.5μl of 
primers (forward and reverse, at a final concentration of 0.5μM each) and 5μl of cDNA, per 
sample. Triplicates of each sample were used in each RT-qPCR plate. Then, the plate was 
covered with a micro-seal B PCR plate sealing film (Bio-Rad, Hercules, CA, USA) and spun down 
at 13,000 rpm for 1min. The ABI 7900HT Sequence Detection System (Applied Biosystems, CA, 
USA) was used to run the RT-qPCRs, with the following program: 95°C for 10min; 40 cycles of 
95°C for 30sec followed by optimal Tm for 1min; and dissociation stage. The dissociation stage 
aimed to generate a melting curve profile and consisted in a heating to 95ºC for 15sec, 
followed by cooling to Tm for 1min, and heating again to 95ºC for 15sec. 
The results were analysed as follows. First, the standard error of the triplicates (of each 
sample) was calculated and all the samples with triplicates presenting a standard deviation 
≥1 were excluded. Second, the fold change expression for each gene was calculated, using the 
ΔΔCt method (derived from the Livak & Schmittgen (2001)). For this, the mRNA expression of 
each target gene was first normalised to the reference gene (beta-actin), by subtracting the 
Ct value of the reference gene (Ctref) from the Ct value of the gene of interest (CtGOI) (Formula 
1). The result of this equation is commonly called ΔCt. Then, the ΔCt of the ‘control’ group 
(ΔCtcontrol) was subtracted from the ΔCt of the ‘test’ group (ΔCttest), obtaining the ΔΔCt value 
(Formula 2). Finally, the fold change was calculated using Formula 3. Unless otherwise stated, 
the ‘control’ group refers to the WT young group. 
The ΔΔCt method was considered valid to analyse the data in this project because the 
efficiency curve of target and reference genes were relatively similar. The calculation of the 
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average ΔCt between the reference gene and each target gene in a dilution series, revealed 
efficiency curves with a slope of ≤0.13 (p53: 0.089; p21: 0.134; p16: 0.132; cyclin g1: 0.079). 
 
Formula 1 ΔCt = 𝐶𝑡𝐺𝑂𝐼 − 𝐶𝑡𝑟𝑒𝑓 
Formula 2 ΔΔCt = Δ𝐶𝑡𝑡𝑒𝑠𝑡 − Δ𝐶𝑡𝑐𝑜𝑛𝑡𝑟𝑜𝑙 




2.6 RNA Sequencing (RNA Seq) 
RNA was extracted as described in section 2.5.1. The RNA samples used in RNA Seq were 
first analysed by bioanalyzer (Agilent) and all of them presented a RIN ≥9.   
The RNA Seq was performed by Matthew Wyles (BSc, MPhil), at the Genomics and 
Sequencing facility of Sheffield Institute for Translational Neuroscience (SITraN). I observed 
all the procedure and did the subsequent analysis. 
 
2.6.1 mRNA isolation and fragmentation 
mRNA was prepared from total RNA by removal of rRNA, non-coding RNA and degraded 
RNA. This was performed using the Oligo dT Beads approach, in which only RNA that contains 
poly(A) tails (mature mRNA) can bind to the magnetic beads.  
NEBNext Poly(A) mRNA Magnetic Isolation Module (New England Biolabs Inc) was used to 
isolate the mRNA, following manufacturer’s instructions. Therefore, unless otherwise stated, 
all the reagents used during the protocol were provided by this Kit.  
Briefly, a total of 500ng of RNA per sample was diluted in nuclease-free water to a final 
volume of 50μl and mixed with 50μl of Oligo dT Beads (Agencourt AMPure XP, Beckman 
Coulter, Indianapolis, IN, USA). To facilitate the binding of mRNA to the beads, the RNA was 
denatured by incubating the solution at 65°C for 5min and then cooling it down to 4°C (with 
the lid set at >75°C to prevent evaporation). To allow binding of mRNA to the beads, the 
solution was then incubated at RT for 5min and then placed in a magnetic rack, still at RT, 
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until the solution became clear (≈2min). To remove unbound RNA, the supernatant was 
removed and discarded without disrupting the beads; and the beads were washed twice with 
200μl of Wash Buffer. Every wash consisted of placing the solution in the magnetic rack until 
the solution was clear and then removing and discarding the supernatant. For the first elution 
of the mRNA from the beads, 50μl of Tris Buffer was added to each sample, and the resultant 
solution was heated at 80°C for 2min, then cooled to 25°C (with lid set at >90°C). To re-bind 
the mRNA to the beads, 50μl of RNA binding buffer (2x) was added to the beads. After an 
incubation period of 5min at RT, the buffer was washed out and the beads were washed one 
final time with Wash Buffer.  
Later, the purified mRNA was eluted from the beads and fragmented. To do this, 11.5μl of 
First Strand Synthesis Reaction Buffer and Random Primer Mix (2x) (40% and 10% each, 
respectively) were added into each sample and incubated at 94°C for 15min (with the lid set 
at 105°C), before cooling down to 4°C. The resulting solution was placed in the magnetic rack 
and the unbound fragmented mRNA was collected (10μl in total).  
 
2.6.2 First- and second-strand cDNA synthesis 
To synthesise the first strand of cDNA, the 10μl of fragmented mRNA was mixed with 8μl 
of NEBNext Strand Specificity Reagent and 2μl of NEBNext First-Strand Synthesis Enzyme Mix 
(total of 20μl). These reagents are part of the kit above mentioned. The solution was 
incubated for 10min at 25°C, followed by 15min at 42°C, 15min at 70°C and then held at 4°C.  
To synthesise the second strand of cDNA, the 20μl of first-strand synthesis product was 
mixed with the following: 8μl of NEBNext Second Strand Synthesis Reaction Buffer with dUTP 
Mix (10x), 4μl NEBNext Second Strand Synthesis Enzyme Mix and 48μl of nuclease-free water 
(total of 80μl). The resulting solution was then incubated at 16°C for 1h. All the reagents are 
part of the kit above mentioned.  
The double-stranded cDNA (dscDNA) was then purified in order to remove any enzymes, 
buffers or primers from the solution. To do this, the second strand synthesis reaction product 
was incubated with 144μl of NEBNetx Sample Purification Beads, for 5min at RT, placed in the 
magnetic rack and washed. This was followed by three washes in 200μl of 80% ethanol; the 
beads were then air-dried. Finally, the dscDNA was eluted from the beads by incubating the 
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solution with 53μl of 0.1x Tris-EDTA (TE) Buffer for 2min at RT in the magnetic rack. All the 
reagents are part of the kit above mentioned. After this, the dscDNA (total of 50μl) was 
collected and stored at -20°C. 
 
2.6.3 Library preparation 
To prepare the library, the NEBNext Ultra Directional RNA Library Prep Kit (Illumina) was 
used, following manufacturer’s instructions. Unless otherwise stated, all the reagents used in 
this protocol were provided by this Kit. 
 
2.6.4 Adaptor ligation 
First, the dscDNA was prepared for adaptor ligation. The 50μl of dscDNA was mixed with 
7μl of NEBNext Ultra II End Prep Reaction Buffer (10x) and 3μl of NEBNext Ultra II End Prep 
Enzyme Mix (total of 60μl). The solution was incubated as follows: at 20°C for 30min, at 65°C 
for 30min and then hold at 4°C (always with the lid set at >75°C). This process generates an 
end-repair/ dA-tailing in the extremities of the dscDNA to enable the ligation of the adaptors 
(that have single T overhangs).  
For the adaptor ligation, 60μl of product from the previous step were mixed with 2.5μl of 
adaptor (after 5-fold dilution in Adaptor Dilution Buffer), 1μl of NEBNext Ligation Enhancer 
and 30μl of NEBNext Ultra II Ligation Master Mix. Together, this solution is called ‘Ligation 
Reaction’ and contains the dscDNA with the adaptors. After incubating the Ligation Reaction 
at 20°C for 15min, the USER Enzyme was added, and the resulting solution was incubated at 
37°C for 15min (the lid set at >45°C). This step removes uracil nucleotides from the dscDNA, 
making it accessible for PCR. 
In order to remove enzymes and excess adaptor, the Ligation Reaction was purified with 
87μl of Oligo dT Beads (Agencourt AMPure XP). The beads were then washed 3x in 200μl of 
ethanol 80% and air-dried. Finally, purified dscDNA was eluted from the beads by adding 17μl 






2.6.5 PCR enrichment of libraries 
The library PCR enrichment is an important step that enables an increase in the library yield 
and incorporation of the barcodes in each sample. The NEBNext Multiplex Oligos for Illumina 
(Index Primers Set 1, New England Biolabs Inc) was used for the PCR reaction. In this kit, each 
set of primers contains a universal primer and an index primer which includes a barcode. This 
means that during the PCR, a unique barcode will be added to each sample, enabling all the 
samples to be sequenced together and then demultiplexed for analysis. The PCR reaction and 
program used are presented in Table 2.6 and Table 2.7, respectively.  
The PCR product (≈50μl) was then purified using 45μl of Oligo dT Beads (Agencourt 
AMPure XP), followed by three washes with ethanol 80%. After air-drying, the dscDNA was 
eluted by adding 23μl of 0.1x TE, and the resulting 20μl of the library were collected. 
Before proceeding with the sequencing, the quality of each library was assessed by 
bioanalyzer (Agilent 2100). The presence of peaks at ≈80bp or ≈128bp suggest primers and 
adaptor-dimer carryover, respectively. To remove the excess adaptor, the samples were 
washed once again with Oligo dT Beads (Agencourt AMPure XP). After this wash, all the 
libraries displayed good electropherograms and therefore were used for sequencing. 
 
2.6.6 Sequencing 
The sequencing was run on an Illumina HiScan SQ sequencer, using a high output run and 
sequencing by synthesis V3 chemistry on a single 100bp run. The sequencing process was 
monitored in real-time using Sequencing Analysis Viewer v1.8.37 Software, and therefore 
quality control was performed during and after sequencing.  
Then, the data was imported into a .FASTQ file format in order to perform the analysis. 
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Table 2.6 Components for the PCR reaction used to prepare the libraries for RNA Seq. 
Component Volume per library 
 
Adaptor ligated dscDNA (resulting from step 
described on section 2.6.4) 
15μl 
Master 25μl 
Universal PCR Primer/ i5 Primer 5μl 





Table 2.7 PCR program used to prepare the libraries for the RNA Seq. 









Denaturation 98°C 10sec  
8 
Annealing/Extension 65°C 75sec 
Final Extension 65°C 5min 1 
Hold 4°C ∞  
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2.6.7 RNA Seq analysis 
Dr Mark Dunning (Director of the Bioinformatics Core at the University of Sheffield) 
performed the initial analysis of the RNA-Seq data, including alignment quality control and 
normalisation. The remaining analysis was performed by me.  
The experimental aim was to identify the differentially expressed (DE) genes, being up- and 
down-regulated in a consistent way over-time, in the zebrafish brain. In order to identify 
those genes, a time-series analysis was performed using the Short Time-series Expression 
Miner (STEM) software (v1.3.12) (Ernst & Bar-joseph, 2006). During this analysis, all time-
points were normalised for the earlier time-point (2 months), which in turn was transformed 
to start at 0 (as baseline). For analysis purposes, the settings were used as follows. For filtering 
the data, I used a maximum number of missing values of 0, a minimum correlation between 
repeats of 0.6 and a minimum absolute expression change of 0.6. For the model profiles, a 
significance level of 0.05 was considered and Bonferroni test was used as the correction 
method. All the genes presenting a p-value adjusted (padj) <0.05 were considered DE genes 
and were therefore selected for further analysis. 
After identifying the DE genes with ageing in each tissue, enrichment analysis was 
performed in order to determine the functions to which the genes were associated with. 
Enrichment analysis was performed in Metascape (Zhou et al., 2019) using a minimum overlap 
of 3, a p-value cut-off of 0.01 and a minim enrichment of 1.5. The enrichment terms identified 
in this software were compared and confirmed by using an extra resource tool, the Gene 
Ontology enRIchment anaLysis and visualization, known as GOrilla (Eden, Navon, Steinfeld, 
Lipson, & Yakhini, 2009). In GOrilla, a p-value cut-off of 0.01 was also considered. 
Networks of genes were analysed using STRING v11.0 (Szklarczyk et al., 2019) and 
Cytoscape v3.7.2 (Shannon et al., 2003) software. More specifically, STRING software was 
used to perform a first assessment of the networks, determining the genes interacting with 
other genes (minimum interaction score of 0.4) and eliminating any disconnected nodes. 
Gene interactions were based on textmining, experiments previously performed, databases, 
co-expression, neighbourhood in the genome, gene fusion and co-occurrence in publications. 
The networks identified in STRING were then deeper analysed in Cytoscape, where it was 
possible to determine the key characteristics of the networks such as the number of nodes, 
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edges (or degree) or neighbourhood connectivity, among others. In order to identify small, 
strongly connected and meaningful networks, the 10 genes with the highest degree (highest 
number of interactions with other genes) from each group of genes were selected. Later, 
STRING software was also used in order to assess specific interactions between genes within 
each network, as well as to make the networks used for display purposes.  
Finally, venn diagrams were performed using the Venny v2.1. 
 
 
2.7 Protein extraction and enzymatic assays 
Enzymatic assays were used in order to analyse chitotriosidase activity, an inflammatory-
associated marker, in the ageing brain and gut. 
 
2.7.1 Protein extraction  
Fish were culled by Schedule 1 method as described in section 2.3. Tissues were dissected 
rapidly, transferred to a microcentrifuge tube and immediately snap-frozen in liquid nitrogen. 
The samples were stored at -80°C until protein extraction. 
The tissue was homogenised in 100μl of ultra-pure water using a mechanical homogenizer 
(VWR International) and RNAse-free disposable pestles (Thermo Fisher Scientific) for 
approximately 30sec, on ice. Then, the samples were spun down at 4°C, at 2,000rpm, for 5min. 
After transferring the supernatant to a new tube, samples were stored at -80°C until further 
use.  
 
2.7.2 Protein quantification 
Protein extracts were quantified by the bicinchoninic acid (BCA) method, using the Pierce™ 
BCA Protein Assay Kit (Thermo Fisher Scientific). The BCA assay is a colorimetric method that 
consists in a biuret reaction that leads to a reduction of copper (Cu+2 to Cu+1) in the presence 
of an alkaline solution. The chelation of 2 molecules of BCA to Cu+1 result in a purple-coloured 
product, which can be measured by a plate reader. 
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In order to perform the BCA assay, a standard curve was prepared with a range of 0.2-2μm 
of BSA (from the kit), along with a blank control (containing ultra-pure water only). At the 
same time, 5μl of each protein extract was mixed with 1ml of BCA (from the kit), in 
microcentrifugation tubes, and incubated at 37°C for 10min in a water bath. After adding an 
additional 20μl of copper sulphate (from the kit), the solution was mixed and incubated at 
37°C for 20min. Then, 200μl of each sample (or BSA standard curve) were transferred to a 
Corning™ Costar™ Brand 96-Well EIA/RIA Plate (Thermo Fisher Scientific), in duplicates, and 
absorbances were read in a Varioskan Plate Reader (at Sheffield RNAi Screening Facility) at a 
wavelength of 562nm.  
Sample concentrations were calculated as follows. Firstly, the blank duplicates were 
averaged and subtracted from all of the other optical densities. Secondly, the total amount of 
protein from each sample was interpolated from the standard curve using GraphPad Prism 
7.0 software (‘linear regression’ -> interpolate unknowns from standard curve’). Finally, the 
protein concentration of each sample was calculated. 
 
2.7.3 Chitotriosidase activity assay 
In order to measure chitotriosidase activity levels, I used the same protocol previously 
described in zebrafish by Keatinge et al., (2015). This method allows to assess the hydrolyse 
capacity of 4–methylumbelliferyl–β-D-N, N’, N”-triacetylchitotriose (4-MU-chitotrioside), by 
chitotriosidase enzyme. Chitotriosidase activity assay was performed as follows. 
A total of 10μl of protein extract per sample was mixed with 100μl of substrate solution 
and incubated at 28°C for 60min. A blank control containing 10μl of ultra-pure water was 
prepared alongside with the samples. Substrate solution consisted in 4-MU-chitotrioside 
(SIGMA-ALDRICH) diluted in McIlvaine solution at pH 5.2 (1.73mg of 4-MU-chitotrioside per 
100 ml of McIlvaine solution). To make the McIlvaine solution, stock solutions of 0.1M citric 
acid (SIGMA-ALDRICH) and 0.2M di-sodium hydrogen phosphate (SIGMA-ALDRICH) were 
mixed at a ratio of 45% and 55%, respectively, obtaining a final pH of 5.2.  
After incubation, 1ml of stop solution (0.25M glycine buffer, pH 10.4, containing 0.01% 
Triton X-100 (SIGMA-ALDRICH)) was added to each sample (and blank control), and 200μl of 
the final solution was transferred to a Corning™ Costar™ Brand 96-Well EIA/RIA Plate (Thermo 
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Fisher Scientific). Duplicates of each sample were used. An extra microcentrifuge tube was 
prepared with 200μl of standard solution (5μm 1,4-Methylumbelliferone, SIGMA-ALDRICH) 
and 900μl of stop solution. A volume of 200μl of the final solution was transferred to the 96-
well plate, in duplicates. The fluorescence was then read in a Varioskan Plate Reader 
(excitation: 365nm; emission: 450nm).  
Finally, the chitotriosidase activity was calculated in nM/h/ml, using Formula 4. 
 
T, fluorescence of test samples 















2.8 In vivo assays 
In this study, in vivo assays were performed in order to test BBB and gut barrier 
permeability with ageing, in zebrafish. 
 
2.8.1 Testing BBB permeability 
To test BBB permeability, a total of 5μl of 0.1% IRDye 680RD Dextran (LI-COR Biosciences, 
Lincoln, NE, USA) diluted in Hanks' Balanced Salt solution (HBSS, Thermo Fisher Scientific) 
were injected by IP. Two different sizes of the compound were tested, with the following 
molecular weights: 4kDa and 70kDa. A group of fish injected with 5μl of HBSS alone was used 
as a vehicle control group. The fish were culled 3h after IP, and the brains were collected and 
imaged using a LI-COR Odyssey CLx machine (LI-COR). The brain fluorescence was then 






2.8.2 Testing gut barrier permeability: “Smurf” assay 
In this project, the “smurf” assay was used to test gut permeability with ageing. This assay 
involves feeding the animal with a blue food colourant and then observe changes in the skin 
colouration. In a young, healthy animal, the food colourant is not expected to cross the gut 
barrier and no blue should be observed in the skin. However, if there is increased gut 
permeability, as it is predicted with ageing, there should be increased blue colouration in the 
skin (Dambroise et al., 2016). The “smurf” assay was performed by water immersion, as 
described in Dambroise et al. (2016). Briefly, the fish were immersed in aquarium water 
containing 2.5% of filtered blue food colourant (Blue #1 stock solution, Erioglaucine disodium 
salt, Acros Organics, Thermo Fisher Scientific), for 30min. Then, fish were rinsed in clear water 
until excess surface blue colouration was removed (Fig 2.3). After the “smurf” assay, fish were 









Fig 2.3. Illustrative pictures of the “smurf” assay by water immersion. The fish were exposed to 
blue dye (food colourant) diluted in water, for 30min (top image). Then, the fish were rinsed in 
clear water (middle image) until the blue colouration wore off (bottom image). The rinsing time 




At the end of the protocol, fish skin colouration was quantified by the median intensity of 
the mean, using ImageJ Fiji software. This was done in the white stripes of the skin only, as 
the blue stripes of the zebrafish skin could be a confounding factor.  
 
2.9 Behavioural assays 
Behavioural assays were performed to test whether age-associated cellular and molecular 
dysfunctions occur at the same time as age-related behavioural alterations. 
 
2.9.1 Open field (OF) and novel object (NO) tests 
OF and NO tests were used to test locomotion and anxiety-like behaviour in zebrafish, with 
ageing. These tests were performed at the behaviour room (BMS Department of the tUoS). 
Before the experiment, all fish were acclimatised to the behaviour room for at least 1h. 
During this period, fish were maintained in crossing tanks containing approximately 2.5L of 
water, in groups of 3 fish. OF and NO tests were performed one after the other, using a 
27x14x14cm tank (length x width x height) containing 7cm of water depth. The walls of the 
test tank were covered in white paper in order to avoid external visual stimuli (Fig 2.4A). A 
fish was gently placed into the test tank with a net and the recording of the test behaviour 
started immediately, using a top camera. After 10min of OF test, the fish was transferred to 
the holding tank for 2min. During this interval, a red 3x1.5x1.5cm object (length x width x 
height) was placed in the centre of the test tank (Fig 2.4B, C). The fish was gently placed again 
in the test tank for additional 10min (NO test). In the end, the fish was returned to its tank. 
During the 20min trial, the fish behaviour was recorded for later data analysis. The test was 
carried for one fish at each time. The water in the test tank was replaced in between every 
fish. 
The assays were performed for 3 consecutive days and 10 to 20 fish were tested per day. 
The day and time of experiment were semi-randomly determined so that all the fish from 
each group were equally distributed for the morning and afternoon sessions of each day of 





Fig 2.4. Representative images of the setup used to perform OF and NO tests.  (A) Picture of the 
tank and top camera used to record the fish behaviour. (B) Top view of the test tank with novel 
object placed in the centre. (C) Close picture of the object used for the NOT. 
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Later, fish behaviour was analysed using the video tracking software EthoVision XT (Noldus 
Information Technology Inc., Lessburg, VA, USA). This analysis was performed at the 
University of Leicester, in the laboratory of Dr William Norton, who generously lent me the 
software with respective key.  
Locomotion behaviour was analysed by measuring the total distance swam during the OF 
test. Anxiety-like behaviour was analysed in both OF and NO tests. In the OF test, anxiety-like 
behaviour was assessed by the time spent on the edge versus the centre of the tank – the 
preference for staying in the edges of the tank is called thigmotaxic behaviour and can be 
used as a measure of anxiety in zebrafish (Allan Kalueff et al., 2013). In the NO test, anxiety-
like behaviour was measured by the time spent near the novel object. Poor exploratory 
activity regarding the object is considered a signal of anxiety in zebrafish (Allan Kalueff et al., 
2013). Two times the width of the fish was the measure used to delimit the area considered 
as the ‘edges of tank’ in the OF test, and the area considered to be ‘near the object’ in the NO 
test. 
 
2.9.2 Novel object recognition (NOR) test  
The NOR assay aimed to test cognition, more specifically working memory, with ageing, in 
zebrafish. This test was also performed in the behaviour room of the BMS Department of the 
University of Sheffield. This test consists in 2 phases. In Phase 1 (exploratory phase) the fish 
are exposed to two different objects and are allowed to explore them. In Phase 2 (test phase), 
one of the previous objects is replaced by a new one (novel object) and therefore the fish can 
explore two objects – the novel versus the familiar object. It is considered that the fish can 
distinguish the novel from the familiar object when the fish shows a preference for one of the 
objects during the test phase. This preference is evaluated by the time spent near the objects.  
Before the experiment, all the fish were acclimatised to the behaviour room for at least 1h 
as described in section 2.8.1. The NOR test was performed in a 32x17.5x17.5cm tank (length 




Fig 2.5. Representative images of the setup used to perform the NOR test. (A) Picture of the tank 
and top camera used to record the fish behaviour. (B) Top view of the test tank with two equidistant 




In Phase 1, the test tank contained two equidistant objects (Object A and Object B), of 
approximately 3x3cm each. A fish was gently placed into the test tank and its behaviour was 
recorded for 10min. After Phase 1, the fish were placed in a holding tank for 2min and then 
returned to the test tank for Phase 2. In Phase two, the test tank contained two equally distant 
objects, Object A (familiar object) and Object C (novel object). In the end, the fish was 
returned to its tank. During the 20min trial, the fish behaviour was recorded for later data 
analysis. Like in the OF and NO tests, in the NOR test each fish was tested at a time and the 
water of the test tank was replaced between every fish. 
The NOR test was performed for 3 consecutive days, where 10 to 20 fish were semi-
randomly assigned to each morning/afternoon to test an equal number of fish from each 
group in the different days of experiment. Moreover, the designation (A, B or C) of the 3 
objects available and their location (left or right) in the test tank were semi-randomly assigned 
in each day of experiment in order to avoid bias towards a possible favourite object or tank 
location.  
Fish behaviour was analysed by measuring the time spent near the familiar and novel 
objects. Object discrimination was accessed by Formula 5, where positive values indicate a 
preference for the familiar object and negative values indicate a preference for the novel 
object. A mean value statistically significant from 0 was considered a successful discrimination 
between the two objects.  
 
TS, time spent 
DI, discrimination index 
 




2.10 Statistical analysis 
All the statistical analysis was performed with GraphPad Prism v7.00, except for the 
random effect ANOVA which was analysed with the IBM SPSS Statistics v25.  
Normality was assessed by the Shapiro-Wilk test. Unpaired t-test or Mann Whitney test 
were used to compare 2 data points, depending on whether the samples presented a 
Gaussian distribution or not, respectively. One-way ANOVA or two-way ANOVA followed by 
post-hoc tests with Bonferroni post-correction were used in order to compare more than 2 
data points in 1 or 2 groups from the same tissue, respectively. Kruskal-Wallis followed by 
Dunn’s post-hoc test replaced the One-Way ANOVA for non-normally distributed data.  
Telomere length (or telomere/centromere ratio) was analysed by random effects ANOVA. 
Here, the intensity value of the mean (per cell) was used as the biological identity and the 
animals within each experimental group were analysed as a random variable. By doing so, the 
intensity value of the mean of each cell was taken into consideration within each animal. To 
perform a random effects ANOVA, linear mixed models were applied using the following 
script. 
 
Telo_Centro, dependent variable (intensity values of the mean) 
Genotype, independent variable of genotype (WT versus tert-/-) 
Age, independent variable of age (young versus old) 
Animal, random variable, containing all the animals used in this study. 
 
Script: 
MIXED Telo_Centro BY Genotype Age Animal  
  /CRITERIA=CIN(95) MXITER(100) MXSTEP(10) SCORING(1) SINGULAR(0.000000000001) 
HCONVERGE(0,  
    ABSOLUTE) LCONVERGE(0, ABSOLUTE) PCONVERGE(0.000001, ABSOLUTE)  
  /FIXED=Genotype Age Genotype*Age | SSTYPE(3)  
  /METHOD=REML  
  /PRINT=DESCRIPTIVES  
  /RANDOM=Animal | COVTYPE(VC)  
  /EMMEANS=TABLES(Genotype)  
  /EMMEANS=TABLES(Age)  
  /EMMEANS=TABLES(Genotype*Age) 
  /EMMEANS=TABLES(Genotype*Age) COMPARE(Age) ADJ(LSD) 
  /EMMEANS=TABLES(Genotype*Age) COMPARE(Genotype) ADJ(LSD). 
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Moreover, Wilcoxon signed-ranked test against the hypothetical value of 0 was used to 
assess object discrimination during the NOR test. This is because a discrimination index close 
to 0 indicate that there is no discrimination between familiar and novel object. The higher the 
discrimination index, the better discrimination between the two objects. 
A critical value for significance of p<0.05 was used throughout the study. Unless otherwise 
stated: p-value≥0.05; *p-value<0.05; **p-value<0.01; and ***p-value<0.001.  
Finally, power calculations were performed in order to calculate the sample sizes required 
for each experiment. To do so, I calculated the effect sized following the 3R guidelines 
(http://www.3rs-reduction.co.uk/html/6__power_and_sample_size.html), using Formula 6. 
 
M1, mean of group 1 
M2, mean of group 2 
SE, Standard error 
 






Then, it was identified the minimum sample size required to detect a 25% difference with 
90% power and 5% significance level in a two-sided test, using a reference table (available in 
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Age-related retinal degeneration is insufficient to 
stimulate the Müller glia regenerative response in 
zebrafish, leading to gliosis and loss of vision
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Ageing is a significant risk factor for developing retinal degenerative diseases and vision 
loss. Regenerative therapies offer great promise in the treatment of these devastating 
blinding conditions, but it remains unclear how old age impacts retinal homeostasis and its’ 
ability to regenerate in response to chronic damage. We used the zebrafish model to 
characterise retinal ageing in the wild type and the premature ageing telomerase mutant 
(tert-/-) model. We show that the zebrafish retina undergoes thinning due to an overall 
neuronal degeneration with ageing, which is largely telomerase independent. Despite its well-
documented regenerative potential after damage, this neurodegeneration with ageing is 
insufficient to stimulate the Müller glia (MG) regenerative response. This occurs even though 
MG do maintain their regenerative capacity until old age following an acute retinal damage. 
In contrast, chronic neurodegeneration with ageing results in a gliotic response, thereby 
recapitulating several hallmarks of human retinal degeneration with ageing. Our work 
identifies gliosis as a key difference between chronic and acute damage, a key consideration 
for targeting endogenous regeneration mechanisms to treat human retinal disease. 
 
3.2.1 Graphical abstract 
 
 
Our data suggest that the mechanisms driving regeneration in response to acute damage 
versus chronic, age-related damage, are different. It may be that either the number of cells 
dying in natural ageing is not enough to stimulate MG to proliferate, or the low number of 




Ageing is a significant risk factor for human retinal degenerative disease, such as age-
related macular degeneration (AMD) and vision loss. As the population is ageing worldwide, 
the identification and potential treatment of the underlying cellular and molecular 
dysfunctions will be critical for global health going forward. Regeneration-based therapies, 
such as stimulating endogenous regenerative mechanisms, offer great promise for the 
treatment of many human blinding diseases. Intensive efforts have been made to uncover 
the molecular mechanisms regulating the retinas’ endogenous regenerative responses in 
lower vertebrates (Fischer & Reh, 2001; Lenkowski & Raymond, 2014; Raymond et al., 2006; 
Thummel et al., 2008; Wan & Goldman, 2016). While the mammalian retina lacks significant 
regenerative capacity (Jadhav et al., 2009; Ooto et al., 2004), re-introduction of key molecular 
signals into Müller glia (MG) has shown great promise to stimulate the genesis of new neurons 
after damage (Jorstad et al., 2017, 2020; Karl et al., 2008). However, these studies in lower 
vertebrates and mammals are typically carried out in young adults. As advanced age is 
strongly associated with the pathogenesis of many retinal degenerative conditions, 
understanding the effects of ageing on the regenerative potential in the retina is an important 
consideration for the efficacy of such treatments going forward.  
The zebrafish is a well-established model to study retinal development, disease and 
regeneration (Cameron, 2000; Eastlake et al., 2017; Richardson et al., 2017; Stenkamp, 2015). 
In the retina, the principal cells tasked with supporting retinal circuits throughout life are the 
MG. MG do this by providing a myriad of support functions to neurons, including trophic 
support, neurotransmitter recycling and energy metabolism (Reichenbach & Bringmann, 
2013). While these functions are critical to the maintenance of healthy retinal function, MG 
also play a prominent role in disease and after neuronal insult. In the mammalian retina, 
degeneration results in a MG gliotic response. This leads to the up-regulation of stress 
proteins and morphology changes, which are thought to be neuroprotective initially, but may 
ultimately culminate in dysfunction (Bringmann et al., 2009). In contrast to mammals, after 
damage, the MG in the zebrafish retina will undergo a brief reactive gliosis-like phase that 
transitions into a de-differentiation and proliferation of the MG progenitor cell to generate 
new neurons (Eastlake et al., 2017; Thomas et al., 2016; Thummel et al., 2008). While MG 
may be the primary source of neurons after injury in teleosts, regeneration can also occur 
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from the ciliary marginal zone (CMZ) (Raymond et al., 2006). CMZ is a population of 
progenitors found in the peripheral retina that is thought to contribute to retinal growth 
throughout life (Fig 3.1A). Additionally, rods can originate from rod-specific progenitors 
(Johns & Fernald, 1981; Julian et al., 1998) found in the outer retina. Rod-specific progenitors 
are derived from MG that slowly divide in the WT retina (Bernardos et al., 2007; Otteson et 
al., 2001; Raymond et al., 2006). Multiple acute injuries do not appear to reduce the overall 
regenerative response of MG; however, there does appear to be chronic inflammation after 
successive rounds of injury (Ranski et al., 2018). It should be noted that studies of MG-derived 
regeneration are often carried out in young adult animals, and it remains unclear how ageing 
impacts regenerative potential throughout the life course. While the zebrafish retina has been 
shown to display decreased cell density and increased cell death with increasing age (Van 
Houcke et al., 2019), it remains unclear if this age-related cell death stimulates endogenous 
regeneration and repair mechanisms, or how natural age impacts the regenerative potential 
of the MG.  We hypothesised that the zebrafish retina loses its steady state regenerative 
capacity with ageing, thereby leading to degeneration and vision loss. 
Recent studies have shown that zebrafish display key human-like hallmarks of ageing in 
most tissues. Depending on the tissue, this includes telomere shortening and consequent 
DNA damage, decreased proliferation, and increased apoptosis or accumulation of 
senescence (Anchelin et al., 2013; C. Carneiro et al., 2016; Henriques et al., 2013). Zebrafish 
thus offer an attractive model to study regeneration in a human-like, ageing model. Telomere 
shortening is a hallmark of ageing implicated in many age-related diseases (López-Otín et al., 
2013). Telomeres, a protective cap in linear chromosomes, shorten significantly with each cell 
division, in proliferative tissues, due to the end-replication problem and consequent oxidative 
damage of the lagging end (Levy et al., 1992). Progressive shortening of telomeres can have 
damaging effects, such as cellular senescence, which is characterized by permanent cell cycle 
arrest and persistent DNA damage response. Telomerase is the enzyme with the ability to 
correct this end-replication problem, but most somatic cells maintain a low level of 
telomerase expression (Forsyth et al., 2002; Henriques & Ferreira, 2012). Given that 
telomerase activity correlates to a cell’s proliferation potential, this enzyme is perceived as a 
positive aspect in the context of regeneration. In fact, telomerase has been shown to be 
essential for tissue regeneration, namely in the mammalian liver (Lin et al., 2018) and in the 
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zebrafish heart (Bednarek et al., 2015). Furthermore, there is some evidence that telomerase 
is important for retina’s health. In humans, age-related diseases of the retina, such as AMD, 
have been reported to be alleviated by telomerase reactivation (Dow & Harley, 2016; Rowe-
Rendleman & Randolph, 2004), suggesting that limited expression of telomerase may play a 
role in retina ageing. Accordingly, the telomerase mutant zebrafish model (tert-/-), known to 
age and die prematurely (Carneiro et al., 2016; Henriques et al., 2013), have been reported 
to display accelerated retina thinning (Anchelin et al., 2013). As it has been shown that cellular 
proliferation is a key factor in retinal homeostasis (Van Houcke et al., 2019), and that 
telomerase and telomere stability play an important role in cell proliferation, we sought to 
determine whether retinal degeneration and vision impairment with ageing is telomerase-
dependent. 
Here, we used zebrafish as a model to determine how ageing impacts the retina’s steady-
state homeostasis and whether this is telomerase-dependent. Our work shows that zebrafish 
retina ageing is characterised by structural and morphological alterations in the central retina, 
resembling human retina ageing. These include retina thinning, neuronal loss and 
disorganisation of the photoreceptors, culminating in visual impairment. Interestingly, retina 
ageing and consequent vision loss is not significantly accelerated by lack of telomerase 
expression. Importantly, contrary to what occurs in situations of acute damage, we observed 
no compensatory proliferation in response to age-related neuronal degeneration. Despite 
lack of regeneration in response to chronic, age-related damage, MG retain their capacity to 
proliferate and restore lost neurons in response to an acute damage until old age. In contrast, 
with chronic age-related degeneration, in MG cells undergo a gliosis-like phenotype, including 
characteristic changes in morphology and localisation of glial fibrillary acidic protein (GFAP) 
intermediate filaments. Together, our work suggests key molecular differences between 





3.4.1 Zebrafish retina ageing is characterised by telomerase-independent central 
retina thinning, morphological alterations, and neurodegeneration 
Similar to humans, the zebrafish retina consists in three nuclear layers separated by two 
plexiform layers. The nuclear layers consist in the outer nuclear layer (ONL) containing 
photoreceptors; the inner nuclear layer (INL) containing bipolar cells (BCs), amacrine cells 
(ACs), horizontal cells (HCs) and Müller glia (MG); and the ganglion cell layer (GCL) mainly 
containing retinal ganglion cells (RGCs) (Fig 3.1A). Furthermore, the zebrafish retina can be 
divided into discrete regions based on age (Fu, Nagashima, Guo, Raymond, & Wei, 2018). Here, 
we characterise two regions: the central retina containing the oldest cells, born during early 
development; and the peripheral retina containing the ciliary marginal zone (CMZ) and the 
immediately adjacent tissues, comprising the newest born cells (Fig 3.1A). 
A key hallmark of human retinal ageing is the thinning in the central retina (Eriksson & Alm, 
2009). Previously it was shown that the linear cell density in the central region of the adult 
zebrafish retina also declines with age, with exception of rods (Van Houcke et al., 2019). 
However, it remained unclear whether telomerase played a role on this. As such, we 
quantified retinal thickness in the central and peripheral adult zebrafish retina by DAPI stain 
at defined time-points of adulthood. Our results show that the WT retina progressively thins 
with ageing in the central region (Fig 3.1B, B’), as previously shown. Retina thinning is not 
accelerated in the prematurely aged tert-/- model when compared to its WT counterpart at 
any age analysed, suggesting that thinning of central retina with ageing is independent of 
telomerase (Fig 3.1B, B’; Supplementary Fig 1A). Proliferation in the central retina is low but 
it still decreases significantly with ageing (Fig 3.1D, D’). However, this is not accelerated in the 
absence of telomerase (tert-/-), suggesting different mechanisms other than telomere 








Fig 3.1. Zebrafish retina ageing is characterised by thinning of the central retina, 
accompanied by decreased proliferation and increased apoptosis and DNA damage. This 
occurs independently of telomerase. (A) Schematic figure of the zebrafish retina with 
respective layers and cell types. (B) Representative images of the central and (C) peripheral 
retina in both WT and tert-/-, at young (5 months) and old ages (>30 months in WT and 20 in 
tert-/-). The staining was performed in 4μm-thick paraffin sections. Bars: 20μm. (B’-C’) 
Quantifications of the overall retina thickness (in μm) using DAPI staining, in (B’) central and 
(C’) peripheral retina. The black line represents WT and the red line represents tert-/-. Error 
bars represent the standard error of the mean (SEM). N=3. (D-F) Representative images of 
central retina immunolabelled with (D) PCNA (proliferative cells, in green), (E) TUNEL 
(apoptotic cells, in green) and (F) γH2AX; EdU (DNA damage, in white, and proliferating cells, 
in purple), in the central retina of both WT and tert-/-, at young (5 months) and old ages (>30 
months in WT and 12 or 20 in tert-/-). Bars: 20μm. The staining was performed in (E, F) 16μm-
thick or (E) 4μm-thick paraffin sections. (F) Yellow arrows highlight γH2AX+; EdU- cells, 
putative senescent cells. (D’-F’) Quantifications of the number of (D’) PCNA+ cells, (E’) TUNEL+ 
cells and (F’) γH2AX+; EdU- cells, per area (10 000 μm2). The black line represents WT and red 
line represents tert-/-. Error bars represent the SEM. (D’) N=6-12; (E’, F’) N=3-4. Statistics: two-
way ANOVA (WT vs tert-/- at young versus old ages) and one-way ANOVA (WT and tert-/- over-
time). Differences between genotypes are indicated above each time-point, whereas 
differences over-time in each genotype are indicated in the end of the lines, in black WT, in 
red tert-/-. P-value: * <0.05; ** <0.01; *** <0.001. 
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Contrary to the central retina, there is no obvious overall thinning of the peripheral retina 
with natural ageing nor in the absence of telomerase (Fig 3.1C, C’ and Supplementary Fig 1B). 
Although the CMZ is known to be proliferative, its proliferation activity decreases with ageing 
(Supplementary Fig 1C) and seems to be insufficient to drive telomere-dependent arrest of 
cell cycle. Reduced proliferation with ageing is therefore unlikely to be the driving 
mechanisms for retinal degeneration, whereas cell death is likely to play a more important 
role. 
Increased activated caspase-3 has been shown in the aged zebrafish retina (Van Houcke et 
al., 2019). However, this was not quantified, and it remains unclear whether this was 
associated with telomerase-dependent DNA damage. Moreover, there are other forms of cell 
death that are not caspase-3 dependent. We therefore used a more generalised early cell 
death marker which labels DNA breaks, Terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL). We found that there is significantly increased cell death in the aged central 
retina (Fig 3.1E, E’). Again, cell death occurs independently of telomerase, as increased 
number of dying cells was not accelerated in the tert-/- model when compared with their WT 
counterpart.  
Cellular senescence, which is characterised by a permanent cell cycle arrest and persistent 
DNA damage response (reviewed in Tchkonia et al., 2013), has also been suggested to 
increase in the aged retina, in mammals and zebrafish (Majji et al., 2000; Van Houcke et al., 
2019; Wing et al., 1978). Our results show that the decrease in cell proliferation with ageing 
is accompanied by accumulation of strong γH2AX nuclear foci, a molecular marker for DNA 
damage, in non-proliferating cells (EdU-negative) (Fig 3.1F, F’), potentially representing 
senescent cells. We now show that this increase in DNA damage also occurs in a telomerase-
independent manner, as no differences are identified between genotypes at any time-point 
analysed.  
Together, these data show that aging in the retina is characterized by decreasing 
proliferation, accompanied by increasing DNA damage and cell death. These events are likely 
to contribute to the retinal thinning observed in the aged retina. Importantly, although this 
DNA damage is likely underpinning the previously reported increase in SA-β-gal (Van Houcke 
et al., 2019), we show that this is unlikely to be a telomere-dependent and therefore unlikely 
to be replicative senescence. 
78 
 
3.4.1.1 Morphological alterations and neurodegeneration  
Besides its role in cellular proliferation, telomerase has been shown to have telomere-
independent (i.e. non-canonical functions), including in zebrafish (Alcaraz-pe et al., 2014). For 
instance, in the central nervous system, it has been suggested that telomerase has a 
neuroprotective role against oxidative damage (Ahmed et al., 2008; Haendeler et al., 2009). 
In fact, telomerase activity is identified in post-mitotic neurons in the adult zebrafish retina 
(Wui-Man Lau et al., 2008), where telomerase could exert telomere-independent functions. 
We therefore tested whether telomerase played a role in age-related morphological 
alterations and neurodegeneration in the zebrafish retina. To test this, we carried out cell 
labelling using immunohistochemistry for several molecular markers (Supplementary Table 
1) throughout the lifespan of zebrafish, in the presence and absence of telomerase (tert-/-).  
The loss of photoreceptor integrity is one of the key features of human retina ageing and 
disease, including decreased photoreceptor number and integrity (Nian & Lo, 2019) and this 
has been shown to also happen with ageing in the zebrafish retina (Van Houcke et al., 2019). 
Rhodopsin immunolabelling confirmed that, like in humans, rod photoreceptor outer 
segments in the zebrafish retina undergo dramatic structural changes with ageing, losing their 
long and rectangular characteristic shape (Fig 3.2A). Qualitative analysis of rhodopsin shows 
that 100% of young WT fish present long and aligned outer segments whereas 100% of old 
WT fish present short and misaligned outer segments (Fig 3.2A’). Like for other phenotypes, 
these defects are not accelerated in the tert-/- at the comparable age tested of 5 months old, 
suggesting this is likely a telomerase-independent phenomenon (Fig 3.2A’). The structural 
changes we observe in the rods’ outer segments are accompanied by disruption of the tight 
junction protein zonula occludens (ZO-1) (Fig 3.2B), a marker for the outer limiting membrane 
thought to be involved in photoreceptor degeneration (Fu et al., 2018). Qualitative analysis 
shows that whereas the majority of young WT fish show a continuous ZO-1 line underlying 
the photoreceptors, all of the old WT fish present breaks in the ZO-1 (Fig 3.2B’). These defects 
are also not accelerated in the tert-/- at the comparable age tested of 5 months old, suggesting 







Fig 3.2. Retina thinning with ageing is accompanied by structural and morphological 
alterations, and neurodegeneration, which occur independently of telomerase. (A-C) 
Representative images of central retina immunolabelled with (A) rhodopsin (photoreceptors 
outer segments, in green), (B) ZO1 (outer limiting membrane, in red) and (C) ribeye (pre-
synaptic ribbons, in green), in both WT and tert-/-, at young (5 months) and old ages (>30 
months in WT and 12 months in tert-/-). The staining was performed in 4μm-thick paraffin 
sections. The red arrows in panel B point to the outer limiting membrane (ZO-1-expressing 
line). Bars: 20μm. (A’-C’) Quantification of the percentage of fish presenting defects in (A’) 
rhodopsin (short and misaligned outer segments), (B’) ZO1 (broken outer limiting membrane) 
and (C’) ribeye (collapsed ribeye layers). The black line represents WT and the red line 
represents tert-/-. Error bars represent the SEM. (A’-B’) N=3-6; (C’) N=4-9. (D) Representative 
images of central retina immunolabelled with HuCD and protein kinase C, or PKC (amacrine 
in magenta and bipolar cells in green, respectively), in both WT and tert-/-, at young (5 months) 
and old ages (>30 months in WT and 12 months in tert-/-). The staining was performed in 
16μm-thick paraffin sections. Bars: 20μm. (E-H) Quantifications of the number of HuCD-
positive neurons (E) in the overall retina, (F) in the GCL (ganglion cells) and (G) in the INL 
(amacrine cells). (H) Quantifications of the number of PKC-positive neurons in the INL (bipolar 
cells). (E-H) The black line represents WT and red line represents tert-/-. Error bars represent 
the SEM. N=3-4. The quantifications were performed per area of the retina (10 000 μm2). CMZ: 
ciliary marginal zone; BP: bipolar cell; AC: amacrine cell; MG: müller glia; RGC: retinal ganglion 
cell; GCL: granular cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer 
plexiform layer; ONL: outer nuclear layer; PR: photoreceptor. Statistics: (A’-C’) Qui-square; (E-
H) two-way ANOVA (WT vs tert-/- at young versus old ages) and one-way ANOVA (WT and tert-
/- over-time). Differences between genotypes are indicated above each time-point, whereas 
differences over-time in each genotype are indicated in the end of the lines, in black WT, in 
red tert-/-. P-value: * <0.05; ** <0.01; *** <0.001. 
81 
 
The RGCs, ACs and BCs are neurons that come together to make connections in the major 
synaptic neuropil, called the inner plexiform layer (IPL). We confirmed alterations in the 
synaptic IPL layer with ageing. Usually, the IPL is characterised by 6 distinct layers of pre- 
synaptic ribbons, as observed in zebrafish young ages (Fig 3.2C). However, this structure is 
collapsed in the aged zebrafish retina, where IPL displays decreased number and 
disorganisation of pre-synaptic ribbons (Fig 3.2C’). This pre-synaptic ribbon pathology is not 
accelerated in the tert-/- at the comparable age tested of 5 months old, suggesting this is likely 
a telomerase-independent phenomenon. Such alterations in the synapses of the IPL are 
known to influence neurotransmission in the retina. We therefore investigated the potential 
role of telomerase in more subtle alterations in the number of RGCs in GCL, and BCs and ACs 
in INL (Fig 3.2D). As expected, there is an overall neuronal loss with ageing in the zebrafish 
retina (Fig 3.2E). Importantly, this neuronal loss is not due to a decreased number of HuC/D-
expressing RGCs in the GCL (Fig 3.2F), but due to a decreased number of HuC/D-expressing 
ACs (Fig 3.2G), and PKC-expressing BCs in the INL layer (Fig 3.2H). Additionally, in the aged 
zebrafish retina, BCs display disorganised axon terminals in the IPL. However, once again, 
neuronal loss is not accelerated in the absence of telomerase, suggesting that this is also a 
telomerase-independent phenomenon. 
 
3.4.2 MG do not proliferate in response to chronic retinal neurodegeneration with 
ageing 
Our data show there is significant accumulation of cell death and neuronal loss 
accompanying retinal thinning with ageing. However, it remains unclear whether these age-
related degenerations are being counteracted to some degree by compensatory proliferation 
and, in particular, by the well-described regenerative response of MG in the retina. PCNA 
staining in the central retina suggested that there was no compensatory proliferation in this 
region (Fig 3.1E, E’). To characterise the steady state regenerative capacity of the retina until 
old age, we carried out a 3-day pulse of EdU followed by 0- and 30-days chase, in young and 
old WT and tert-/- zebrafish (Fig 3.3A). It is known that acute injury elicits a compensatory 
proliferation response in the zebrafish retina. We therefore hypothesised that the observed 










Fig 3.3. Aged zebrafish retina does not show signs of regeneration in response to 
spontaneous cell death and neuronal loss. (A) Schematic figure of the experimental design: 
3-day pulse of EdU, by IP injection, followed by 0- or 30-day chase; (B) and respective 
expected results. We anticipated that in a healthy young fish, the retina has some cells 
proliferating in the CMZ, which, over-time, will replace older cells in the central retina. In the 
case of injury, we anticipate that there will be elevated levels of proliferation in peripheral 
and central retina in order to replace the death cells. (C-D) Representative images of central 
and peripheral retina immunolabelled with EdU (in purple), at (C) 0- and (D) 30-days chase, in 
WT at young (5 months), middle (12 months) and old ages (>30 months), and tert-/- young (5 
months) and old (12 months). The staining was performed in 16μm-thick paraffin sections. 
Bars: 20μm. (C’, C’’, D’, D’’) Quantifications of the number of EdU-retaining cells per area (10 
000 μm2), in the overall (C’) central and (C’’) peripheral retina at 0-days chase and in the 
overall (D’) central and (D’’) peripheral retina at 30-days chase. (E) Quantifications of the 
number of EdU-retaining cells per area (10 000 μm2), per layer of the retina, at 0-days chase. 
Error bars represent SEM. N=3-6. (F) Representative images of central retina immunolabelled 
with GS (müller glia, in red) after a 3-day pulse of EdU, by IP injection, at 0-days chase, in WT 
at young (5 months) and old ages (>30 months). The staining was performed in 16μm-thick 
paraffin sections. Bars: 20μm. (F’) Quantifications of the number of GS+; EdU+ cells per area 
(10 000 μm2). Error bars represent SEM. N=3-6. CMZ: ciliary marginal zone. Statistics: Two-
way ANOVA (WT vs tert-/- at young versus old ages) and one-way ANOVA (WT and tert-/- over-
time). Differences between genotypes are indicated above each time-point, whereas 
differences over-time in each genotype are indicated in the end of the lines, in black WT, in 
red tert-/-.  P-value: * <0.05; ** <0.01; *** <0.001. 
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However, we observe few EdU positive cells and, instead of a compensatory proliferation 
response, we detect less EdU positive cells with ageing, suggesting overall reduced 
proliferative capacity (Fig 3.3C, C’). These levels are also reduced after a 30-days chase (Fig 
3.3D, D’), suggesting that there are very few cells proliferating at all in the aged central retina. 
As the CMZ is known to be the most proliferative area in the adult retina, we tested whether 
we could detect more EdU-retaining cells in the peripheral retina in both young and old 
zebrafish. In the peripheral retina, at 0-days chase, we see double of the EdU-retaining cells 
than in the central retina (Fig 3.3C, C’, D, D’). Nevertheless, as in the central retina, 
proliferation decreases with ageing (see also PCNA staining in Supplementary Fig 1C), 
suggesting that there is no compensatory proliferation in response to the observed increased 
cell death in natural ageing.  
To test whether there was any compensatory proliferation with ageing occurring from rod-
specific progenitors found scattered throughout the ONL of the retina (Johns & Fernald, 1981; 
Stenkamp, 2015), we quantified levels of EdU positive cells in the ONL. These progenitors are 
derived from slowly dividing MG (Bernardos et al., 2007; Lenkowski & Raymond, 2014; 
Otteson et al., 2001; Raymond et al., 2006). These rod precursors undergo a terminal mitosis 
to generate new rod photoreceptors (Johns & Fernald, 1981). Although we observe EDU+ cells 
in the central ONL of 5 months WT (likely to be rod precursors dividing), there are barely any 
detected in >30 months old aged WT. Once again, removing telomerase (tert-/-) had no further 
effect (Fig 3.3E). This shows that there is also no compensatory proliferation occurring in this 
region in response to the increased cell death with ageing, in the presence nor absence of 
telomerase. 
Finally, as proliferation of MG is the primary source of neurons after injury in fish 
(Bernardos et al., 2007), we sought to determine whether there was any compensatory 
proliferation occurring in this cell population. To do so, we co-labelled cells with the classical 
marker of MG, glutamine synthetase (GS), and EdU, and identified the GS-positive; EdU-
positive cells. We detected very few GS-positive; EdU-positive cells in the central retina in 
both WT and tert-/-, at any time-point throughout their lifespan (Fig 3.3F, F’), suggesting MG 
are also not proliferating in the central retina at old ages. Together, our data show that there 
is no compensatory proliferation in response to age-related degeneration in the zebrafish 
retina, by any of the known sources of regeneration and neurogenesis: CMZ, rod precursor 
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cells and MG. Perhaps not surprisingly given the very low levels of proliferation in the first 
place and the fact that there is no compensatory proliferation, removing telomerase (tert-/- 
mutants) has no further effect. In summary, contrary to acute damage, our data show that 
age-related chronic cell death does not trigger proliferation of MG cells. 
 
3.4.3 Zebrafish vision declines with ageing, independently of telomerase 
Loss of visual acuity and contrast sensitivity with advancing age in humans has been well 
documented (Marshall, 1987; Salvi et al., 2006). As we observe pathological cellular changes 
in the aged zebrafish retina, we next wondered if vision is affected in the aged zebrafish. 
Visual testing in the zebrafish has been used to screen for mutants with defects in retinal 
development and function (Brockerhoff et al., 1995; Gross et al., 2005; Lessieur et al., 2019; 
Neuhauss et al., 1999). However, it is unclear if zebrafish show age-associated changes in 
visual acuity. In order to determine age-related changes in vision in naturally aged adult WT, 
we used the optokinetic response (OKR) assay. The OKR is a well-established assay to measure 
innate visual responses and provides a readout of visual acuity (Brockerhoff et al., 1995; 
Tappeiner et al., 2012) (Fig 3.4A). Our results show a decreased number of eye rotations per 
minute in aged fish (Fig 3.4B), suggesting that zebrafish vision declines with ageing. As it was 
previously shown that telomerase expression is important for macular function in humans 
(Dow & Harley, 2016; Rowe-Rendleman & Randolph, 2004), we used the tert-/- zebrafish 
model to test whether reduced telomerase expression with ageing could underpin changes in 
vision. Our data show that, in comparison with its WT counterpart, the tert-/-  zebrafish does 
not display and accelerated reduced visual acuity at 5 months or 12 months of age, close to 
the end point of tert-/-  life (Fig 3.4B). Together, our data show that the zebrafish retina 
displays significant age-related decrease of visual acuity. Importantly, these phenotypes are 
occurring in an age-dependent but telomerase-independent manner, as is the case for all key 
hallmarks of retina ageing measured so far (Supplementary Table 1). Telomerase seems 
therefore not required for the maintenance of the key retina steady state homeostasis 








Fig 3.4. Zebrafish vision declines with ageing, independently of telomerase. (A) OKR assay 
was performed by immobilising the fish in between soft sponges, inside a petri dish containing 
water, placed in the centre of a rotation chamber. The walls of the rotation chamber had 0.8 
mm-thick black and white stripes and the chamber was maintained at a constant velocity of 
12 rpm throughout the experiment. (B) The number of eye rotations per minute was manually 
quantified by video observation. The black line represents WT and the red line represents tert-
/-. Error bars represent the SEM. N=5-8. Statistics: two-way ANOVA (WT vs tert-/- at young 
versus old ages) and one-way ANOVA (WT and tert-/- over-time). Differences between 
genotypes are indicated above each time-point, whereas differences over-time in each 




3.4.4 MG retain the ability to regenerate the light damaged retina in aged zebrafish 
It is well described that retinal cell death in response to acute injury leads to a regenerative 
response in zebrafish. However, in the context of chronic damage with ageing, we do not 
observe a MG proliferative regenerative response. Therefore, we next sought to determine 
whether the observed retinal degeneration could be due to the MG cells losing their capacity 
to regenerate in old age. In acute damage models it has been shown that several damage 
paradigms induce retinal neuron death and elicit a regenerative response in young or adult 
zebrafish (Bernardos et al., 2007; Cameron, 2000; Hanovice et al., 2019; Ranski et al., 2018). 
In adults, specifically between 9-18 months of age, repeated light-damage treatments result 
in MG continuously re-entering the cell cycle and proliferate to regenerate lost neurons, 
although they do show signs of chronic activation (Ranski et al., 2018). It remains unknown 
whether this regenerative capacity is maintained until old age. Nevertheless, retinal 
regeneration studies typically focus on adult retinas, not taking into account old age on 
regenerative response. To test this, we used the light-damage model where aged zebrafish 
were treated with light to elicit photoreceptor damage. To detect increased proliferation of 
MG in response to damage, a 3-day pulse of BrdU was performed, followed by a 28-days chase 
period (Fig 3.5A). After a 3-day pulse, BrdU should label both MG and their daughter cells, the 
newly-formed progenitors (Fig 3.5B). Our results show that light-lesion in the retina elicits an 
initial damage response characterized by the strong recruitment of microglia. These microglia 
are preferentially localized near the ONL, suggesting photoreceptors are worst affected, a 
typical feature of this damage model (Fig 3.5C). The recruitment of microglia to the retina 
reaches comparable levels across all ages tested. Moreover, there are no differences in the 
incorporation of BrdU with ageing on any layer, at 72 hours post-light damage (hpL), when 
the initial regenerative response is mounted, or at 28 dpL, when the number of MG that 
initially re-entered the cycle can be identified. Both the unaltered immediate timing of MG 
response and the overall capacity to regenerate each neuronal layer are maintained with 
increased age. Together these results suggest that the regenerative response remains intact 
throughout zebrafish lifespan. Therefore, the lack of compensatory proliferation in response 
to chronic, age-associated cell death in the ageing zebrafish retina is not due to a loss of 
capacity for MG to proliferate per se, but likely due to the absence or insufficient levels of the 







Fig 3.5. Zebrafish MG regenerative capacity upon acute damage is maintained until old ages. 
(A) Schematic image of the experimental design. To damage the retina and induce a 
regenerative response we place zebrafish in 30 minutes of direct light from a UV light source. 
The zebrafish are then immediately placed in light from Halogen lights for up to 4 days. A 
retinal section at 0 hours of light shows the undamaged retina. At 48 hours after the onset of 
light a majority of the photoreceptors (green) are destroyed. (B) Schematic image of the 
expected results. (C) Representative images of the central retina labelled with 4C4 (microglia, 
in green), after light onset, in young (12 months), middle aged 20 months) and old (>30 
months) albino zebrafish. The majority of the microglia response to damage occurs within the 
outer segments (OS) and nuclear layer (ONL) of the retina, where a debris field is present due 
to photoreceptor degeneration. (C’) Quantification of the number of microglial cells which 
responded to photoreceptor damage in the different aged groups (young represented in black, 
middle aged in blue and old in grey). (D) Representative images of the central retina 72 hours 
after light onset, immunolabeled with BrdU (proliferation, in green). (D’). Quantification of 
the number of cells proliferating in the ganglion cell layer (GCL, represented in black squares), 
inner nuclear layer (INL, represented in grey squares), and outer nuclear layer (ONL, 
represented in white squares) in each age group. (E) Representative images of the central 
retina 28 days after light onset. Fish were light treated for 24 hours and BrdU incorporation 
occurred between 24-72 hrs (green), which allowed for BrdU to be washed out the 
proliferating progenitors, leaving only MG which re-entered the cell cycle to be labelled. (E’). 
Quantification of the number of BrdU+ cells observed in the GCL, INL, and ONL of each aged 




3.4.5 The zebrafish retina shows signs of gliosis, not regeneration, with ageing 
In the mammalian retina, including human, gliosis is commonly observed in ageing and in 
response to neuronal damage. Gliosis in the retina typically involves two main glial cells, MG 
and microglia, which are the innate immune cells found in the nervous system. Microglia are 
key players in maintaining tissue homeostasis throughout life. They are activated in many 
neurodegenerative diseases, with increased number at sites of damage, including in the 
photoreceptor layer in many forms of retinal degeneration, reviewed in (Telegina et al., 2018). 
We therefore asked whether the age-dependent degeneration we described so far was 
accompanied by alterations in the number of microglia (4C4-positive cells) in the aged 
zebrafish retina. Surprisingly, despite there being no difference in numbers of microglia (4C4-
positive cells) in the aged WT (Fig 3.6A, B), we observe an increased number of microglia co-
labelling with TUNEL (4C4+ TUNEL+ cells) in natural WT ageing (Fig 3.6A, C). This suggests that 
there is an increased number of microglia encompassing staining for DNA double-strand 
breaks, potentially indicating microglia death or the engulfment of a dying cell. 
MG respond to damage or injury in most, if not all, neurodegenerative diseases. The typical 
mammalian response is gliosis, whereby MG change shape and upregulate structural proteins 
like GFAP to promote a neuroprotective effect (Bringmann et al., 2009; Reichenbach & 
Bringmann, 2013). In the zebrafish retina, the initial regenerative response is similar to 
mammalian gliosis (Ranski et al., 2018; Thomas et al., 2016), which can be enhanced if 
proliferation is blocked (Thummel et al., 2008). Here, we identified MG using GS 
immunolabeling and characterized MG reactivity using the gliosis marker GFAP. We do not 
observe an overall change in MG number with ageing (Fig 3.6D, D’). Despite this, there is a 
significant change in the structure/morphology of the MG cells in the WT aged retina. 
Aberrations in the aged MG cells include disruptions in the radial morphology along the 
synaptic IPL and basal lamina (Fig 3.6E, E’), which are known hallmarks of gliosis in retina 
degeneration (Telegina et al., 2018). Qualitative assessment show that while all young fish 
display long and aligned intermediate filaments, 100% of the old fish present short, 
misaligned intermediate filaments, a marker of gliosis. Thus, similarly to humans, chronic 
neurodegeneration with ageing elicits a gliotic response in the zebrafish retina rather than 







Fig 3.6. Zebrafish retina undergoes neuro-inflammation and gliosis with ageing. (A) 
Representative images of central retina immunolabelled with 4C4 (microglia, in white) and 
TUNEL (apoptotic cells, in green), in WT, at young (5 months) and old ages (>30 months). The 
staining was performed in 4μm-thick paraffin sections. (B-C) (B-C) Quantification of the 
number of (B) 4C4-positive cells (microglia) and (C) 4C4-positive; TUNEL-positive cells 
(microglia entering apoptosis), per area (10 000 μm2). Each dot represents one animal. Error 
bars represent the SEM. N=3. (D, E) Representative images of the central retina 
immunolabeled with GS (müller glia, in red) and (E) GFAP (reactive MG, in green), in WT at 
young (5 months), middle (12 months) and old ages (>30 months). Bars: 20μm. The staining 
was performed in (D) 4μm-thick paraffin sections or (E) 13μm-thick cryosections. (D’-E’) 
Quantifications of the number of (D’) GS-positive cells (MG) per area (10 000 μm2), and (E’) 
percentage of fish presenting disorganised GFAP filaments (gliosis-like phenotype). N= 3-6. 
Statistics: (B-C) unpaired t-tests; (D’) one-way ANOVA followed by Bonferroni post-hoc tests; 




Using a combination of different cell labelling strategies from adulthood into old age in the 
zebrafish retina, we show that the zebrafish retina undergoes degeneration with ageing in a 
telomerase-independent manner. Contrasting to the acute damage contexts, ageing-induced 
cell death is insufficient to stimulate the MG regenerative response to replace lost cells. 
Instead, with ageing, MG develop a gliosis-like phenotype, more similar to the cellular 
changes observed in the aged human eye. 
 
3.5.1 Telomerase dependent and independent hallmarks of retina zebrafish ageing 
Previous work has shown that there are aspects of the human retina particularly sensitive 
to telomere shortening with ageing. Specifically, the RPE is known to be highly proliferative 
and thus have short telomeres. Accordingly, reactivation of telomerase has been described 
to ameliorate symptoms of AMD (Dow & Harley, 2016; Rowe-Rendleman & Randolph, 2004) 
and telomerase activators are currently in clinical trials (e.g. NCT02530255). However, retina 
homeostasis requires more than RPE maintenance. It also requires a steady-state level of 
proliferation of different cell types involved in multiple aspects of retina function. As in other 
proliferative tissues (Anchelin et al., 2013; Carneiro et al., 2016; Henriques et al., 2013), it 
would make sense that telomerase levels would influence zebrafish retina homeostasis. We 
therefore hypothesised that the zebrafish retina would degenerate in a telomerase-
dependent manner, leading to vision loss. However, our data suggest that most age-related 
changes we observe in the retina, including vision loss are largely telomerase independent, 
since depletion of telomerase (tert-/-) does not accelerate or exacerbate any of these 
phenotypes. Telomere dysfunction is well known to affect mostly highly proliferative tissues 
(reviewed in Henriques & Ferreira, 2012), and our data show that in the region most affected 
by ageing phenotypes, the central retina, there is very low levels of proliferation to start with. 
Even in the most proliferative region of the retina, the peripheral region containing the CMZ, 
proliferation is still not high enough to be affected by depletion of telomerase. Importantly, 
proliferation decreases further with ageing in both regions, so it makes sense that removing 
telomerase has no further additive effect. This suggests that replicative exhaustion of 
telomeres is not a limiting factor in the age-associated degeneration of the central retina. 
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Instead, it is likely that chronic exposure to damaging agents such as oxidising UV radiation is 
the key driver of degeneration in the retina. However, we cannot exclude that telomere-
associated damage may still be a contributing factor to the observed increased levels of DNA 
damage and cell death or senescence in the central retina. Telomeres are known to be 
damaged by oxidative stress and can act as sinks of DNA damage, irrespectively of length and 
levels of telomerase (Hewitt et al., 2012). In fact, this is a likely contributor to RPE damage 
with ageing (Wang et al., 2018), potentially explaining why depleting telomerase has no effect 
on the proliferation of the ONL, where photoreceptors reside, nor does it accelerate vision 
loss. 
 
3.5.2 Chronic vs. acute damage in MG responses to natural ageing 
Regenerative mechanisms in the retina are an area of intense study and offer great hope 
for treatment of human disease. As the incidence of retina degeneration increases with age, 
regenerative capacity in the aged retina is a significant consideration for the efficacy of these 
therapies. Our results show that zebrafish develop vision loss with ageing and that this is 
underpinned by retinal neurodegeneration and gliosis. This could seem counter-intuitive, 
given that it is well established that the zebrafish retina is capable of regenerating after acute 
damage. Therefore, our data demonstrating a lack of regeneration after age-related cell death 
suggest that there are critical differences between chronic ageing and repair after an acute 
injury. Further supporting this, we show that this lack of regeneration in the context of ageing 
is not due to an intrinsic inability of MG to proliferate per se, as we show they are still capable 
of doing so in response to an acute injury in old animals. 
Several tissues in the zebrafish retain the ability to regenerate throughout the lifespan of 
the zebrafish, including the fin and the heart (Itou et al., 2012; Pinto-teixeira et al., 2015). 
Likewise, the optic nerve crush paradigm has shown that there is successful recovery and 
function in the zebrafish retinotectal system (Van houcke et al., 2017) suggesting that 
regeneration is still possible at advanced age in the retina. The regenerative capacity of 
vertebrate tissues tends to decrease after repeated injury and as animals advance in age. This 
is likely due to reduced progenitor cell proliferation potential and subsequent differentiation 
(Collins et al., 2007). In the context of the central nervous system, this is aggravated by gliosis, 
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a reactive change in glial cells in response to damage. In the mammalian retina, MG cells 
undergo gliosis in response to damage and in many retina degenerative diseases (Bringmann 
et al., 2009). However, in the zebrafish retina MG cells undergo the initial reactive gliotic 
response after damage but quickly shift to the regenerative pathway. Here, we show that 
while we observe morphology alterations in MG cells in response to age-related 
neurodegeneration, MG in the aged retina retain their ability to regenerate in response to 
acute damage of photoreceptors. It is unclear if alternative damage models will also lead to 
similar regenerative response.  
These observations raise a question about what mechanisms drive the behavioural switch 
of MG cells, from gliotic response to repair, and why they fail to be engaged in aging related 
retinal damage. Previous research in the context of acute damage to the zebrafish retina has 
uncovered some of the mechanisms. For instance, proliferation appears to be a key 
mechanism for the initiation of the regenerative response, as blocking proliferation after 
damage in the zebrafish retina results in MG gliosis and a lack of regeneration, similarly to 
mammals (Thummel et al., 2008). As retinal neurons and their synapses degenerate with age, 
this may result in a loss of neurotransmitter release, such as gamma-aminobutyric acid 
(GABA), which has been shown to facilitate the initiation of MG proliferation (Rao et al., 2017). 
Thus, dysregulation of neurotransmitters upon neurodegeneration could inhibit the key 
molecular pathways regulating regeneration. Alternatively, the initial inflammatory response 
has also been shown to be determinant for the repair process. Upon light-induced retinal 
damage, overexpression and subsequent release of TNFα by apoptotic photoreceptors seems 
to induce MG proliferation (Iribarne et al., 2019; Thomas et al., 2016). It remains unknown 
whether there is increased levels of TNFα with natural ageing and how this levels compared 
with the levels observed in response to acute damage. Additionally, not only there is an 
increased number of microglia upon retina’s injury (Mitchell, et al., 2019) but also its presence 
has been shown to be essential for retina’s regeneration (Conedera et al., 2019). Conversely, 
we show that the number of microglia in the retina does not increase with age. However, it 
remains unknown whether the unaltered number of microglia identified in the ageing retina 
is compromising the regenerative response.  
Finally, it remains unclear what is the consequence of the gliotic-like response on retinal 
neurons in the aged retina, as gliosis is classically thought of as “Janus-faced”, with both pro- 
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and anti- neuroprotective functions (Bringmann et al., 2009). Importantly, the kinetics of this 
gliosis relative to the neurodegeneration may provide further clues to the precise cellular 
breakdown in the retina resulting in widespread neuronal death and retinal dysfunction. 
More specifically, it is unclear whether ageing first affect the MG support functions for 
neurons, and therefore significantly contribute to the neuronal death, or whether it is purely 
a response to the damage. A higher temporal resolution of retina stages throughout life and 
novel markers for glial support functions may provide an answer. 
 
3.5.3 Our proposed model: A molecular “tipping point” required to stimulate 
regeneration in ageing 
Regeneration studies so far have relied on several damage paradigms, including phototoxic 
(Ranski et al., 2018) and ouabain induced lesions (Mitchell et al., 2019), which induce rapid 
cell death post-insult. While acute damage models are suitable to explore the cellular and 
molecular mechanisms underpinning the regenerative potential of the retina, they do not 
allow testing whether this regenerative response is also occurring with natural ageing in the 
retina. “Natural ageing” and associated stress-induced neuronal death play out over months 
or even years and we now show that they do not elicit the same regenerative response. This 
may be because the slow degeneration is not producing a strong enough signal in a short 
amount of time to induce MG to undergo the cellular and molecular process of regeneration 








Fig 3.7. While zebrafish can regenerate the retina upon acute damage until late ages, its 
regenerative capacities do not prevent cell death, degeneration and consequent retina 
thinning with natural ageing. Schematic figure with the working model. In natural ageing, 
zebrafish retina undergoes degeneration characterised by increased cell death and neuronal 
loss. Our current findings show that the proliferation levels are low in young ages and 
decrease even more with advancing age (represented in magenta). Moreover, the number of 
microglia, a key play in retina regeneration, is maintained stable throughout lifespan, with a 
potential increased number of microglia dying. The lack of Müller glia (MG) proliferation in 
response to chronic, age-related damage seems to lead to retina thinning with ageing, where 
death cells are not replaced. Middle: In contrast, in response to acute damage where there is 
a great number of dying cells followed by recruitment of microglia, MG proliferates, 
generating new neuronal cells, which replace the dying ones. Our current findings show that 
zebrafish is able to regenerate its retina in response to acute damage until late ages (>30 
months), suggesting that the lack of regeneration in response to chronic damage is not due 
to MG’s inability of proliferate. 
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Supporting this, it has been shown that the level of cell death can induce a differential 
response of MG cells. Whilst a large amount of rod death causes a regenerative response, 
small amounts do not (Montgomery et al., 2010; Thomas et al., 2012). In support of this 
concept, recent work suggests that there may be key signalling differences underpinning the 
difference between a “regenerative” or a “reparative” response to injury (Conedera et al., 
2019). Thus, we propose that there are yet-to-be determine molecular pathways involved in 
the “tipping point” required to elicit a regenerative response in ageing. Such signal may derive 
from microglia, which are known to stimulate MG proliferation. Indeed, an acute damage in 
the retina is followed by an increased number of microglia, which are recruited to the injury 
site (Mitchell et al., 2019; White et al., 2017). Moreover, recruitment of microglia to the injury 
site has been shown to be crucial for tissue regeneration (White et al., 2017). Is it clear that 
while we detect a great number of microglial cells in the injury site upon light damage, in both 
young and old fish, we detect low numbers of microglia in a normal condition, which is 
maintained throughout zebrafish life-course. It may be that the low-level of damage observed 
in the aged retina is not enough to trigger key signalling pathways that would, in turn, be 
responsible for the microglial recruitment. In parallel, we observed increased number of 
microglia expressing TUNEL staining with ageing, suggesting that microglia might be dying 
with ageing. Nonetheless, it is important to consider that this technique has some limitations 
and therefore co-labelling of 4C4 and TUNEL could also represent a dying cell or cell fragments 
(containing DNA) inside microglial cells. Thus, we cannot exclude the possibility that microglial 
cells have increased, but de-regulated phagocytic capabilities with ageing, or alternatively, 




Our work demonstrates that in response to age-induced neuronal degeneration the MG in 
the zebrafish retina respond by undergoing a response more akin to gliosis, rather than 
regeneration. This resembles what happens in the aged human retina, thereby demonstrating 
it as a suitable model to explore cellular and molecular mechanisms relevant to 
neurodegeneration in the human retina during ageing and disease. Importantly, we show that 
there are key differences between chronic and acute tissue damage, particularly involving 
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gliosis. Thus, gliosis is an important mechanism to consider for targeting endogenous 
regeneration mechanisms, aiming to prevent and/or delay human retinal degeneration and 
visual impairment. 
 
3.6 Materials and Methods 
3.6.1 Zebrafish husbandry 
Zebrafish were maintained at 27-28ºC, in a 14:10 hour (h) light-dark cycle and fed twice a 
day. The OKR was performed in the UCL Institute of Ophthalmology and the phototoxic lesions 
and regeneration experiments were performed at Wayne State University School of Medicine 
(USA). All other experiments were performed in the University of Sheffield. All animal work 
was approved by local animal review boards, including the Local Ethical Review Committee at 
the University of Sheffield (performed according to the protocols of Project Licence 70/8681) 
and the Institutional Animal Care and Use Committee at Wayne State University School of 
Medicine (performed according to the protocols of IACUC-19-02-0970). 
 
3.6.2 Zebrafish strains, ages, and sex 
Three strains of adult zebrafish (Danio rerio) were used for these studies: wild-type (WT; 
AB strain), tert-/- (tertAB/hu3430), and albino (slc45a2b4/b4). tert-/- zebrafish is a premature 
model of ageing and therefore, age and die earlier than the naturally aged zebrafish. While 
tert-/- fish have a lifespan of 12-20 months, WT fish typically die between 36-42 months of age 
(Carneiro et al., 2016; Henriques et al., 2013). In order to study age-related phenotypes in the 
zebrafish retina, here we used young (5 months) WT and tert-/- fish, alongside with middle 
aged (12 months) WT fish, and old WT and tert-/- fish. ‘Old’ was defined as the age at which 
the majority of the fish present age-associated phenotypes, such as cachexia, loss of body 
mass and curvature of the spine. These phenotypes develop close to the time of death and 
are observed at >30 months of age in WT and at >12 months in tert-/- (Carneiro et al., 2016; 
Henriques et al., 2013). In addition, we used adult albino zebrafish for retinal regeneration 
studies (described in detail below). Importantly, none of the animals included in this study 
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displayed visible morphological alterations in the eyes (e.g. cataracts). Whenever possible, 
males where chosen to perform the experiments 
 
3.6.3 OKR assay 
Fish were anaesthetised in 4% tricaine methanesulfonate (MS-222; Sigma-Aldrich) and 
placed in a small bed-like structure made of sponge, located inside a small petri dish 
containing fish water. During the experiment, fish were maintained still by the strategic use 
of needles that sustained the sponges close to the fish so that the fish could not move. The 
petri dish was then placed inside a rotation chamber with black and white striped walls (8 
mm-thick stripes). After fish recovered from anaesthesia, the trial began, and the walls of the 
chamber started rotating at 12 rpm (for 1min to the left side followed by 1 min to the right 
side). The eyes’ movement was recorded using a camera throughout the experiment.  
After the experiment, the number of eye rotations per minute was measured by video 
observation and manually counting. The counting was performed blindly by two independent 
researchers. In the end, the results were normalised for the WT young from the same day / 
batch, in order to control for different days of experiment. 
 
3.6.4 Intense light-damage paradigm with BrdU incorporation 
 A photolytic damage model in adult albino zebrafish was utilized to destroy rod and cone 
photoreceptors and elicit a regenerative response (Thomas et al., 2012). Briefly, adult albino 
zebrafish were dark-adapted for 10 days prior to a 30 min exposure to ~100,000 lux from a 
broadband light source. Next, fish were exposed to ~10,000 lux of light from four, 250 W 
halogen lamps for 24 hrs. Following 24 hrs of light treatment, fish were transferred to a 1L 
solution containing 0.66 g of NaCl, 0.1 g Neutral Regulator (SeaChem Laboratories, Inc. Stone 
Mountain, GA, USA), and 1.5 g BrdU (5mM; B5002; Sigma-Aldrich) for 48 hrs. This timeframe 
for BrdU incubation was based on previous studies in order to label MG cell-cycle re-entry 
(Ranski et al., 2018). Following a 48 hour incubation in BrdU, the fish were split into two 
groups: one group was euthanized by an overdose of 2-Phenoxyethanol and eyes were 
processed for immunohistochemistry as described below; the second group returned to 
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normal husbandry conditions for an additional 25 days (or 28 days after light onset) prior to 
euthanasia and tissue collection. During this time, BrdU incorporation dilutes in actively 
dividing cells, allowing for clear visualization of the number of MG in the INL that only divide 
a single time. It also serves as an indirect measure of regenerative capacity (i.e. an equal loss 
of BrdU-positive cells at 28 dpL between experimental groups would indicate similar numbers 
of progenitor cell divisions earlier in the regenerative process).     
 
3.6.5 Tissue preparation: paraffin-embedded sections and cryosections 
Adult fish were culled by overdose of MS-222, followed by confirmation of death. Whole 
fish or dissected eyeballs were then processed for paraffin-embedded sections or for 
cryosections, as follows: 
Paraffin-embedded sections. Whole fish were fixed in in 4% paraformaldehyde (PFA) 
buffered at pH 7.0, at 4ºC for 48-72h, decalcified in 0.5M EDTA at pH 8.0 for 48-72h, and 
embedded in paraffin by the following series of washes: formalin I (Merck & Co, Kenilworth, 
NJ, USA) for 10 min, formalin II for 50min, ethanol 50% for 1h, ethanol 70% for 1h, ethanol 
95% for 1h 30min, ethanol 100% for 2h, ethanol 100% for 2h 30min, 50:50 of ethanol 100% : 
xilol for 1h 30min, xylene I for 3h, xylene II for 3h, paraffin I for 3h and paraffin II for 4h 30min. 
Paraffin-embedded whole fish were then sliced in sagittal 4 μm-thick or coronal 16 μm-thick 
sections, using a Leica TP 1020 cryostat. 
Cryopreservation and cryosections. Dissected eyeballs were fixed in 4% PFA at 4ºC, 
overnight (ON). Then, they were washed in cold 1x PBS and immersed in 30% sucrose in 
phosphate-buffered saline (PBS), ON at 4ºC, for cryopreservation. Single cryopreserved 
eyeballs were then embedded in mounting media – optimal cutting temperature compound 
(OCT, VWR International), snap-frozen at −80°C, and stored at -20ºC until cryosectioning. 







3.6.6 Immunohistochemistry (IHC) 
Before immunofluorescence (IF) staining, cryosections were hydrated in PBS at room 
temperature (RT) for 10 min, and paraffin-embedded sections were deparaffinised and 
hydrated as follows: histoclear (Scientific Laboratory Supplies, Wilford, Nottingham, UK) 2x 
for 5min, followed by ethanol 100% 2x for 5 min, ethanol 90% for 5min, ethanol 70% for 5min, 
and distilled water 2x for 5 min. After antigen retrieval in 0.01M citrate buffer at pH 6.0 for 
10min, the sections were permeabilised in PBS 0.5% Triton X-100 for 10min and blocked in 3% 
bovine serum albumin (BSA), 5% Goat Serum (or Donkey Serum), 0.3% Tween-20 in PBS, for 
1h. The slides were then incubated with the primary antibody at 4°C ON. After washes in PBS 
0.1% Tween-20 (3x 10 min) to remove excess to primary antibody, the sections were 
incubated with secondary antibody at RT for 1h. Finally, the slides were incubated in 1 μg/ml 
of 4′,6-diamidino-2-phenylindole (DAPI, Thermo Fisher Scientific) at RT for 10 min, washed in 
PBS 1x, and mounted with vectashield (Vector Laboratories, Burlingame, CA, USA). The 




Table 3.1 Primary antibodies used for immunostaining. 
Antibody, 




Company, City, Country 
 




GTX127342; GeneTex, Irvine, CA, USA 
p53 rabbit polyclonal 1:200 AS-55342s; Labscoop, Little Rock, AR, USA 
PCNA mouse monoclonal 1:500 
NB500-106; Novus Biologicals, Littleton, CO, 
USA 
PCNA rabbit polyclonal 1:50 GTX124496; GeneTex, Irvine, CA, USA 
7.4.C4 (4C4) mouse 
monoclonal 
1:100 A gift from A. McGown 
HuCD mouse monoclonal 1:100 
A21271; Thermo Fisher Scientific, Waltham, 
MA, USA 
PKCβ1 rabbit polyclonal 1:100 Santa Cruz, Dallas, TX, USA 
Ribeye rabbit polyclonal 1:10,000 A gift from Teresa Nicholson 
GFAP rabbit polyclonal 1:200 Z0334, Agilent DAKO, Santa Clara, CA, USA 
GFAP mouse monoclonal 1:100 zrf1, ZIRC 
Glutamine Synthase (GS) 
mouse monoclonal 
1:150 mab302, Merck, Kenilworth, NJ, USA 
Rhodopsin rabbit 1:5,000  A gift from David Hyde 
BrdU rat 1:200 
OBT0030A, Accurate Chemical & Scientific, 




Table 3.2 Secondary antibodies used for immunostaining. 
Antibody,  




Company, City, Country 
 




A11008; Invitrogen, Carlsbad, CA, 
USA 
Goat anti-rat IgG Alexa Fluor® 488 1:500 
A11006; Thermo Fisher Scientific, 
Waltham, MA, USA 
Goat anti-rabbit IgG Alexa Fluor® 568 1:500 
10032302; Thermo Fisher Scientific, 
Waltham, MA, USA 
Donkey anti-rabbit IgG Alexa Fluor® 647 1:500 
A31573; Thermo Fisher Scientific, 
Waltham, MA, USA 
Goat anti-mouse IgG Alexa Fluor® 488 1:500 
A11001; Thermo Fisher Scientific, 
Waltham, MA, USA 
Goat anti-mouse IgG Alexa Fluor® 568 1:500 
10348072; Thermo Fisher Scientific, 
Waltham, MA, USA 
Goat anti-mouse IgG Alexa Fluor® 647 1:500 
A21235; Thermo Fisher Scientific, 
Waltham, MA, USA 
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3.6.7 Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) staining 
In paraffin-embedded sections, TUNEL was performed using the In Situ Cell Death 
Detection Kit, Fluorescein (Merck & Co), following the manufacturer’s instructions. Briefly, 
after deparaffinisation, hydration, antigen retrieval and permeabilization, as described above, 
the slides were incubated in enzyme and label solution (1:10) at 37ºC for 1h. The slides were 
then washed in 1x PBS (2x 10 min) before blocking and incubation with primary antibody. 
In cryosections, the slides were washed 1x PBS for 5 min and fixed in 4% PFA at RT for 15 
min. The PFA was washed off in 1x PBS for 5 min and the slides were then incubated in 20 
μg/mL Proteinase K (Fermentas stock #K0721) at RT for 8 min and washed in 1x PBS for 5min. 
The slides were post-fixed in 4% PFA at RT for 5min, rinsed in 1x PBS and stained with In situ 
cell death detection Kit, TMR Red from ROCHE (Cat#12 156 792 910) at 37°C for 1.5hr. Finally, 
the slides were washed in 1x PBS for 5 min and mounted with Vectashield Hard Set medium 
with DAPI (#H-1500). 
 
3.6.8 5-Ethynyl-2’-deoxyuridine (EDU) labelling 
EdU labelling was detected using the Click-iT® EdU Imaging Kit (Thermo Fisher Scientific), 
following manufacturer’s instructions. Briefly, fish were injected with 5μl of 10mM EdU 
diluted in dimethyl sulfoxide (DSMO), by intraperitoneal (IP) injection, for 3 consecutive days 
(3-day pulse). In order to differentiate proliferating cells and low-proliferative EdU-retaining 
cells, the fish were separated into two groups: 0-day chase and 30-days chase groups. The 
fish from the first group were culled 2h30min after the last injection of Edu, whereas the fish 
from the second group were culled 30 days after the last injection of EdU. After culling, whole 
fish were processed for paraffin-embedded sections as described above. 
In order to detect EdU labelling in paraffin-embedded sections, the slides were 
deparaffinised, hydrated, underwent antigen retrieved, were permeabilized and washed in 
1x PBS. The slides were incubated in freshly made EdU-labelling solution (per 1 ml of solution: 
860μl of 1x Click-iT®EdU reaction buffer, 40μl CuSO4, 2.5μl Alexa Fluor® 647 azide working 
solution and 100μl 10x EdU reaction buffer additive) at RT for 30min. Finally, the slides were 
washed in 1x PBS before blocking and incubation with primary antibody (ON, at 4ºC). The 
incubation in secondary antibody was performed as previously described. 
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3.6.9 Imaging and quantifications 
Paraffin-embedded sections were imaged by epifluorescence microscopy, using a 
DeltaVision microscope with a 40x oil objective. Cryosections were imaged by laser scanning 
confocal imaging, using a Leica SP5 microscope or a Nikon A1 Confocal microscope, with a 40x 
oil objective. In both cases, multiple 0.2-0.6 μm thick z-stacks were acquired in order to 
capture the whole section. For each staining, a total of 4 images were taken per retina, 2 from 
central and 2 from peripheral retinal.  
In order to quantify the staining, after making a z-projection, 3 boxes of 100x100 μm were 
drawn in each field of view (FOV). The total number of positive cells was then manually 
counted for each labelling. Rhodopsin, ZO1, ribeye and GFAP staining were an exception to 
this, for which a qualitative assessment was performed instead. To do so, structural and 
morphological defects were identified as follows. For the rhodopsin staining, as young WT 
retinas usually display long and aligned outer segments, all short and/or misaligned outer 
segments were considered defective. For the ZO1 staining, the average number of breaks in 
the ZO1-labelled membrane per animal was quantified. The average of breaks in the WT 
young animals was used as a reference, and any fish presenting an average number of breaks 
bellow this average was considered to present defects in the membrane. For the ribeye 
staining, young retinas usually present two distinguished layers of pre-synaptic ribbons. Thus, 
staining where the two layers of pre-synaptic ribbons are not distinguished, was considered 
defective. GFAP staining usually reveals long and aligned filaments in young WT retinas, and 
therefore broken, short and/or misaligned GFAP filaments were considered defective. 
Through this qualitative assessment it was calculated the percentage of fish per group 
presenting structural and morphological defects. 
Finally, raw images were used for quantification purposes. The images were then 
processed with Adobe Illustrator 21.0.2 for display purposes. 
 
3.6.10 Statistical analysis 
Statistics were performed using the GraphPad Prism v7.00. Normality was assessed by 
Shapiro-Wilk test. For normally distributed data unpaired t-test was used to compare 2 data 
points and one-way ANOVA followed by Bonferroni post-hoc test was used to compare more 
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than 2 data points. For non-normally distributed data, Mann-Whitney test and Kruskal-Wallis 
test followed by Dunn’s post-hoc test were used instead. Two-way ANOVA was used in order 
to compare more than 2 data points in 2 groups different groups (genotypes). Chi-square was 
performed to analyse structure and morphological changes in the retina based on qualitative 
assessment, having into account the number of animals per group displaying defects versus 
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3.10 Supplementary figures 
Fig 3.8. [Supplementary figure 1] Retina thinning in the aged zebrafish central and 
peripheral retina, per layer, and decreased proliferation in the zebrafish aged peripheral 
retina. (A-B) Quantifications of the retina thickness (in μm) using DAPI staining, in (A) central 
and (B) peripheral retina, in young and old WT and tert-/-. Error bars represent the SEM. N=3-
5 (C) Representative images of the peripheral retina immunolabeled with PCNA (proliferation, 
in green), in both WT and tert-/-, at young (5 months) and old ages (>30 months in WT and 20 
in tert-/-). The staining was performed in 16μm-thick paraffin sections. Bars: 20μm. (C’) 
Quantifications of the number of PCNA+ cells per area (10 000 μm2). The black line represents 
WT and red line represents tert-/-. Error bars represent the SEM. N=6-12. Statistics: (A-B) 
Unpaired t-tests; (C’) two-way ANOVA (WT vs tert-/- at young versus old ages) and one-way 
ANOVA (WT). Differences between genotypes are indicated above each time-point, whereas 
differences over-time in each genotype are indicated in the end of the lines, in black WT, in 







Table 3.3 [Supplementary table 1] Summary of the phenotypes observed in the aged 
zebrafish retina, and which phenotypes are telomerase-dependent or independent. 
 
Phenotype of WT aged 
 
Anticipated in tert-/-? 
At 5 
months 
At 12 months (end 
life for tert-/-) 




No No No 




No N/A No 
IPL 
 
No N/A No 
INL 
 
No N/A No 
OPL 
 
No N/A No 
ONL 
 
No N/A No 
Neuronal 
degeneration 
in central retina 
Rods morphology No N/A No 
 
ZO-1 membrane 




No N/A No 
 
BCs (PKC in INL) 
Yes No No 
 
ACs (HuCD in INL) 
No No No 
 
GCs (HuCD in GCL) 
No No No 
Hallmarks of cellular 
ageing 
In central retina 
Apoptosis 
 
No No No 
DNA damage/ 
senescence  









Fig 3.9. [Supplementary figure 2] Aged zebrafish retina does not show signs of regeneration 
in response to spontaneous cell death, neuronal loss and gliosis, in the peripheral retina. 
Moreover, this occurs in a telomerase-independent way. (A-B) Representative images of 
EdU-positive cells (purple) after a 3-day pulse of EdU, by IP injection, (A) at 0- and (B) 30-days 
chase, in the peripheral retina of both WT and tert-/-, at young (5 months) and  time of death 
(TOD, >30 months in WT and 12 months in tert-/-). The staining was performed in 16μm-thick 
paraffin sections. Bars: 20μm. (A’-B’) Quantifications of the number of EdU+ cells per area (10 
000 μm2), at (A’) 0- and (B’) 30-days chase. The black line represents WT and the red line 
represents the tert-/-. N=3-6. Error bars represent SEM. Statistics: two-way ANOVA (WT vs tert-








Chapter 4.  
Exploring if TERT restriction contributes to accumulation 
of cellular senescence in the zebrafish aged brain 
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4.1 Introduction  
Despite being considered predominantly a post-mitotic tissue, the brain displays telomere 
shortening with ageing in humans, rodents (rat and mouse) and fish (Arslan-Ergul et al., 2016; 
Bitto et al., 2010; Flanary & Streit, 2004). As expected, these species present low or 
undetectable levels of telomerase in the adult brain, which is a favoured environment for 
telomere shortening (Allsopp et al., 1995; Anchelin et al., 2011; Caporaso et al., 2003). 
Importantly, G4 TERC-deficient mice (Terc-/-) display increased levels of senescent-
associated markers in neurons (Jurk et al., 2012) and in microglia (Raj et al., 2015), compared 
with age-matched Terc+/+. This suggests that telomerase plays a protective role against 
accumulation of senescence in the ageing brain, via its role at telomeres. However, it remains 
unknown if the TERT component of telomerase also plays a protective role against senescence 
in the brain, either via its telomere-dependent (i.e canonical) or -independent functions (i.e. 
non-canonical). Understanding whether telomerase restriction contributes to cellular 
senescence in the brain and identifying the mechanisms behind it would potentially uncover 
new therapeutic targets to the promotion of healthy brain ageing. 
Evidence suggests that the TERT component of telomerase plays an important role in the 
brain, particularly in enabling cell proliferation capacity. In vitro, neural stem cells (NSCs) 
derived from TERT-deficient G4 TERT-ER mice (knock-in model where endogenous TERT 
expression is induced upon addition of 4-OHT) display impaired proliferation capacity and 
present increased p53 expression, which are rescued upon TERT restoration (Jaskelioff et al., 
2011). In vivo, TERT reactivation restores proliferation in the SVZ (Jaskelioff et al., 2011), 
suggesting that TERT expression affects proliferative regions of the brain. It is still unclear 
whether this is due to telomere length maintenance or non-canonical functions of telomerase, 
since reports suggest that telomerase can promote proliferation independently of telomere 
maintenance (Choi et al., 2008; Sarin et al., 2005). Furthermore, it remains to be investigated 
if TERT expression has any impact on cellular senescence, and whether it also affects non-
proliferative regions of the brain. As it was shown that the zebrafish brain presents low levels 
of TERT in the adult brain, which tend to decrease with ageing (Sprungala, 2009), I hypothesise 
that limited expression of TERT in the aged zebrafish brain contributes to the accumulation 
of senescence with ageing. 
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To test this hypothesis, in this Chapter I aimed to determine if the zebrafish brain 
accumulates cellular senescence with natural ageing and, if so, whether this is accelerated in 
the absence of TERT expression. More specifically, I have assessed if the zebrafish brain 
accumulates senescence with ageing in the presence (WT) and absence (tert-/-) of Tert, in an 
in vivo setting. To do so, I have assessed several senescence-associated markers, using 





4.2 Measuring cellular senescence in the naturally aged zebrafish brain 
In order to test whether there is accumulation of senescence in the zebrafish brain, with 
natural ageing, I have assessed several senescence-associated markers throughout zebrafish 
lifespan. To do this, I used fish of different ages, from young (4-6 months) to old (>30 months).  
As mentioned in Chapter 1, SA-β-Gal expression is a biomarker of cellular senescence, at 
least in most of the cell types tested (Dimri et al., 1995). Apart from accumulating SA-β-Gal, 
senescent cells are known to display increased levels of DNA damage, commonly identified 
through accumulation of γH2AX foci, as well as up-regulation of p53, cdkn1α (p21), cdkn2α 
(p16-like) and cyclin g1 genes (Campisi & d’Adda di Fagagna, 2007; van Deursen, 2014). Thus, 
these markers were assessed by using complementary techniques, including IHC and RT-qPCR. 
 
4.2.1 Assessing SA-β-Gal expression in the naturally aged WT brain 
SA-β-Gal expression was analysed by X-gal staining at pH 6.0, as described in section 2.4.2. 
To validate the assay, I tested whether the blue staining observed in the sections was 
specifically due to the cleavage of X-gal by galactosidase, and not due to an artefact. To test 
this, adjacent sections of the brain were stained with and without X-gal substrate. Only the 
brain sections incubated with X-gal substrate presented the blue chromogenic staining, 
indicating the presence of galactosidase, specifically at pH 6.0 (Fig 4.1). This assay was 
therefore considered viable to assess SA-β-Gal expression in the zebrafish brain. 
In order to test whether there is an increased expression of SA-β-Gal with ageing in the 
zebrafish brain, SA-β-Gal staining was performed in cryosections of young (4-6 months) and 
old (>30 months) WT brains. The percentage of area containing SA-β-Gal staining was then 
quantified in the whole brain, using the method described in section 2.4.4.  
The results showed a significant increase in SA-β-Gal expression with natural ageing in the 
whole zebrafish brain (p=0.0009, Fig 4.2A, B). It was also observed that SA-β-Gal staining did 
not accumulate in all regions of the brain, which suggests that some regions might be more 




Fig 4.1. Control experiment showing that blue staining is specific of X-gal cleavage by galactosidase. 
Representative images from two adjacent brain sections of an old WT fish (rhombencephalon region), after SA-
β-Gal staining. Without X-gal substrate (left) there is no blue staining in the section. The blue staining is only 
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                                           B  
 
Fig 4.2. SA-β-Gal expression in the whole zebrafish brain with natural ageing. (A) Representative 
images of the SA-β-Gal staining in different regions of the brain, in young (4-6 months) and old (>30 
months) WT zebrafish. (B) Quantifications of SA-β-Gal staining, in % of blue area, as described in 
section 2.4.4. Graphs: X-axis, age in months; Y-axis, % of blue area. N=7 per group. Each dot 
represents one animal. Error bars represent SEM. Unpaired t-test: * p<0.05; ** p<0.01; *** p<0.001.  

















4.2.2 Assessing DNA damage in the naturally aged WT brain 
Senescent cells are known to have high levels of DNA damage, commonly measured by the 
accumulation of γH2AX foci. Hence, in order to test whether there is accumulation of DNA 
damage with ageing in the zebrafish brain, I compared the number of γH2AX foci in paraffin 
sections of young (9-17 months) and old (>30 months) WT fish. γH2AX foci were detected by 
IF, using the anti-γH2AX antibody, as described in section 2.3.2. This antibody had already 
been tested in the laboratory and previously published (Carneiro et al., 2016). The percentage 
of cells containing >5 γH2AX nuclear foci in sections of the whole zebrafish brain was then 
assessed as described in section 2.3.5.  
The results showed a small increase in the number of γH2AX-positive cells in the zebrafish 
whole brain, over-time, that did not reach statistical significance (p=0.075, Fig 4.3A, B). Similar 
results were identified when assessing the number of non-proliferative cells expressing DNA 
damage (PCNA-negative; γH2AX-positive cells – data not shown), suggesting that these cells 






    B 
 
 
Fig 4.3. DNA damage foci in the whole zebrafish brain with natural ageing. (A) Representative 
image of yH2AX staining by IF, in young (9-17 months) and old (>30 months) adult zebrafish brain. 
(B) Quantification of the percentage of yH2AX+ cells with ageing in the whole brain. Graphs: X-axis, 
age in months; Y-axis, percentage of yH2AX+. N=5-6 per group. Each dot represents one animal. Bar 
errors represent the SEM. Unpaired t-test: * <0.05; ** <0.01; *** <0.001. 
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4.2.3 Assessing the expression of senescence-associated markers downstream of 
yH2AX, in the naturally aged WT brain 
In response to increased DNA damage, senescent cells commonly display up-regulation of 
p53, p21 and p16, accompanied by down-regulation of target genes essential for cell-cycle 
(Coppé et al., 2008; van Deursen, 2014). Since I had observed a trend for increased DNA 
damage in the aged brain, I then sought to measure the gene expression of p53, p21 and p16-
like, in order to further characterise which pathways of senescence are being activated in the 
naturally aged WT zebrafish brain. Here, I also analysed the expression of cyclin g1, a cyclin-
dependent kinase known to be a target of p53 in zebrafish (Danilova et al., 2010).  
In order to measure gene expression of p53, p21, p16-like and cycling g1 over-time in the 
zebrafish brain, mRNA expression was analysed by RT-qPCR, as described in section 2.5.3. The 
mRNA analysed in this experiment was derived from whole brain tissue from young (6-9 
months), middle aged (22-24 months) and old (>30 months) fish. The mRNA expression of the 
genes of interest was then normalised for beta-actin (reference gene) and analysed using the 
ΔΔCt method, as described in section 2.5.3. 
Prior to the experiment, the primers were optimised, as described in section 2.5.3, with all 
sets of primers presenting slopes between 3.206 and 3.397 (Fig 4.4A-E). Moreover, no non-
specific amplifications were observed during the melting curve of the tested primers (Fig 4.4F). 
As shown in Fig 4.5A-D, the results revealed no significant differences in the expression of 
p53 (6-9m vs 22-24m: p=0.551; 6-9m vs >30m: p=0.769), p21 (6-9m vs 22-24m: p=0.142; 6-9 
vs >30m: p=0.863), p16-like (6-9m vs 22-24m: p=0.127), or cyclin g1 (6-9m vs 22-24m: p=0.999; 
6-9 vs >30m: p=0.999), in the whole zebrafish brain with natural ageing.  
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Fig 4.4. Optimisation of primers. Efficiency curves for all the genes optimised: (A) beta-actin, (B) 
p53, (C) p21, (D) p16-like and (E) cyclin g1. (F) Representative image of a melting curve; this is 



















Fig 4.5. mRNA relative expression of key downstream effectors of γH2AX in the whole zebrafish 
brain. mRNA relative expression of (A) p53, (B) p21, (C) p16-like and (D) cyclin g1 genes, in the young 
(6-9 months), middle aged (22-24 months) and old (>30 months) zebrafish brain. For this, the mRNA 
expression of each target gene was normalised to the reference gene (beta-actin) and analysed 
using the ΔΔCt method, as described in section 2.5.3. Graphs: X-axis, age in months; Y-axis, mRNA 
relative expression normalised to the WT 6-9 months of age, as described in section 2.5.3. N=3-6 
per group. Each dot represents one animal. Bar errors represent the SEM. Statistics: (A, B, D) 
Kruskal-Wallis test followed by Dunn’s post-hoc test or (C) Mann-Whitney test. * <0.05; ** <0.01; 
*** <0.001.  
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4.3 Determining the role of TERT in senescence accumulation in the zebrafish brain 
If accumulation of senescence in natural WT ageing were telomerase (TERT) dependent, 
then one would predict that removing TERT would accelerate it. To test this, I compared the 
levels of senescence in the WT brain with the telomerase mutant zebrafish (premature ageing 
model tert-/-), over-time. As mentioned in Chapter 1, the tert-/- model ages faster and dies 
prematurely, at around 12-18 months of age as compared to >30 months in WT. Thus, here I 
compared young (4-6 months) tert-/- versus WT brain, and old tert-/- (12-17 months) versus 
WT (>30 months) brain.  
As I previously observed that SA-β-Gal expression accumulates differently between the 
different regions of the brain (see Fig 4.2), instead of assessing the whole brain, here I sought 
to determine which specific regions of the brain accumulate cellular senescence with ageing. 
To do this, I quantified senescence-associated markers in the 5 main macroareas of the 
zebrafish brain, at different ages throughout their life-course. The macroareas analysed 
included the telencephalon (Tel), the optic tectum (OT), the diencephalon (Die), the 
cerebellum (Ce) and the medulla oblongata (MO). 
 
4.3.1 Assessing SA-β-Gal expression in the tert-/- brain 
In order to test whether increased expression of SA-β-Gal with ageing is accelerated in the 
absence of TERT, SA-β-Gal staining was performed in brain cryosections of young (4-6 months) 
tert-/- fish, and compared with young (4-6 months) and old (>30 months) WT fish. SA-β-Gal 
was assessed by X-gal staining at pH 6.0, as described in section 2.4.2. The percentage of blue 
area (SA-β-Gal staining) in each macroarea of the brain was then quantified as described in 
section 2.4.4. 
SA-β-Gal staining was detected in both WT old and tert-/- young fish in specific regions of 
the forebrain, midbrain and hindbrain. In particular, in the forebrain, SA-β-Gal staining was 
observed along the midline of the telencephalon (Fig 4.6A-B, C1) and, in abundance, 
throughout all the diencephalon with exception of the hypothalamus (Fig 4.6A-B, C2-3). In 
the midbrain, SA-β-Gal staining was detected in the periventricular grey zone (PGZ) and 
stratum opticum (SO) of the optic tectum (Fig 4.6A-B, C2-3). In the hindbrain, SA-β-Gal 
staining was observed in discrete spread zones of the cerebellum, appearing to be more 
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prominent in the Purkinje cell layer (PCL) (Fig 4.6A-B, C4), as well as in the medulla oblongata. 
The medulla oblongata was the macroarea that presented the highest levels of SA-β-Gal, 
displaying blue staining everywhere, with the strongest staining being identified close to the 
medullary canal (Fig 4.6A-B, C4-5). 
Quantification of the SA-β-Gal staining per macroarea revealed no statistically significant 
differences in SA-β-Gal expression over-time, in the WT telencephalon and optic tectum (Tel: 
p=0.182; OT: p=0.359) (Fig 4.7A, B). SA-β-Gal expression was not accelerated in the absence 
of telomerase in the optic tectum, as no differences were detected between WT and tert-/- at 
4-6 months in this region (p=0.859). Nonetheless, there was a small increase in SA-B-Gal 
expression in the young tert-/- telencephalon, when compared with the age-matched WT, that 
did not reach statistical significance (p=0.061). 
In contrast with the telencephalon and optic tectum, the results showed a significant 
increase of SA-β-Gal expression over-time in the WT diencephalon (p=0.028, Fig 4.7C) and a 
small increase in the cerebellum, that did not reach statistical significance (p=0.075, Fig 4.7D). 
Interestingly, 4-6 months old tert-/- already presented higher levels of SA-β-Gal than its WT 
counterpart, in both macroareas (Die: p=0.028; Ce: p=0.036). 
Finally, in the medulla oblongata, SA-β-Gal staining was already observed in some young 
WT fish (4-6 months), and no increasing SA-β-Gal expression was identified with natural 
ageing (p=0.258, Fig 4.7E), or in the absence of TERT (p=0.600).
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Fig 4.6. Representative images of SA-β-Gal staining in the different brain macroareas, in young 
and old WT fish, and tert-/- young fish. (A) Schematic figure of the zebrafish brain and respective 
macroareas. (B) Key for coloured arrows. (C) Representative images of SA-β-Gal staining in the 
different macroareas of the brain, in young (4-6 months) and old (>30 months) WT and young (4-6 
months) tert-/-. Scale bar: 200μm. Numbers 1 to 5 represent different locations of the brain, from 
the anterior to the posterior part of the brain. Abbreviations: OB, Olfactive Bulb; Tel, Telencephalon; 
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Fig 4.7. Telomerase-dependent accumulation of SA-β-Gal in the ageing brain in the different brain 
macroareas. Quantifications of SA-β-Gal staining, as described in section 2.4.3, in the (A) 
telencephalon (B) optic tectum, (C) diencephalon, (D) cerebellum and (E) medulla oblongata. 
Graphs: X-axis, age in months; Y-axis, % of blue area. N=3-10 per group. Each dot represents one 
animal. Error bars represent the SEM. Mann Whitney test: * p<0.05; ** p<0.01; *** p<0.001. 
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4.3.2 Assessing DNA damage in the tert-/- brain 
In order to test whether accumulation of DNA damage with ageing is accelerated in the 
absence of TERT, DNA damage was quantified in paraffin sections of young (4-5 months) and 
old (9-17 months) tert-/- fish, and compared with young (4-5 months), middle aged (9-17 
months) and old (>30 months) WT fish. DNA damage was assessed by the presence of γH2AX 
foci, detected by IF, as described in section 2.3.2. The percentage of γH2AX-positive cells in 
each macroarea of the brain was then quantified as described in section 2.3.5. 
The results showed no significant change in the percentage of γH2AX-positive cells with 
natural ageing, in the telencephalon and optic tectum (WT: Tel: p=0.156; OT: p=0.567) (Fig 
4.8A, B). Moreover, accumulation of DNA damage in these macroareas was not accelerated 
in the absence of TERT, as no differences were detected between tert-/- and WT at any time-
point tested (Tel, 4-6m: p=0.999; 9-17m: p=0.999; OT, 4-6m: p=0.999; 9-17m: p=0.228).  
In contrast, there was an increased percentage of γH2AX-positive cells with natural ageing 
in the diencephalon and cerebellum (Die: p=0.006, Ce: p=0.0003 Fig 4.8C, D). In the 
diencephalon this was specifically observed between the ages of 9-17 and >30 months 
(p=0.016). Moreover, tert-/- model presented higher levels of DNA damage in both 
macroareas at the age of 9-17 months, when compared with its WT counterpart (Die: p=0.025, 
Ce: p=0.031).  
Due to technical issues it was not possible to obtain slides with tissue from the medulla 
oblongata in WT and tert-/- groups, and therefore DNA damage in this macroarea was not 
analysed.  
Overall, the results showed an accumulation of DNA damage in brain, with natural ageing, 
specifically in the diencephalon and cerebellum, the same regions where it was identified 
accumulation of SA-β-Gal. Furthermore, accumulation of DNA damage and SA-β-Gal in these 
regions, but not in other regions of the brain, was accelerated in the tert-/- model. Together, 
these data show that there is accumulation of cellular senescence in the zebrafish 












Fig 4.8. Age-dependent accumulation of DNA damage with ageing in the different brain 
macroareas, in the presence and absence of telomerase. Quantifications of γH2AX-positive cells in 
different macroareas of the zebrafish brain: (A) telencephalon (B) optic tectum, (C) diencephalon 
and (D) cerebellum. Graphs: X-axis, age in months; Y-axis, % of γH2AX-positive cells. N=3-7 per 
group. Each dot represents one animal. Error bars: SEM. Statistics: two-way ANOVA test was used 
to compare WT versus tert-/- at 4-5m versus 9-17m; Kruskal-Wallis followed by Dunn’s post-hoc test 
was used to analysis WT over-time. * p<0.05; ** p<0.01; *** p<0.001.  
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4.4 Assessing potential replicative senescence in the aged zebrafish brain 
Cells that undergo replicative senescence are characterised by a lack of proliferative 
activity and by the presence of critically short telomeres (Hayflick, 1965; Hayflick & Moorhead, 
1961). Therefore, to test whether the accumulation of SA-β-Gal and DNA damage in the 
ageing brain are associated with replicative senescence, I measured proliferation levels and 
telomere length in the ageing zebrafish brain, in WT and tert-/-. Using the tert-/- here allowed 
to have a control for what it can be considered short telomeres and associated replicative 
senescence, as it has been previously described in other tissues (Anchelin et al., 2013; 
Carneiro et al., 2016; Henriques et al., 2013). 
 
4.4.1 Assessing proliferation levels in the ageing WT and tert-/- brain  
Given that senescent cells are non-proliferative cells, as cellular senescence accumulates 
in the tissue, one would expect decreased number of proliferating cells. In order to test 
whether there is decreased cell proliferation with ageing in the zebrafish brain, and whether 
this is accelerated in the absence of TERT (i.e. telomerase-dependent), proliferation levels 
were quantified in paraffin sections of young (4-5 months) and old (14-17 months) tert-/- fish, 
and compared with young (4-5 months), middle aged (14-17 months) and old (>30 months) 
WT fish. Proliferation was detected by IF, using an antibody against PCNA, an antigen that 
label cells during S-phase, as described in section 2.3.2. This antibody had already been tested 
in the laboratory and previously published in zebrafish (Carneiro et al., 2016; Henriques et al., 
2013). The percentage of PCNA-positive cells (proliferating cells) was counted as described in 
section 2.3.5 and used as a measure of proliferative activity. 
The results did not show any differences in proliferation with natural ageing, in the 
telencephalon and optic tectum (Tel: p=0.448; OT: p=0.694) (Fig 4.9A-C). Moreover, 
decreased levels of proliferation in these macroareas were not accelerated in the absence of 
TERT, as no differences were detected between WT and tert-/- at any time-point tested (Tel: 
4-5m: p=0.999 14-17m: p=0.999; OT: 4-5m: p=0.999, 14-17m: p=0.999).  
In the diencephalon, there was a small decrease in proliferation over-time in natural ageing 
that was borderline significant (p=0.058, Fig 4.9D). Moreover, in the cerebellum, there was a 
reduced percentage of cells dividing with natural ageing (p=0.022, Fig 4.9E). Decreased 
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proliferation levels were not accelerated in the absence of TERT as no differences were 
identified between WT nor tert-/- at any time-point tested, either in the diencephalon (4-5m: 
p=0.999, 14-17m: p=0.999) or in the cerebellum (4-5m: p=0.999, 14-17m: p=0.999). 
Proliferation levels were not assessed in the medulla oblongata due to technical issues. In 












Fig 4.9. Proliferation in the ageing brain zebrafish brain, per macroarea, in the presence (WT) and 
absence of telomerase (tert-/-). (A) Representative images of PCNA staining in the diencephalon of 
adult zebrafish. (B-E) Quantifications of % of PCNA-positive cells in the different macroareas of the 
zebrafish brain, including: (B) telencephalon, (C) optic tectum, (D) diencephalon and (E) cerebellum. 
Graph: X-axis, age in months; Y-axis, % of PCNA-positive cells. N=3-6 per group. Each dot represents 
one animal. Bar errors represent the SEM. Statistics: two-way ANOVA test was used to compare WT 
versus tert-/- at 4-5m versus 9-17m; Kruskal-Wallis followed by Dunn’s post-hoc test was used to 
analysis WT over-time: * <0.05; ** <0.01; *** <0.001. 
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4.4.2 Measuring relative telomere length in the aged WT and tert-/- brain 
Accumulation of cellular senescence with natural ageing, assessed by SA-β-Gal and DNA 
damage, was particularly detected in the diencephalon and cerebellum (see Fig 4.7, Fig 4.8), 
and this was accompanied by decreased proliferation levels (see Fig 4.9). Therefore, I then 
sought to test whether accumulation of cellular senescence was associated with critically 
short telomeres, which would suggest this would be replicative senescence. If this were to be 
replicative senescence, then it would be telomerase dependent, and therefore removing TERT 
would accelerate it. To test this, I measured relative telomere length, in situ, in brain tissue of 
young and old tert-/- fish (3-5 versus 12-17 months), and compared it against young and old 
WT fish (3-5 versus >30 months).  
Relative telomere length was assessed in situ, by telo-FISH, by hybridising the tissues with 
a PNA telomere oligonucleotide, as described in section 2.3.3. The probe signal intensity was 
then measured as described in section 2.3.3. A centromere-specific probe was used alongside, 
and its signal intensity was used to calculate the telomeres/centromeres ratio, ensuring that 
telomere length was controlled for proliferation state. This technique had already been tested 
in the laboratory. 
The results showed no significant differences in telomere length in the WT brain over-time 
(p=0.146) (Fig 4.10A, B). Nonetheless, there was a small decrease in telomere length in the 
tert-/-, in comparison with its WT counterpart, at 3-5 months of age, that did not reach 








Fig 4.10. Relative telomere length in the whole zebrafish brain with ageing. (A) Representative 
images of telomeres and centromeres in the diencephalon of adult zebrafish. (B) Quantification of 
telomeres/centromeres ratio analysed as described in section 2.3.3. Graphs: X-axis age in months; 
Y-axis, telomeres/centromeres ratio, expressed in mean intensity value. N=4-5 per group. Each dot 




Replicative senescence is likely to accumulate in proliferative zones, where there is 
accelerated telomere attrition. Therefore, I decided to test whether telomere shortening 
occurs in specific areas of the brain. To do this, telomere length was measured in all the 
individual macroareas of the brain. This was performed in paraffin sections of young (3-5 
months) WT and tert-/- fish, and compared with old WT (>30 months) and old tert-/- (14-17 
months) fish. 
The results showed a decrease in telomere length with natural ageing in the telencephalon, 
optic tectum and cerebellum (Tel:  p=0.034, OT: p=0.027, Ce: p=0.046) (Fig 4.11A, B, D). In 
contrast, telomere shortening with natural ageing was not observed in the diencephalon and 
medulla oblongata (Die: p=0.215, MO: p=0.327) (Fig 4.11C, E). Additionally, the tert-/- model 
displayed already shorter telomeres than its WT counterpart at the age of 3-5 months in the 
optic tectum (p=0.009). A small decrease in telomere length was also observed in the tert-/- 
model when compared with WT (3-5 months), in the telencephalon (p=0.076), diencephalon 
(p=0.077) and medulla oblongata (MO: p=0.054). However, this did not reach statistical 
significance. In contrast, no differences between genotypes were identified at 3-5 months of 
age in the cerebellum (p=0.106), or at 12-17 months of age in any of the macroareas (Tel: 
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Fig 4.11. Relative telomere length in the ageing zebrafish brain, per macroareas. (A-E) 
Quantification of telomeres/centromeres ratio analysed as described in section 2.3.3, per 
macroareas: (A) telencephalon, (B) optic tectum, (C) diencephalon, (D) cerebellum and (E) medulla 
oblongata. Graphs: X-axis, age in months; Y-axis, telomeres/centromeres ratio, expressed in mean 
intensity value. N=4-6 per group. Each dot represents a cell. Bar errors represent the SEM. Random 
effects ANOVA: * <0.05; ** <0.01; *** <0.001. 
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This Chapter aimed to determine whether TERT expression plays a role in protecting the 
ageing zebrafish brain against accumulation of cellular senescence. If so, whether this was 
due to its role at telomeres. In order to test this, I aimed to determine whether: (1) the 
zebrafish brain accumulates senescence with ageing and whether this is accelerated in the 
absence of TERT, and (2) whether accumulation of TERT-dependent senescence is 
accompanied by telomere shortening and therefore likely to be replicative senescence. 
 
Accumulation of cellular senescence in the naturally aged zebrafish brain 
In order to test if there is accumulation of cellular senescence in the zebrafish brain, with 
natural ageing, and whether this is accelerated in the absence of telomerase, I assessed 
different markers of senescence in the WT and tert-/- zebrafish, throughout their lifetime. My 
initial study of the whole brain (i.e. without looking at any specific macroareas) identified 
increased SA-β-Gal expression in the brain, with natural ageing, accompanied by a small 
increase in DNA damage that did not reach significance. Similarly, a previous study in zebrafish 
had already identified accumulation of DNA damage in the whole brain from 12 months of 
age onwards (S. Zhu & Coffman, 2017). Moreover, accumulation of cellular senescence in the 
ageing brain is not an exclusive characteristic of zebrafish, as mice also display increased levels 
of SA-β-Gal and γH2AX in the aged brain, at least in some cell populations (Jurk et al., 2012). 
Nonetheless, this project failed in identifying any alteration in gene expression of down-
effectors of γH2AX, commonly associated with cellular senescence, including p53, p21 and 
p16. Although it remains unknown if these genes are up-regulated in the aged zebrafish brain, 
up-regulation of these genes has been identified in the aged mice brain, at least in some cell 
populations. These cell populations include endothelial cells (p16 and p21) (Yamazaki et al., 
2016), microglia (p21) (Raj et al., 2015), and cortical and Purkinje neurons (p53) (Jurk et al., 
2012). It is important to note, though, that the SA-β-Gal staining hinted at potential 
accumulation of cellular senescence in specific macroareas, which could explain the lack of 
results when assessing whole brain expression of p53, p21 and p16 genes. Indeed, further 
analysis showed this to be the case. 
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Analysis per macroareas of the brain revealed that accumulation of cellular senescence 
does not occur homogeneously throughout the brain. Instead, this accumulation seems to 
occur specifically in the diencephalon and cerebellum, the only regions of the brain displaying 
increased levels of SA-β-Gal and DNA damage foci with natural ageing (see Table 4.1).  
The fact that the small increase in SA-β-Gal expression in the aged cerebellum was 
borderline significant may be due to the reduced sample size used. Effect sizes showed that 
this experiment was underpowered, and it would be required a minimum of 34 animals per 
group, warranting further investigation with an increased number of animals.  
Moreover, the fact that accumulation of senescence was only identified in two macroareas 
of the brain may explain the lack of differences observed in the expression of p53, p21, and 
p16 in the aged zebrafish brain. As gene expression was analysed in RNA extracted from whole 
brain, the signal from a low number of senescent cells (which is expressed only in certain 
regions of the brain) is likely to have been masked by non-senescent cells in the surrounding. 
The analysis of p21, p16 and p53 expression in the whole brain tissue therefore revealed to 
be a technical limitation in this project. In the future, it would be important to confirm these 
results by analysing individual macroareas, or even specific cell populations after cell sorting.  
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Table 4.1 Summary of the brain macroareas that display accumulation of senescence, reduced 
proliferation and telomere shortening with ageing in WT and tert-/- zebrafish. In WT, the age 
represents the time-point from which differences started being observed. In tert-/-, the age represents 
the time-point where differences are detected in comparison with their WT counterpart. Age is 
represented in months. Tel: Telencephalon, OT: Optic tectum, Die: Diencephalon, Ce: Cerebellum, MO: 
Medulla oblongata. 
 SA-β-Gal  DNA damage  Proliferation  Telomere length  
WT tert-/- WT tert-/- WT tert-/- WT tert-/- 
Tel - 4-6m* - - - - >30m 3-5m* 
OT - - - - - - >30m 3-5m 
Die >30m 4-6m >30m 9-17m >30m* - - 3-5m* 
Ce >30m* 4-6m >30m 9-17m >14-17m - >30m* - 
MO - - - - - - - 3-5m* 




The role of TERT in accumulation of cellular senescence in the zebrafish brain 
Importantly, accumulation of senescence in the diencephalon and cerebellum, but not in 
other macroareas of the brain, was accelerated in the tert-/- (versus the WT). A slight but non-
significant increase in SA-β-Gal was also observed in the telencephalon of tert-/- at 4-6 months 
of age (versus young WT). However, in the absence of DNA damage it is not possible to 
conclude that there is increased senescence in this region of the brain. This is because, as 
mentioned in section 1.3.2, SA-β-Gal alone cannot be considered a universal marker of 
senescence and, ideally, should be used in combination with other markers of senescence. 
Together, the data shown here suggest that there is accumulation of cellular senescence in 
the zebrafish diencephalon and cerebellum, with natural ageing, as assessed by increased 
levels of DNA damage and SA-β-Gal. Importantly, this is accelerated in the absence of TERT, 
suggesting that the TERT component of telomerase plays a protective role against 
accumulation of cellular senescence in the aged zebrafish brain.  
Contrary to what was found in this project, a previous study in WT zebrafish had reported 
an increased expression of SA-β-Gal in the telencephalon at >26 months of age (Arslan-Ergul 
et al., 2016). However, in that study the authors did not assess other markers of senescence 
(Arslan-Ergul et al., 2016). Considering that in some contexts SA-β-Gal can be expressed in 
non-senescent cells (Severino et al., 2000; Yang & Hu, 2005), and that no other marker of 
senescence was not used in the study, it is not possible to conclude with certainty that there 
is accumulation of cellular senescence in the aged zebrafish telencephalon. To my knowledge, 
there are no other studies in zebrafish assessing cellular senescence in the different regions 
of the brain. Nevertheless, some studies in mice have reported accumulation of cellular 
senescence with ageing in different brain regions.  
Similarly to what was observed in this project, increased SA-β-Gal and γH2AX foci are 
identified in the aged mice cerebellum, particularly in Purkinje cells (PCs) (Jurk et al., 2012). 
Additionally, this is aggravated in the absence of TERC (G4 TERC-/-) (Jurk et al., 2012). 
Cerebellar PCs are thought to be one of the most sensitive neuronal populations in the brain, 
suffering several age-associated changes that lead to loss of function (Zhang, Zhu, & Hua, 
2010). In mammals, degeneration of this neuronal population has been associated with 
impairment of motor skills, spatial orientation and associative learning (Bernard & Seidler, 
2014; Zhang et al., 2010). As zebrafish cerebellum is functionally similar to mammals (Knogler 
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et al. 2019; Matsui et al., 2014), PCs dysfunction with ageing may also contribute to motor 
and cognitive decline in zebrafish. As growing evidence now suggests that accumulation of 
cellular senescence may affect PCs, it is reasonable to hypothesise that accumulation of 
senescence in the cerebellum may contribute to motor and/or cognitive impairment in ageing. 
Additionally, as this project identified accelerated accumulation of senescence in the 
cerebellum in the absence of TERT, it might be that this component of telomerase is required 
for cerebellum-dependent behaviours. Lee et al. showed that even though WT mice displayed 
decreased spontaneous locomotion (a cerebellum-dependent behaviour) with ageing, this 
was not accelerated in the G4 Tert-/- mice model (Lee et al., 2010). This suggests that TERT is 
unlikely to affect locomotive behaviour in mice. However, it remains unexplored whether it 
affects other cerebellum-dependent behaviours, both in mammals and in zebrafish. 
Apart from the cerebellum, markers of senescence have also been identified in the cortex, 
hippocampus (Bussian et al., 2018; Jurk et al., 2012), substantia nigra, ventral tegmental area 
(VTA), (Shaerzadeh et al., 2020), and SVZ of old mice (Molofsky et al., 2006). To my knowledge, 
it has not been tested whether lack of TERT expression is associated with cellular senescence 
in most of these regions of the brain. Nonetheless, some evidence now implies that this 
component of telomerase may be associated with senescence in the SVZ, a neurogenic niche 
in the mammalian brain, containing NSCs (Gage, 2000). More specifically, in vitro, mice-
derived NSCs display higher levels of p53 accompanied by impaired proliferation capacity in 
the absence of TERT, which is rescued by telomerase reactivation (Jaskelioff et al., 2011). In 
vivo, the authors reported decreased proliferation activity in the SVZ of G4 Tert-/- mice in 
comparison to their G4 Tert+/+ counterparts, which again was rescued by telomerase 
reactivation (Jaskelioff et al., 2011). It remains unknown whether there is increased 
expression of p53 together with other markers of senescence in the SVZ, in vivo, and whether 
this is accelerated in the absence of TERT. 
The dorsal pallium in the zebrafish telencephalon is thought to be a rudimentary cortex, 
homologous to the mammalian isocortex. Within the dorsal pallium, the dorsal lateral region 
(Dl) is considered to be the homologous of the mammalian hippocampus, a structure with an 
important role in memory (Mueller et al., 2011; O’Connell & Hofmann, 2011). Contrary to 
what was observed in mice (Bussian et al., 2018; Jurk et al., 2012), this study did not show 
accumulation of senescence in the zebrafish dorsal pallium, or specifically in the Dl region. 
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Nonetheless, it is important to mention that the hippocampus, more specifically the sub-
granular zone (SGZ) in the dentate gyrus, constitutes one of the neurogenic niches in the 
mammalian brain (Ming & Song, 2011). Proliferative cells in the hippocampus may therefore 
be more vulnerable to cellular senescence in comparison to other, non-proliferative regions 
of the brain. Accordingly, the second neurogenic niche in the mammalian brain, the SVZ, has 
been also shown to display markers of senescence in the aged mice (Molofsky et al., 2006). I 
also did not find increased expression of SA-β-Gal in the ventral nuclei of the ventral 
telencephalon (Vv), considered the homologous to the SVZ (Schmidt et al., 2013). In 
opposition to mammals where neurogenesis is constrained to two niches (Ming & Song, 2011), 
zebrafish present several proliferative regions (Grandel et al., 2006; Schmidt et al., 2013). The 
so far described proliferative areas of the zebrafish brain include the outer layer of the 
telencephalon, but not specifically the Dl or the Vv (Grandel et al., 2006; Schmidt et al., 2013). 
The differences in proliferation rate between mice hippocampus and zebrafish Dl, or between 
mice SVZ and zebrafish Vv, may therefore explain the differences in accumulation of 
senescence observed between the species. Further investigation would be required to test 
this hypothesis. 
Substantia nigra and VTA are known as the core of the mammalian dopaminergic system, 
which is mainly involved in reward and motivation. These brain regions constitute an intense 
area of research in PD, a neurodegenerative disease mainly associated with degeneration and 
death of dopaminergic neurons. Unlike mammals where dopaminergic neurons are mainly 
distributed in the substatia nigra and VTA, zebrafish display a population of tyrosine 
hydroxylase (TH)-expressing neurons, thought to be dopaminergic neurons in zebrafish, in the 
posterior tuberculum of the diencephalon (Rink & Wullimann, 2001). This population of 
neurons is thought to project their axons to the subpallium region of the telencephalon, 
homologous to the mammalian striatum, constituting the ‘dopaminergic system’ in zebrafish. 
In addition, other clusters of TH-expressing neurons (‘dopaminergic neurons’) are also 
identified in other regions of the zebrafish diencephalon, including the pretectum, the ventral 
thalamus and the hypothalamus (Rink & Wullimann, 2001). In mice, it was recently reported 
that microglia undergo cellular senescence with ageing in the substancia nigra and VTA, 
possibly affecting the dopaminergic system (Shaerzadeh et al., 2020). If the same was to occur 
in zebrafish, then I would expect to see an increased number of microglia accumulating 
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senescence in the diencephalon region and, possibly, in the subpallium region of the 
telencephalon. Indeed, although this project did not identify increased senescence in the 
subpallium, accumulation of senescence was found widely spread in the diencephalon with 
exception of the hypothalamus. It remains unknown if microglia are undergoing senescence 
in the zebrafish diencephalon, over-time, and whether these cells are located near TH-
expressing neurons. It would be interesting to explore these questions in a future experiment.  
Of note, apart from the posterior tuberculum (a structure involved in the ‘dopaminergic 
system’ in zebrafish), the zebrafish diencephalon is constituted by the hypothalamus, 
prethalamus, thalamus and habenula, structures shared with mammals (Mueller, 2012). As I 
identified a large area of the diencephalon expressing SA-β-Gal in this project, it is likely that 
some of these structures also accumulate cellular senescence with ageing. Nonetheless, a 
more detailed analysis would be necessary to determine which structures and nuclei of the 
diencephalon accumulate senescence over-time. Additionally, it also remains unexplored 
whether these diencephalon-associated structures accumulate senescence in the mammalian 
brain. Overall, the diencephalon is one the most complex structures of the brain, containing 
multiple nuclei that serve as bridges between the cortex and subcortical regions, and 
interacting with various systems (sensorial, motor, endocrine, limbic) (Mueller, 2012). Thus, 
the diencephalon constitutes a relevant area to further study accumulation of senescence 
with ageing and to explore what are the putative consequences of accumulation of 
senescence in this region of the brain. 
It is important to note that this project identified elevated expression of SA-β-Gal in the 
medulla oblongata from young ages, in both WT and tert-/- fish, with no further increase over-
time. Nonetheless, it remains unclear whether this reflects real cellular senescence given that 
it was not possible to assess DNA damage in this macroarea due to technical issues. If the SA-
β-Gal staining were indeed representing cellular senescence in the medulla oblongata, it 
would be fair to hypothesise that accumulation of senescence occurs at an earlier age than 
the ones analysed (<4-6 months). In zebrafish, the medulla oblongata contain the nuclei of 6 
out of 12 cranial nerves, constituting a privileged place of communication between the brain 
and the periphery, known to be bidirectional (Moens & Prince, 2002). Part of this bidirectional 
communication occurs through the vagus nerve, which has been shown to be part of the gut-
brain axis in the last few years (Carabotti, et al. 2015; Matteoli et al., 2014). Importantly, this 
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route of communication (through the vagus nerve) has been implicated in neurodegenerative 
diseases such as PD (Sampson et al., 2016). Considering this, it would be highly relevant to 
confirm whether the medulla oblongata already presents high levels of senescence at the age 
of 4-6 months and whether accumulation of senescence in the medulla oblongata precedes 
other macroareas of the brain. If this were to be the case, then it would be interesting to test 
how accumulation of senescence in this macroarea correlates with senescence in other 
tissues. It could well be that senescence in the medulla oblongata is contributing to 
accumulation of senescence not only in other parts of the brain but also in peripheral tissues. 
Alternatively, it could also be that peripheral tissues are contributing to accumulation of 
senescence in the medulla oblongata. 
 
Potential mechanisms underlying the protective role of TERT against accumulation of 
senescence 
After identifying that there is accumulation of senescence in the aged zebrafish brain, 
specifically in the diencephalon and cerebellum, and that this is anticipated in the absence of 
telomerase, I tested whether senescence in the brain was associated with telomere 
shortening (i.e. replicative senescence). In order to test this, telomere length was assessed in 
both WT and tert-/-, throughout their life course. If cellular senescence observed in the aged 
brain were associated with replicative senescence, then I would expect to see telomere 
shortening in the same macroareas where I observed accumulation of senescence. Within the 
macroareas accumulating cellular senescence with ageing, telomere shortening was 
identified in the WT cerebellum but not in the diencephalon, at >30 months of age (Table 4.1). 
In addition, as accumulation of cellular senescence in the diencephalon and cerebellum was 
accelerated in the tert-/- model, I expected to see the same pattern in telomere shortening. 
Nonetheless, although tert-/- model presented shorter telomeres in the diencephalon than 
their WT counterparts, at 3-5 months of age, no differences between genotypes were 
observed in the cerebellum. Furthermore, decreased telomere length was also observed in 
regions of the brain where accumulation of senescence was not observed. The inconsistency 
of these results in particular, together with a possible lack of sensitivity of the telo-FISH 
technique (see section 6.5 for details), did not enable to take any relevant conclusions.  
145 
 
So far, these results raise two main hypotheses. (1) If TERT-associated senescence in the 
aged brain occurs in proliferative regions and is associated with telomere shortening, then it 
is likely that the protective role of telomerase against senescence is associated with its 
functions at telomeres (i.e. canonical functions). (2) If, instead, TERT-associated senescence 
in the aged brain occurs in non-proliferative regions and is independent of telomere length, 
then it is likely that the protective role of telomerase against senescence is associated with 
functions of telomerase that are independent of telomeres (i.e. non-canonical functions). 
This project identified accumulation of SA-β-Gal, with ageing, not only in regions known to 
be proliferative areas in the adult zebrafish brain, but also in non-proliferative regions (Fig 
4.12). Intriguingly, accelerated accumulation of SA-β-Gal in the absence of telomerase was 
also observed mainly in non-proliferative regions of the brain. These findings may suggest 
that TERT expression plays a protective role against accumulation of cellular senescence even 
in non-proliferative areas. Since telomerase is best known to be essential for proliferation, 
these results are unexpected at first glance. Nonetheless, TERT expression has been identified 
in the adult zebrafish brain in both proliferative and non-proliferative regions, and its overall 
expression reduced with ageing (Sprungala, 2009). This suggests that telomerase is likely to 
play other important roles in the brain, independently of its functions at telomeres. Hence, it 
would be important to confirm whether TERT-associated accumulation of senescence in the 
aged zebrafish brain is associated with proliferation and telomere shortening. This could be 
done by assessing cellular senescence in specific cell populations (for example, NSCs versus 
mature neurons) and by confirming the results in relation to telomere length. Ideally, this 
could be done by micro-dissecting specific cell types and assessing their telomere length using 
a more quantitative and sensitive technique. Such technique would involve a telomere 
specific RT-qPCR or Telomere Restriction Fragment (TRF) analysis by Southern blot. Both 





Fig 4.12. Schematic figure illustrating the regions of the brain where I identified accumulation of 
SA-β-Gal and the regions that have been reported to be proliferative in the zebrafish adult brain, 
accordingly to Grandel et al., (2006). Abbreviations: Tel, Telencephalon; OT, Optic Tectum; Die, 




In summary, this Chapter shows that there is accumulation of senescence with ageing in 
the zebrafish brain, specifically in the diencephalon and cerebellum. Importantly, this 
accumulation is accelerated in the absence of TERT, suggesting that this component of 
telomerase play a protective role against senescence in the zebrafish brain. Nonetheless, it 
remains unclear whether this protective role is associated with canonical or non-canonical 
functions of telomerase and further investigation is required to address this question.  
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Chapter 5.  





In the previous chapter I observed that accumulation of cellular senescence with ageing in 
the zebrafish diencephalon and cerebellum occurs at earlier ages in the absence of Tert, 
suggesting that Tert activity exerts a protective effect against accumulation of senescence in 
these regions of the brain. Although this accumulation of senescence was detected in 
proliferative and non-proliferative regions of the brain, it was not possible to conclude 
whether the protective effect of Tert in the aged brain was associated with canonical or non-
canonical functions of telomerase. Better understanding the mechanisms behind the 
accumulation of cellular senescence may help to find more targeted therapies to prevent 
accumulation of senescent cells with ageing and respective consequences. Hence, it is 
important to further explore what are the Tert-associated mechanisms that are affecting the 
aged brain and which of these mechanisms are involved in the protective effect of Tert against 
cellular senescence.  
Within its non-canonical functions, telomerase has been reported to play a role in 
transcriptional regulation of inflammatory-associated genes (Choi et al., 2008; Ghosh et al., 
2012). Moreover, cellular senescence has been associated with inflammation. On one hand, 
in some contexts, immune cells have been shown to be recruited to sites of cellular 
senescence (Demaria et al., 2014; Krizhanovsky et al., 2008). On the other hand, senescent 
cells have been shown to release pro-inflammatory factors (part of SASP), which can 
contribute to paracrine senescence  (Acosta et al., 2013) as well as to tissue inflammation 
(Franceschi & Campisi, 2014; Campisi & d’Adda di Fagagna 2007). It could well be that the 
protective effects of Tert in the aged zebrafish brain are associated with inflammation, 
through its role at transcriptional regulation of inflammatory genes.  
In this Chapter, I aimed to test whether there is increased inflammation in the zebrafish 
brain, with ageing, in a Tert dependent manner, and whether increased inflammation in the 
aged brain is correlated with accumulation of senescence. To test this, I assessed 
inflammation levels by IHC and enzymatic assays, in both WT and tert-/- zebrafish, throughout 
their lifetime. In addition, I sought to uncover other potential Tert-dependent mechanisms of 
ageing that affect the brain and be involved in cellular senescence. To do so, whole brains 
from WT and tert-/- zebrafish of different ages were analysed by RNA Sequencing. Network 
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analysis was performed in the RNA Sequencing data in order to find key sets of genes 




5.2 Determining the role of TERT in inflammation in the aged zebrafish brain 
Here, I sought out to test whether there is increased inflammation in the zebrafish brain, 
with ageing, and whether this is accelerated in the absence of TERT. To test this, I quantified 
the overall number of immune cells and assessed chitotriosidase activity, as a measure of 
immune activation, over-time, in the presence (WT) versus in the absence of Tert (tert-/-). 
 
5.2.1 Measuring the number of immune cells in the WT and tert-/- aged brain 
In order to test whether there is increased number of immune cells in the brain, with 
natural ageing, I determined the percentage of immune cells from young (4-5 months), middle 
aged (9-17 months) and into old age (>30 months) WT brain. Immune cells were detected by 
IF, using the pan-leukocyte marker L-plastin (anti-LCP1 antibody), known to label all immune 
cell populations (see section 2.3.2). This antibody had already been tested in the laboratory. 
The percentage of immune cells was then counted as described in section 2.3.5. 
The results showed an increased percentage of immune cells in the naturally aged brain 
(p=0.004, Fig 5.1A, B), more specifically at the age of >30 months (4-5m versus >30m: p=0.009, 








Fig 5.1. Percentage of immune cells with natural ageing in the whole zebrafish brain. (A) 
Representative images of L-plastin staining in the diencephalon of adult zebrafish. (B) 
Quantifications of percentage of L-plastin-positive cells in the whole zebrafish brain with natural 
ageing. Graph: X-axis, age in months; Y-axis, % of L-plastin-positive cells. N=5-7 per group. Each dot 
represents one animal. Error bars represent the SEM. One-way ANOVA followed by post-hoc test 
with Bonferroni correction: * p<0.05; ** p<0.01; *** p<0.001.  
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This increased number of immune cells in the whole zebrafish WT brain at >30 months, is 
occurring at the same age where I previously detected increased cellular senescence (see Fig 
4.2). I therefore sought out to quantify whether accumulation of senescence was locally 
associated with increased number of immune cells. Since I previously determined that 
accumulation of senescence was accelerated in the absence of telomerase (tert-/-), specifically 
in the cerebellum and diencephalon (see Fig 4.6), I then tested whether the increased 
percentage of immune cells was also TERT-dependent, in the same macroareas. To test this, 
I quantified the percentage of immune cells in each macroarea individually, in young (4-5 
months) and old (9-17 months) tert-/-, and compared with young (4-5 months), middle aged 
(9-17 months) and old (>30 months) WT fish. Immune cells were identified and counted as 
previously described (see sections 2.2.2 and 2.2.5). 
The results showed that all the macroareas of the brain presented an increased percentage 
of immune cells with natural ageing, more specifically at >30 months of age (Tel: p=0.005, OT: 
p=0.002, Die: p=0.017, Ce: p=0.001, MO: p=0.005) (Fig 5.2A-E). The region with the higher 
number of immune cells was the medulla oblongata, followed by the optic tectum and 
diencephalon. Moreover, increased number of immune cells in the aged brain was not 
accelerated in the absence of Tert, as no differences were detected between WT and tert-/- 
model in any of the macroareas, at 4-6 months (Tel: p=0.999; OT: p=0.999; Die: p=0.999; Ce: 
p=0.999; MO: p=0.692) or at 9-17 months of age (Tel: p=0.999, OT: p=0.607; Die: p=0.622; Ce: 
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Fig 5.2. Increased percentage of immune cells in the ageing brain is not explained by any specific 
macroarea of the brain. Quantifications of L-plastin-positive cells in the different macroareas of the 
brain: (A) telencephalon, (B) optic tectum, (C) diencephalon, (D) cerebellum, (E) medulla oblongata. 
Graphs: X-axis, age in months; Y-axis, % of L-plastin-positive cells. N=4-9 per group. Each dot 
represents one animal. Error bars represent the SEM. Statistics: two-way ANOVA test was used to 
compare WT versus tert-/- at 4-5m versus 9-17m. Non-parametric Kruskal-Wallis followed by Dunn’s 
post-hoc test was used to analysis WT over-time. * p<0.05; ** p<0.01; *** p<0.001.  
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5.2.2 Measuring the number of microglia/macrophages in the WT and tert-/- aged 
brain  
Although no correlation was identified between location of general immune cells (L-
plastin+ cells) and senescent cells, I cannot exclude the possibility that there may be a 
subpopulation of immune cells associated with senescence. Therefore, I decided to look at 
specific immune cell populations. Microglia are known to be important for CNS immune 
surveillance and clearance. Therefore, I set out to test whether there is increased number of 
microglia/macrophages, specifically, in the ageing brain, and whether this is accelerated in 
the absence of telomerase.  
To differentiate microglia/macrophages from other immune cells in the brain (e.g. 
neutrophils, T-cells, B-cells), the mpeg-mcherry.caax immune reporter line was used. Anti-
RFP antibody was used to detect the mpeg-positive cells by IF, as described in section 2.3.2. 
To test the specificity of the anti-RFP antibody, cells were co-labelled with anti-LCP1 (L-plastin) 
and anti-RFP antibody. As shown in Fig 5.3, only a subpopulation of L-plastin-positive cells 
express mpeg, showing that the anti-RFP antibody detects only microglia/macrophages in the 
mpeg-mcherry.caax immune reporter line. This thus allowed the distinction between 
microglia/macrophages and other immune cell types. 
The results showed that increased number of immune cells in the ageing brain is primarily 
due to an increased number of microglia/macrophages rather than other immune cell 
populations. This is because I detected an increased number of L-plastin-positive; mpeg-
positive cells (p=0.049, Fig 5.4A, B), but not of L-plastin-positive; mpeg-negative cells (p=0.086, 
Fig 5.4A, B’), in the whole brain of naturally aged zebrafish. Furthermore, this increase in 
microglia/ macrophages is accelerated in the absence of TERT. Specifically, in the tert-/- brain 
the number of L-plastin-positive; mpeg-positive cells at the age of 4-5 months was already 





Fig 5.3. Testing the anti-RFP antibody by IF. Representative images of cells co-labelled with 












Fig 5.4. Increased percentage of immune cells in the ageing (whole) brain is associated with 
increased number of mpeg-positive cells. (A) Representative images of mpeg and L-plastin staining 
in the diencephalon of adult zebrafish. The yellow arrow highlights a Lplastin+; mpeg- cell. (B) 
Quantifications of L-plastin-positive; mpeg-positive cells and (B’) L-plastin-positive; mpeg-negative 
cells in the whole zebrafish brain. N=3-6 per group. Each dot represents one animal. Error bars 
represent the SEM. Unpaired t-tests: * p<0.05; ** p<0.01; *** p<0.001. 
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Next, I sought to test whether the increased number of microglia/macrophages (L-plastin-
positive; mpeg-positive cells) in the ageing brain is occurring in the same regions where I 
previously detected cellular senescence (diencephalon and cerebellum). When looking at 
each macroarea individually, the results showed an increased percentage microglia/ 
macrophages in natural ageing in the telencephalon (p=0.016), optic tectum (p=0.017), 
cerebellum (p=0.057) and medulla oblongata (p=0.021) but not in the diencephalon (p=0.109) 
Fig 5.5A-E). Furthermore, there was no significant difference in the percentage of microglia/ 
macrophages in the young (4-5 months) tert-/-, when compared to its WT counterpart, in the 
telencephalon (p=0.227), optic tectum (p=0.161) and cerebellum (p=0.792). However, I 
observed a higher number of microglia/ macrophages in the tert-/- model at 4-5 months of 
age, when compared with its WT counterpart, particularly in the diencephalon (p=0.044) and 
medulla oblongata (p=0.011). 
On the other hand, there was no change in the percentage of L-plastin-positive; mpeg-
negative cells (which would represent all immune cells apart from microglia/ macrophages) 
with natural ageing in the telencephalon (p=0.185), optic tectum (p=0.08), diencephalon 
(p=0.266) or cerebellum (p=0.09) (Fig 5.6A-D). Only the medulla oblongata showed a slight 
increase in the number of L-plastin-positive; mpeg-negative cells over-time, borderline 
significant (p=0.046) (Fig 5.6E). Moreover, no differences were detected between WT and 
tert-/- at 4-5 months in any of the macroareas analysed (Tel: p=0.861; OT: p=0.167; Die: 
p=0.779; Cer: p=0.345; MO: p=0.656). 
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Fig 5.5. Percentage of L-plastin+; mpeg+ cells in the aged zebrafish brain. Quantifications of L-
plastin; mpeg cells in the (A) telencephalon, (B) optic tectum, (C) cerebellum, (D) diencephalon, and 
(E) medulla oblongata. N=3-6 per group. Each dot represents one animal. Error bars represent the 
SEM. Unpaired t-tests (B, C, E) or Mann Whitney (A, D) test: * p<0.05; ** p<0.01; *** p<0.001. 
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Fig 5.6. Percentage of L-plastin+; mpeg- cells in the aged zebrafish brain. Quantifications of L-
plastin+; mpeg- cells in the (A) telencephalon, (B) optic tectum, (C) cerebellum, (D) diencephalon, 
and (E) medulla oblongata. N=3-6 per group. Each dot represents one animal. Error bars represent 
the SEM. Unpaired t-tests (A, C, D, E) or Mann Whitney (B) test: * p<0.05; ** p<0.01; *** p<0.001. 
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Altogether, these data suggest that the increased number of immune cells in the ageing 
brain is associated with an increased number of microglia/ macrophages (mpeg-positive cells) 
in all the macroareas. Nonetheless, there are other immune cell populations apart from 
microglia/ macrophages that are contributing, at least in part, to the increased number of 
immune cells in the ageing medulla oblongata and, to a lesser extent, the ageing cerebellum. 
Additionally, these data suggest that there is no correlation between the location of 
senescent cells and mpeg-positive immune cells (microglia/macrophages) or mpeg-negative 
immune cells (e.g. neutrophils, T-cells). 
Interestingly, the increased number of immune cells in the natural ageing brain does not 
seem to be explained by increased proliferation of these cells, since I did not observe any 
differences in the number of immune cells proliferating over-time in any of the brain 
macroareas (Tel: p=0.428, OT: p=0.581, Die: p=0.874, Ce: p=0.403, MO: p=0.378) (Fig 5.7). 
Furthermore, there was also no difference in the proliferation of immune cells in the absence 
of TERT, in most of the macroareas, as no differences were identified between WT and tert-/- 
at 4-5 or 9-17 months of age, in the telencephalon (4-5m, p=0.954; 9-17m,p=0.999), optic 
tectum (4-5m, p=0.999; 9-17m,p=0.658), cerebellum (4-5m, p=0.999; 9-17m,p=0.999) or 
diencephalon (4-5m, p=0.999; 9-17m,p=0.999). The medulla oblongata was an exception to 
this. Whilst no differences between genotypes were identified at 4-5 months of age (p=0.999), 
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Fig 5.7. Percentage of immune cells proliferating with ageing, in the different brain macroareas. 
Quantification of L-plastin-, PCNA-positive cells in the different macroareas of the brain: (A) 
telencephalon, (B) optic tectum, (C) diencephalon, (D) cerebellum, (E) medulla oblongata. Graphs: 
X-axis, age in months; Y-axis, % of L-plastin-positive that are proliferating (PCNA-positive). N=4-10 
per group. Each dot represents one animal. Error bars represent the SEM. Statistics: two-way 
ANOVA test was used to compare WT versus tert-/- at 4-5 versus 9-17 months. Non-parametric 
Kruskal-Wallis followed by Dunn’s post-hoc test was used to analysis WT over-time. * p<0.05; ** 
p<0.01; *** p<0.001. 
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5.2.3 Measuring chitotriosidase activity in the WT and tert-/- aged brain 
Inflammation is not only characterised by increased number of immune cells but also by 
increased immune activation. Therefore, then I set out to test whether there is increased 
immune activation in the ageing brain and whether this is accelerated in the absence of 
telomerase. To do this, chitotriosidase activity was measured in the whole WT and tert-/- brain 
at different time-points, as described in section 2.7.3. Chitotriosidase is an enzyme expressed 
by activated macrophages and other phagocytic cells and therefore it is a good biomarker of 
microglia/macrophages activation.  
In this experiment, the glucocerebrosidase 1 deficient (GBA-/-) zebrafish model was used 
as a positive control. This is a model that presents a mutation in the glucocerebrosidase 1 
gene (Keatinge et al., 2015), leading to Gaucher’s disease. This disease is a lysosomal storage 
disorder, characterised by extremely high levels of chitotriosidase activity, making it a good 
reference model for extremely high level of chitotriosidase.  
The results showed increased chitotriosidase activity over-time in the naturally aged brain, 
identified at >30 months of age (p=0.005, Fig 5.8). Although no differences in chitotriosidase 
activity were identified between WT and tert-/- at the age of 5 months (p>0.999), tert-/- animals 
at the age of 14-16 months presented higher chitotriosidase activity than their WT 
counterparts (p=0.008).  
Overall, the data suggest that there are increased levels of chitotriosidase in the naturally 
aged brain and that this is accelerated in the absence of telomerase. Interestingly, although 
there is increased chitotriosidase activity with ageing in both WT and tert-/-, the maximum 




Fig 5.8. Chitotriosidase activity in the whole brain. Graphs: X-axis, age in months; Y-axis, 
chitotriosidase activity in nmol/h/ml, analysed as described in section 2.7.3. Statistical analysis: WT 
versus tert-/- of 4-6 versus 14-16 months of age were analysed by two-way ANOVA followed by 
planned comparisons with Bonferroni corrections. Additionally, one-way ANOVA was performed to 
compared WT over-time, including >30 months of age. N=3-6 per group. Each dot represents one 




5.3 Assessment of BBB permeability in WT and tert-/- aged zebrafish brain 
As shown in Fig 5.5 and Fig 5.7, I previously identified increased number of immune cells 
in the ageing zebrafish brain, which is not explained by increased proliferation of immune 
cells. Hence, I then tested whether infiltration of peripheral immune cells in the aged brain 
could explain the increased number of immune cells observed. Immune cells should not cross 
the BBB and invade the brain in a healthy condition unless the BBB is compromised. I 
therefore sought out to test the BBB integrity in young and old zebrafish. It has been described 
that zebrafish presents a functional BBB from the 10th dpf (Fleming et al., 2013), from which 
age molecules such as horseradish peroxidase (HRP, 44,000Da), evans blue (961Da), and 
sodium fluorescein (376Da) do not cross this barrier (Fleming et al., 2013; Jeong et al., 2008). 
However, it remained unknown whether zebrafish BBB becomes leaky with ageing. Here, a 
BBB permeability assay was performed in both WT and tert-/- at the ages where increased 
number of immune cells were identified in the brain, >30 months and 14-17 months, 
respectively. As described in section 2.8.1, in this assay I used an infrared fluorescent dye (0.1% 
IRDye 680RD Dextran diluted in HBSS), injected by IP. This dye had never been tested in 
zebrafish before and therefore I firstly tested if this compound is suitable to test BBB 
permeability in adult zebrafish: if it spreads easily throughout the body after IP injection, 
reaching the brain; and if it is quantifiable in an accurate way. 
First, I performed a pilot study where I used the IRDye 680RD Dextran (fluorescent dye) 
conjugated with two molecules of different weights: 70kDa and 4kDa. In order to detect the 
fluorescent dextran, live fish were anaesthetised and imaged at several time-points after IP 
injection (30min, 1h, 2h, 3h). After an incubation period of 3h, the fish were culled, and the 
bodies were imaged in order to test for the presence of the dextran dyes. As shown in Fig 5.9, 
the 4kDa dextran (in green) was detected in the 800 channel while the 70kDa dextran (red) 
was detected in the 700 channel. The 4kDa dextran spread throughout the body in 30min, 
becoming stronger 3h after IP injection. The 70kDa dextran was only identified in the 
peritoneal area 30min after injection and, although it spread slowly during the 3h period, it 
did not reach the head in all the animals. If the dye does not spread well throughout the body 
to reach the brain, it does not constitute a good tool to test BBB permeability. Therefore, the 





Fig 5.9. Pilot experiment showing whole-body fluorescence after IP injection of 4kDa and 70kDa 
dextran. Whole-body fluorescence before IP injection, and 30min and 3h after IP injection with 




To test BBB permeability, animals were injected with 4kDa, by IP. Three hours after 
injection, the fish were culled, the brains dissected and the fluorescence in the brains was 
measured to assess the BBB permeability. The results showed increased dextran-associated 
fluorescence in the naturally aged zebrafish brain at >30 months, when compared to 14-17 
months brains (p=0.0001) (Fig 5.10). Importantly, the fluorescence levels at >30 months, but 
not at 14-17 months, were significantly higher than the age-matched vehicle control animals 
(experimental vs vehicle control group, at 14-17m: p=0.161; at >30m: p<0.001). In the tert-/- 
model, there was a small increase in fluorescence at 14-17 months when compared to their 
WT counterparts, but this did not reach statistical significance (p=0.08). Nevertheless, 14-17 
months old tert-/- brains already presented higher levels of dextran-associated fluorescence 
when compared to the age-matched vehicle control animals (p=0.046). 
These findings suggest that there is increased BBB permeability in the naturally aged brain, 
at >30 months of age, and that this is accelerated in the tert-/-, where BBB disruption is 
detected at 14-17 months of age. Furthermore, the results suggest that increased BBB 
permeability occur at the same age or at a later age as increased number of 
microglia/macrophages and elevated chitotriosidase activity is observed (at >30m in WT and 
4-5m in tert-/-).  
168 
 
                      A 
 
 
Fig 5.10. BBB permeability in the zebrafish aged brain, in the presence and absence of 
telomerase. (A) Whole brain fluorescence 3h after IP injection of 4kDa dextran, in WT and tert-/- 
at different ages. Graphs: X-axis, age in months; Y-axis, fluorescence intensity (AU). N=9-20 per 
group in the tested animals; N=3-6 per group in the vehicle control animals. Each dot represents 





5.4 Analysis of behavioural alterations in the WT and tert-/- aged zebrafish 
It is known that both ageing and inflammation can influence behaviour. For example, 
natural ageing has been reported to be accompanied by several behavioural alterations in 
both mammals and fish, including reduced locomotion and impairment of memory and 
learning abilities (Altun et al., 2007; Shoji et al., 2016; Yu et al., 2006). Moreover, 
lipopolysaccharide (LPS)-induced peripheral inflammation has been shown to lead to 
behavioural alterations in rodents, in a dose-dependent manner, including decreased 
locomotion activity and increased anxiety-like behaviour (Bassi et al., 2012; Tarr et al., 2012; 
Zhu et al., 2019). Therefore, I set out to test whether there are age-related behavioural 
alterations in zebrafish at the same age as it is identified increased inflammation. Locomotion, 
anxiety-like behaviour and short-term memory were assessed, as described in sections 2.8.1 
and 2.8.2. 
Locomotion behaviour was assessed through an open-field test. The results showed 
decrease distance swam by WT fish at the age of >30 months (versus 14-17 months, p=0.018) 
(Fig 5.11). These findings suggest that zebrafish present reduced locomotion behaviour with 
ageing, more specifically at the age when increased inflammation and BBB permeability are 
identified. If TERT were to have a protective effect towards impaired locomotion, then 
removing TERT would further exacerbate or accelerate this behavioural dysfunction. To test 
this, I determined locomotion behaviour of tert-/- fish in parallel to WT counterparts. However, 
I found no significant differences between WT and tert-/- at 14-17 months of age (p=0.473). 
Anxiety-like behaviour was assessed by the open-field and novel object tests. The open 
field test showed that, with ageing, WT fish tend to spend more time in the central area of 
the tank (14-17 versus >30m: p=0.009) (Fig 5.12A). Similarly, with ageing, fish spent more 
time near the object during the novel object test (14-17 versus >30m: p=0.014), (Fig 5.12B). 
Increased time spent in the central area of the tank and/or exploring the novel object suggest 
decreased anxiety-like behaviour with natural ageing. Interestingly, there was a trend for the 
tert-/- fish to display decreased anxiety-like behaviour at 14-17 months when compared with 
their WT counterpart, in both tests performed (OF: p=0.091; NO: p=0.072). However, this did 




Fig 5.11. Alterations in locomotion with ageing, in WT and tert-/- zebrafish. Distance moved (cm) 
over-time in the WT and tert-/-, accessed by OF test and analysed as described in section 2.9.2.  N=7-
9. Bar errors represent the SEM. Unpaired t-tests: * p<0.05; ** p<0.01; *** p<0.001 
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Fig 5.12. Alterations in anxiety-like behaviour with ageing, in the presence and absence of 
telomerase. (A) Anxiety-like behaviour assessed by OF test. Top: heatmap representing young vs 
old fish locomotion in the tank throughout the OF test. Bottom: time spent (s) in the central area of 
the tank, over-time, in the WT and tert-/-. (B) Anxiety-like behaviour assessed by NO test. Top: 
heatmap representing young vs old fish locomotion in the tank throughout the NO test. Bottom: 
time spent (s) near the novel object, over-time, in the WT and tert-/-. N=7-9. Bar errors represent 




Short-term memory was assessed through a novel object recognition test. To test whether 
WT can discriminate between two objects to start with, as a baseline control, I tested whether 
young (4-6 months) WT fish display a preference for one of the objects. The data showed that 
the young WT tend to prefer the novel object, but this was just below statistical significance 
(p=0.078) (Fig 5.13). This suggests that WT fish are able to discriminate, at least partially, the 
two objects. With ageing, WT fish animals seem to lose this potential ability to discriminate 
between objects, as no preference was identified in middle aged or old WT groups (14-17m: 
p=0.094; >30m: p=0.313). The inability to discriminate the two objects at old ages, compared 
with young ages, would suggest reduced short-term memory with ageing. However, as it was 
not identified any statistically significant preference in the WT young fish, the results are 
inconclusive. Nevertheless, this non-statistically significant trend is accelerated in the absence 
of TERT, which display no preference already at young ages (p=0.297), warranting further 
investigation with a larger number of animals. 
Overall, these data suggest that zebrafish display age-associated reduced locomotion and 
decreased anxiety-like behaviour. Nonetheless, it is unclear whether this is accompanied by 
cognitive impairment. Despite the great variability observed in tert-/- behaviour, the results 
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Fig 5.13. Results from the NOR test. (A) Heatmaps illustrating the locomotion of the fish during the 
test phase of the NOR test, when the fish discriminate the objects (top) and when it does not 
(bottom). (B) Assessment of object discrimination during the first 5 min of test phase, as described 
in section 2.9.2. N=6-8. Bar errors represent the SEM. Statistics: wilcoxon signed-ranked test against 
the hypothetical value of 0. * p<0.05; ** p<0.01; *** p<0.001 
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5.5 Assessing potential TERT-associated mechanisms of ageing in the zebrafish brain  
My results so far show that the zebrafish brain accumulates cellular senescence with 
ageing and that this is accelerated in the absence of telomerase. Thus, I next set out to explore 
which TERT-associated molecular mechanisms could be associated with the ageing process in 
the brain, and how these mechanisms could be linked to cellular senescence. In order to test 
this, I performed RNA Sequencing in whole brain tissue from WT and tert-/- adult zebrafish, at 
different time-points throughout their lifespan, more specifically at the ages of 2, 9, 22 
and >30 months in WT, and at the ages of 2, 9 and 22 months in tert-/- fish.  
The first analysis of the RNA Sequencing data revealed a Q30-score (probability of having 
a wrong nucleotide is 1:1,000) of 92%, with all samples presenting a total of 14.4-17.3 million 
reads. In order to observe the distribution of the samples per age and genotype, a quality 
assessment was performed with unsupervised methods, including heatmap and principle 
component analysis (PCA). Both the heatmap (Fig 5.14A) and the PCA (Fig 5.14B) showed that 
different ages form individual clusters, suggesting that there are differences in gene 
expression with ageing. This was particularly visible in the WT at >30 months of age, the group 
with the greatest distance to all the other clusters. Whilst no obvious clusters were identified 
between WT and tert-/- fish at the ages of 9 or 22 months, at 2 months of age the two 
genotypes presented two distinguished clusters, with the 2 months old tert-/- samples being 
closer to the 9 months of age samples. 
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Fig 5.14. Quality assessment of the RNA Sequencing data, using unsupervised methods. (A) 
Heatmap showing the clustering of all samples from WT and tert-/- fish at different ages. (B) PCA 
representing the sample distribution by genotype (WT and tert-/-) and age.  
176 
 
5.5.1 RNA Sequencing analysis of the aged brain, in the WT versus tert-/-  
In order to identify which genes are being up- and down- regulated over-time in a 
consistent way (i.e. constantly being up/down-regulated over-time), time-series analysis was 
performed using the STEM software, as described in section 2.6. This analysis was performed 
in each group separately: brain WT and brain tert-/-.  
Time-series analysis of the whole WT brain identified 11 different profiles with a total of 
1,447 differentially expressed genes with ageing (Fig 5.15A). Within those, 6 profiles clustered 
a total of 645 up-regulated genes and 5 profiles grouped a total of 1,551 down-regulated 
genes. After identifying the differentially expressed genes in the ageing zebrafish brain, 
enrichment analysis was performed in order to test which functions these genes were 
associated with.  
Enrichment analysis was performed as described in section 2.6. The results showed that 
the up-regulated genes were mostly associated with regulation of the immune system and 
immune response (Fig 5.15B). Within those, there were genes associated with antigen 
processing and presentation of peptide antigen via major histocompatibility complex (MHC) 
class I (GO: 0002474, enrichment: 25.183), leukocyte migration (GO: 0050900, enrichment: 
4.197), regulation of cytokine production (GO: 0001817, enrichment: 4.361) and interleukin-
1 family signalling (R:DRE-446652, enrichment: 6.769). Down-regulated genes, on the other 
hand, were mainly associated with proliferation and DNA repair (Fig 5.15C), including genes 
associated with cell cycle process (GO: 0022402, enrichment: 6.868), cell division (GO: 
0051301, enrichment: 5.864), and double-strand break repair via break-induced replication 




Gene profiles from WT brain 










Down-regulated genes in the ageing WT brain (total of 802 DE genes) 
 
 
Fig 5.15. Time-series and enrichment analysis in the whole WT brain, throughout the zebrafish 
life-course. (A) Profiles with DE genes in the ageing WT brain, obtained after time-series analysis 
using STEM software, as described in section 2.6. Values were normalised for the 2 months time-
point. Each colour represents a cluster of genes. (B-C) Enrichment analysis of (B) up- and (C) down-
regulated genes in the natural aged brain. Enrichment analysis was performed using the Gorilla and 
Metascape software, and the graphs were generated by last software, as described in section 2.6. 
In the graphs, terms are ordered by log10(P). Orange arrows are highlighting the terms and/or 
pathways associated with immune response, proliferation, DNA repair and mitochondrial function.  
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In the absence of TERT, time-series analysis identified 4 different profiles of differentially 
expressed genes over-time, which included a total of 2,392 genes (Fig 5.16A). Half of the 
profiles consisted in a total of 841 up-regulated genes whereas the other half consisted in 
1,551 down-regulated genes. Enrichment analysis showed that up-regulated genes were 
mostly related with immune response and mitochondria function (Fig 5.16B). These included 
regulation of innate immune response (GO: 0045089, enrichment: 8.0003), p38MAPK cascade 
(GO: 0038066, enrichment: 22.918), TNF receptor superfamily members mediating non-
canonical NF-kB pathway (R-DRE-5676594, enrichment: 11.459) and nicotinamide adenine 
dinucleotide (NAD) : ubiquinone oxidoreductase (M00142, enrichment: 13.096). On the other 
hand, down-regulated genes were mostly associated with proliferation (Fig 5.16C), including 
functions such as mitotic cell cycle (GO:0000278, enrichment: 4.952), cell division (GO: 
0051301, enrichment: 4.011) and regeneration (GO: 0031099, enrichment: 3.904).
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                                  A 
Gene profiles from tert-/- brain 









Down-regulated genes in the ageing tert-/- brain (total of 1,551 DE genes) 
 
Fig 5.16. Time-series and enrichment analysis in the whole tert-/- brain, throughout the zebrafish 
life-course.(A) Profiles with DE genes in the ageing tert-/- brain, obtained after time-series analysis 
using STEM software, as described in section 2.6. Values were normalised for the 2 months time-
point. Each colour represents a cluster of genes. (B-C) Enrichment analysis of (B) up- and (C) down-
regulated genes in the natural aged brain. Enrichment analysis was performed using the Gorilla and 
Metascape software, and the graphs were generated by last software, as described in section 2.6. 
In the graphs, terms are ordered by log10(P). Orange arrows are highlighting the terms and/or 
pathways associated with immune response, proliferation, DNA repair and mitochondrial function. 
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To further confirm the previous analysis, I used an alternative method to identify 
differentially expressed genes common to both genotypes, WT and tert-/-. These would likely 
represent TERT-dependent mechanisms. This analysis was performed after identifying the 
common genes being up- and down- regulated in both genotypes, after time-series analysis.  
The results showed that there were 151 genes being up-regulated and 191 genes being 
down-regulated in both genotypes over-time (Fig 5.17A). Enrichment analysis of these genes 
revealed similar results as the previous ones. Whilst most of the up-regulated genes were 
associated with immune response (Fig 5.17B), most of the down-regulated genes are 












Down-regulated genes in the ageing brain, in both WT and tert-/- 
 
 
Fig 5.17. Venn-diagram showing DE genes in the whole brain of WT and tert-/- zebrafish, and 
enrichment analysis of DE genes with ageing, common to both WT and tert-/- genotypes. (A) Venn 
diagram showing the up- and down- regulated genes in both WT and tert-/- ageing brain. (B-C) 
Enrichment analysis of (B) up- and (C) down-regulated genes over-time, common to both 
genotypes. Venn diagram and enrichment analysis were performed as described in section 2.6.  
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5.5.1.1 Network analysis in the WT versus tert-/- aged brain 
Previously I identified the genes being consistently up- and down-regulated in the ageing 
brain, in the presence and absence of TERT.  On one hand, the up-regulated genes in both WT 
and tert-/- ageing were mainly associated with immune response, supporting my previous 
findings that there is TERT-dependent increased number of immune cells and immune 
activation in the aged brain. On the other hand, the down-regulated genes in both genotypes 
are associated with proliferation capacity and DNA repair, which goes in hand with the 
previous observations that there is TERT-dependent accumulation of DNA damage and 
decreased proliferation in the ageing brain. Considering this, I then sought to determine 
which set of genes could be associated with TERT-dependent ageing that could potentially 
contribute to accumulation of senescence and/or inflammation in the ageing brain. 
To do this, I performed network analysis on the DE genes previously identified by time-
series analysis. Network analysis was performed as described in section 2.6. In order to 
identify small and strong networks, from all the up- or down-regulated genes, the 10 genes 
with the highest number of connections (or edges) were considered a tight, strong network. 
The connections between genes are recognised by the software based on the identification 
of previous experiments, online databases, co-expression, proximity in the genome and/or 
co-occurrence in publications. This approach was chosen because the genes with the highest 
number of connections are putative key players in the whole network, influencing and/or 
being influenced by many other genes. Of note, other approaches were tested, including 
analysis per clusters and analysis per functions (enrichment terms) (data not shown). 
Moreover, the data was also analysed considering up- and down-regulated genes together or 
separately. All the different analysis had similar results and therefore the first approach was 
considered consistent and appropriate to use.  
Within the over-expressed genes with natural ageing, in the brain, I identified a set of 
genes with a total of 21 edges between them (Fig 5.18A). Consistently with the previous 
findings, all these genes were associated with immune response. Accordingly, proteasome 
activator complex subunit 2 (psme2), proteasome subunit beta type-8 (psmb8) and rac family 
small GTPase 1 (rac1l) are associated with MAPK6/MAPK4 signalling (DRE-5687128, 
FDR=0.00013) as well as with the AKT signalling (DRE-1257604< false discovery rate, 
FDR=0.0008). psme2, psmb8 and cluster of differentiation 40 (CD40) are associated with 
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tumour necrosis factor receptor 2 (TNFR2) non-canonical NF-kB pathway (DRE-5668541, 
FDR=0.00013). Moreover, psme2, psmb8, together with beta-2-microglobulin like (b2ml) and 
beta-2-microglobulin (b2m) seem to be involved in cytokine signalling (DRE-1280215, 
FDR=0.00013). 
A more strongly connected network was identified within the genes being down-regulated 
with natural ageing, where the 10 genes formed a total of 45 edges between them (Fig 5.18B). 
All the genes from this network were associated with cell cycle and mitosis process. Indeed, 
budding uninhibited by benzimidazoles 1 (bub1), polo-like kinase 1 (plk1), mitotic arrest 
deficient 2 like-1 (mad2l1), cyclin a2 (ccna2), cell division cycle 20 (cdc20), cyclin dependent 
kinase 1 (cdk1) and cyclin b1 (ccnb1) are all associated with cell cycle (DRE-04110, FDR=1.31E-
13).  
In the tert-/- model, within the up-regulated genes I detected a network with 23 edges (Fig 
5.18C). A large number of these genes was associated with antigen processing, involving 
ubiquitination and proteasome degradation (DRE-983168, FDR=1.05E-08). These included 
ankyrin repeat and couple suppressor of cytokine signalling (SOCS) box containing 4 (asb4), 
ankyrin repeat and SOCS box containing 15b (asb15b), ankyrin repeat and SOCS box 
containing 1 (asb1), ring finger and CHY finger domain containing protein 1 (rchy1), F-box 
protein 32 (fbxo32) and zinc finger and BTB domain-containing 16b (zbtb16b or LOC569773).  
Importantly, the network identified within the down-regulated genes in tert-/- was quite 
similar to the one previously identified in natural ageing, with only one different node (ccnb2 
instead of ccna2) (Fig 5.18D). Like what I found in natural ageing, the majority of these genes 
were associated with cell cycle and proliferation (DRE-04110, FDR=9.17E-14). These included 
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from down-regulated genes (tert-/-) 
 
 
Fig 5.18. Network analysis of the DE genes identified in the ageing zebrafish brain, in the presence 
and absence of TERT. (A-B) Networks formed by the 10 genes with higher degree being: (A) up-
regulated in natural ageing, (B) down-regulated in natural ageing, (C) up-regulated in the absence 
of TERT and (D) down-regulated in the absence of TERT. Networks were generated using the SRING 
software, as described in section 2.6. Thickness of the edges represents the confidence of the 
connections, with thicker stripes indicating that the evidence supporting it is stronger. Colour of the 
nodes do not have any meaning. PPI: protein-protein interaction. 
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5.5.1.2 Analysing hand-picked senescence-associated genes in the ageing brain 
When I had previously tested selected genes known to be senescence-associated markers, 
more specifically, known downstream effectors of the DNA damage response, I detected no 
differences with ageing. These included p53, p21 and p16-like (see Fig 4.5). To confirm these 
results, I hand-picked these and other related genes from the RNA Sequencing data. To do 
this, Log2 values from young and old brains from WT and tert-/- fish were used to plot the 
heatmap.  
The results showed only small, subtle changes in the expression of these genes with ageing, 




Fig 5.19. Heatmap with hand-picked genes associated with senescence in young (2m) and old 
(>30m in WT, 23m in tert-/-) whole brains. Heatmap was generated using the Morpheus software: 





In this Chapter, I aimed to uncover some TERT-dependent mechanisms of ageing that could 
affect the zebrafish brain and contribute to accumulation of cellular senescence, which I 
showed to occur (see Chapter 4). Ultimately, this aimed to uncover some mechanisms that in 
the future could be further explored, aiming to develop targeted therapies for preventing or 
ameliorating cellular senescence in ageing. To do so, I firstly determined whether 
accumulation of cellular senescence in the aged brain was accompanied by increased 
inflammation in a telomerase-dependent manner. This was determined by measuring the 
number of immune cells as well as immune activation, in both WT and tert-/-, at different ages. 
Secondly, I explored other potential TERT-dependent mechanisms of ageing affecting the 
zebrafish brain, through network analysis of RNA Seq data performed in whole brain of WT 
and tert-/- fish.  
 
The role of TERT in inflammation, in the aged zebrafish brain 
This study identified an increased number of immune cells (L-plastin+ cells) in the whole 
brain of old zebrafish; however, this was not accelerated in the tert-/- model, suggesting it to 
be telomerase-independent. Interestingly, though, I observed an increased number of 
microglia/ macrophages (Lplastin+; mpeg+ cells) in the brain, over-time, which was 
accelerated in the absence of TERT. Moreover, increased number of microglia/ macrophages 
with ageing was accompanied by increased levels of chitotriosidase activity, which again, was 
accelerated in the tert-/- in comparison to its WT counterpart. These findings are in agreement 
with the literature, as neuro-inflammation is a characteristic of the mammalian CNS (Popescu 
et al. 2016). Neuro-inflammation is known to involve increased number of microglia as well 
as increased immune activation, with ameboid-shaped microglia and increased levels of pro-
inflammatory cytokines (Damani et al., 2011; Crowe et al., 2016). Similarly, two recent studies 
in zebrafish reported increased number of microglia/ macrophages in the aged brain, more 
specifically in the telencephalon and optic nerve (Van houcke et al., 2017; Zambusi et al., 
2020). In the telencephalon, microglia were also shown to display an ameboid shape in the 
aged fish, suggesting to be more activated (Zambusi et al., 2020). Furthermore, 
chitotriosidase activity has been proposed as a putative marker of microglial/ macrophage 
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activation in mammals. In humans, increased levels of chitotriosidase activity have been 
reported to increase with normal ageing (in serum) (Ramanathan et al., 2013) and 
exacerbated in pathologies associated with chronic inflammation, including in ALS (in the 
spinal cord) (Steinacker et al., 2018). Hand in hand with the literature, the increased 
chitotriosidase activity identified in this project correlated with the increased number of 
microglia/macrophages. 
Analysis per macroarea revealed that increased number of microglia/ macrophages with 
ageing occurs in the telencephalon, optic tectum, cerebellum, and medulla oblongata, but not 
in the diencephalon (Table 5.1). Nevertheless, it is important to mention that the lack of 
differences observed in the diencephalon may be due to the small sample size used. Power 
calculations showed that it would be required a minimum sample size of 22 animals to detect 
a 25% difference with 90% power between the groups. This experiment should therefore be 
repeated with more animals in order to strengthen the results. In addition, in comparison to 
the WT, increased number of microglia/ macrophages was only accelerated in the tert-/- in the 
diencephalon and medulla oblongata. If inflammation in the aged brain were associated with 
senescence, then I would expect to find increased number of immune cells in the same 
regions where I find accumulation of cellular senescence. Contrary to this prediction, the 
location of microglia/ macrophages does not correlate with location of senescence (see Table 
5.1), suggesting that senescence is unlikely to be associated with increased number of 
microglia/ macrophages. Despite this and considering the unexpectedly insufficient sample 
sizes used in these experiments, it would be important to repeat these experiments with 
more animals to confirm the results. 
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Table 5.1 Summary of the brain macroareas that accumulate senescence and increased number of 
immune cells with natural ageing and in the absence of TERT (in comparison with WT counterpart). 
In WT, the age represents the time-point from which differences started being observed. In tert-/-, the 
age represents the time-point where differences are detected in comparison with their WT 
counterpart. Age is represented in months. Tel: Telencephalon, OT: Optic tectum, Die: Diencephalon, 
Ce: Cerebellum, MO: Medulla oblongata. 
 Senescence No. of L-plastin
+ cells No. of mpeg+ cells 
WT tert-/- WT tert-/- WT tert-/- 
Tel - - >30m - >30m - 
OT - - >30m - >30m - 
Die >30m 4-6m >30m - - 4-6m 
Ce >30m 4-6m >30m - >30m - 
MO - - >30m - >30m 4-6m 
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It is interesting to note that the medulla oblongata was the macroarea with higher number 
of microglia/ macrophages. This is relevant because in Chapter 4 I showed that the medulla 
oblongata was the region of the brain containing higher expression of SA-β-Gal. It remains 
unclear whether this is a real association between inflammation and senescence or if this 
reflects an artifact. This is because some immune cells, including macrophages, can express 
SA-β-Gal when activated (Hall et al., 2017). It would be important to confirm this by 
determining if most of the cells expressing SA-β-Gal staining are indeed immune cells (L-
plastin+ or mpeg+ cells). I tried to test this by co-labelling cells with SA-β-Gal and anti-L-plastin 
antibody, in cryosections of the brain. Preliminary data (not shown) revealed that most of the 
L-plastin+ cells are surrounding the blue staining, and not co-localising with it, suggesting that 
the immune cells are unlikely to be expressing SA-β-Gal themselves. Nonetheless, further 
experiments should confirm if this observation is real or if this represents an artifact. This is 
because in this experiment I did not test whether L-plastin staining would be affected by the 
incubation with X-gal, or vice-versa. To confirm this, I would need to use adjacent sections of 
the brain with the following staining conditions: (1) L-plastin; (2) SA-β-Gal, and (3) L-plastin 
and SA-β-Gal. If the distribution of immune cells and SA-β-Gal staining were identical in 
conditions 1 and 3 or in conditions 2 and 3, respectively, then I would be more confident 
about the results of this experiment. This extra test was not performed due to time 
constraints and lack of samples available. 
As great part of the cranial nerves (with afferent and efferent innervations) are connected 
to the medulla oblongata, this macroarea is likely to affect and to be affected by peripheral 
tissues (see section 5.6). Assuming that the SA-β-Gal staining observed in the medulla 
oblongata is real cellular senescence, it would be plausible to hypothesise that inflammation 
in peripheral tissues may contribute to inflammation in this macroarea. In support of this 
hypothesis, it has been shown that peripheral inflammation (upon IP injection of TNFα or LPS) 
leads to increased inflammation in the brain. Moreover, this seems to occur through the 
vagus nerve, at least partially, as vagotomy or electric stimulation of this nerve decreased the 
inflammatory response in the brain (Bonaz et al., 2018; Meneses et al., 2016; Zielinski et al., 
2013).  
Additionally, it would be important to explore what accumulates first, if inflammation or 
cellular senescence, and whether one causes the other. One hypothesis is that immune cells 
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could be recruited to sites of cellular senescence, stimulated by SASP factors released by 
senescence cells themselves, based on what was previously described at wound site (Demaria 
et al., 2014). An alternative hypothesis is that the presence of pro-inflammatory factors in the 
environment could trigger cellular senescence, based on the evidences that SASP factors can 
lead to paracrine senescence (Acosta et al., 2013). As an example, it was recently shown in 
mice that macrophage-derived transforming growth factor β1 (TGFβ1) contributed to 
paracrine senescence and that inhibition of its receptor led to reduced accumulation of 
senescence (Bird et al., 2018).  
 
Possible routes for increasing number of immune cells in the aged brain 
My results suggested that increased number of immune cells in the aged zebrafish brain 
was not associated with increased immune proliferation. Nonetheless, this was assessed in L-
plastin+ cells, representing all populations of immune cells. It remains unknown if microglia/ 
macrophages, specifically, increase their proliferation activity over-time. It would be 
important to assess proliferation levels specifically in microglia/ macrophages in order to 
confirm these results. This was not done in this project due to time constraints. Despite 
previous reports suggesting an increased number of microglia/ macrophages in the aged CNS 
in mammals and fish (Damani et al., 2011; Crowe et al., 2016; van houcke et al., 2017; Zambusi 
et al., 2020), the authors failed to clarify whether this were due to increased proliferation of 
this cell population. It is reasonable to hypothesise that immune proliferation contributes to 
it, at least partially, as increased microglial proliferation has been reported to occur in 
response to injury as well as in contexts where there is chronic damage, such as in AD and PD 
(Spittau, 2017). Moraga et al., (2015) have also reported higher microglial proliferation 
activity with ageing in a mice model of cerebral ischemia (Moraga et al., 2015). It remains 
unclear whether this reflects what happens in ‘normal’ ageing or if this observation is 
triggered by increased damage, in this case, due to permanent cerebral artery occlusion. 
Apart from immune proliferation, there are other mechanisms that could contribute to the 
increased number of immune cells in the aged brain. The BBB constitutes a protective barrier 
between the blood and the CNS, avoiding the entrance of foreign molecules into the brain, 
including the entrance of peripheral immune cells. However, the BBB loses its integrity with 
192 
 
ageing (Pakulski et al., 2000), which can lead to the infiltration of peripheral immune cells in 
the brain (Deverman & Patterson, 2009). Moreover, the choroid plexus holds some 
populations of resident immune cells, mostly including T-cells and monocytes but also B-cells, 
dendritic cells and natural-killer cells (Meeker, et al., 2012). These resident immune cells are 
now thought to be able to invade the brain parenchyma, at least in response to inflammation 
(Strominger et al., 2018). Importantly, it has been described that with ageing auto-reactive T-
cells (Coder et al. 2015) are capable of penetrating the brain, both through the bloodstream 
and lymphatic vessels (Louveau et al., 2015). These lymphatic-like vessels in the brain are in 
close contact with the meninges and carry cerebrospinal fluid as well as immune cells 
(Louveau et al., 2015). Additionally, circumventricular organs constitute another mechanism 
by which peripheral immune cells could invade the brain. These are brain structures that lack 
the classical BBB and display high permeability (Ganong, 2000), constituting vulnerable 
regions to the infiltration of large molecules and possibly, cells, into the brain parenchyma. 
Therefore, increased number of immune cells in the aged brain is likely to be associated 
with the following mechanisms: (1) increased proliferation of immune cells, particularly of 
microglia; (2) recruitment of immune cells from the periphery, through the BBB; (3) crossing 
of resident immune cells from the cerebrospinal fluid (choroid plexus and meninges) into the 
brain parenchyma; and/or (4) infiltration of peripheral immune cells, through the 
circumventricular organs. Although the data found in this project does not support the first 
mechanism, it does support the second one. In fact, in this study I identified increased BBB 
permeability with natural ageing, in zebrafish, similarly to what has been reported to occur in 
mammals (Pakulski et al., 2000). Importantly, this project also identified that BBB 
permeability with ageing is accelerated in the absence of TERT. Thus, this project suggest that 
the increased number of immune cells found in the aged zebrafish brain might be due to BBB 
leakiness. The other potential mechanisms were not explored in this project. 
 
TERT-dependent mechanisms of brain ageing 
In the second part of this Chapter, I explored other potential TERT-dependent mechanisms 
of ageing that may affect the zebrafish brain and that could be associated with accumulation 
of senescence. I did this through RNA Seq analysis of the whole zebrafish brain. The data 
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showed that most of the genes being up-regulated with ageing are associated with immune 
function, in both WT and tert-/-. These observations strengthen my previous results showing 
that there is increased inflammation with ageing, in a telomerase-dependent manner. In 
addition, the data showed that most of the genes being down-regulated over-time are 
associated with proliferation and DNA repair, in both WT and tert-/-. Once again, this 
strengthens the previous findings showing that there is increased DNA damage accompanied 
by decreased proliferation in the naturally aged brain (see Chapter 4). Moreover, in Chapter 
4 I had observed an accelerated accumulation of DNA damage in the tert-/-, which goes hand 
in hand with the results obtained by RNA Seq. Despite this, reduced proliferation with ageing 
was not observed in the tert-/-, which goes against the RNA Seq data. Further analysis showed 
that the experiment assessing PCNA staining by IF (section 4.4.1) was underpowered and it 
would be necessary a minimum of 12 animals per groups in order to detect any differences. 
Thus, it would be important to confirm this, by repeating the experiment by IF with a larger 
sample size and by analysing proliferation using an alternative technique, such as by RT-qPCR. 
Furthermore, network analysis of differentially expressed genes in the ageing brain 
revealed that both genotypes have a set of 9 common down-regulated genes, with a very 
strong connection between them. These might be good candidates for TERT-dependent 
mechanisms of brain ageing and therefore it is important to further explore their potential 
roles on ageing. These genes include CDK1, bub 1, aurkb, plk1 mad2l1, ndc80, cdc20, ccnb1, 
and kif11, which are protein kinases involved in the regulation of different phases of mitosis, 
and therefore essential to maintain cell cycle and to secure chromosomal stability during cell 
division. To my knowledge, none of these genes have been associated with TERT; however, 
some of them are known to be associated with ageing.  
Down-regulation of kif11 with ageing is not a zebrafish-specific phenotype, as reduced 
expression of this gene was recently identified in aged mice and humans. Although it is not 
known what the consequences of decreased expression of Kif11 are in aged mammals, the 
equivalent gene in Caenorhabditis elegans (C. elegants), Bim subfamily of kinesin-1 (bmk-1), 
has been shown to regulate lifespan. In C. elegants, inhibition of bmk-1 was shown to reduce 
lifespan, whereas over-expression of bmk-1 was shown to extend lifespan (Qian et al., 2015). 
It remains unknown whether reduced expression of kif11 also contributes to reduced lifespan 
in zebrafish and, if so, whether it occurs in a telomerase-dependent manner. Furthermore, 
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reduced levels of bub1 have been shown to contribute to age-related phenotypes, including 
accumulation of cellular senescence, being associated with shorter lifespan in mice (Baker et 
al., 2004). Not only senescent cells express low levels of bub1, but also silencing bub1 leads 
to premature senescence in both mice and human cells (Andriani et al., 2016; Gjoerup et al., 
2007). Similarly to bub1, inhibition of aurkb, plk1 and mad2 have been reported to induce 
senescence in human cells, through a p53-dependent mechanism  (Kim et al., 2013; Kim et al., 
2011). It remains unknown whether TERT expression prevents and/or delays down-regulation 
of these genes in the aged zebrafish brain, and if so, whether it presents and/or delays 
senescence accumulation with ageing. My RNA Seq data suggests this to be the case; however, 
further experiments would be required to confirm this. 
My RNA Seq data point to kif11, bub1, aurkb, plk1 and mad2 as potential TERT-dependent 
mechanisms of ageing affecting the zebrafish brain. In the future, it would be important to 
further explore this. To do so, firstly, it would be important to confirm the results from the 
RNA Seq using an alternative technique such as RT-qPCR. After confirmation, it would be 
important to test whether TERT expression regulates these genes. One way of testing this 
would be to cross mutants of these genes (i.e. kif11, bub1, aubkb, plk1 and mad2) with tert-/- 
fish, and then to assess whether the resultant mutants would display a worsened phenotype 
in comparison with the tert-/- (i.e. accelerated and/or exacerbated senescence and 
inflammation in the brain). A complementary way of testing this would be to rescue 
telomerase in the tert-/- model and measuring the expression of each target gene. Increased 
levels of the target genes after telomerase rescuing, in comparison with tert-/- alone, would 
suggest that TERT expression is involved in the regulation of these target genes. If this was to 
be confirmed, then further investigation would be necessary to explore what mechanisms of 




In summary, this Chapter shows that there is increased inflammation in the aged zebrafish 
brain, characterised by increased number of microglia/ macrophages and elevated levels of 
chitotriosidase activity. Moreover, this is accelerated in the tert-/- fish, suggesting that TERT 
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plays a protective role against accumulation of inflammation in the aged brain. Nonetheless, 
as the location of immune cells does not correlate with the location of cellular senescence, it 
remains unclear whether inflammation is associated with accumulation of senescence in the 
aged brain. Further investigation would be necessary to confirm this and to further determine 
whether inflammation causes cellular senescence or vice-versa. Additionally, RNA Seq 
analysis identified a tight cluster of genes being differentially expressed with ageing in both 
WT and tert-/-, being potential TERT-dependent mechanisms of ageing. Hence, this work 
encourages further investigation to test the role of these genes in zebrafish ageing, aiming to 
unravel potential targets that can be used, in the future, to prevent or delay age-associated 
phenotypes including cellular senescence. 
196 
 
Chapter 6.  
Comparing accumulation of senescence with ageing in 
high versus low proliferative tissues 
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6.1 Introduction  
Since replicative senescence is linked to telomere shortening (Bodnar et al., 1998) and 
there is accelerated telomere erosion in tissues with higher cell turnover (Carneiro et al., 2016; 
Lee et al., 1998), high proliferative tissues are more likely to accumulate replicative 
senescence. In Chapter 4, I observed an accumulation of cellular senescence in the aged 
zebrafish brain, specifically in the diencephalon and cerebellum, which was anticipated in the 
absence of TERT (tert-/-). It remained unclear whether, in comparison to the brain and within 
the same individual, high proliferative tissues display exacerbated and/or accelerated 
accumulation of cellular senescence and whether this accumulation is associated with 
telomere shortening (i.e. replicative senescence). This is relevant because understanding the 
mechanisms behind the accumulation of cellular senescence in different tissues may help to 
find more targeted therapies to prevent accumulation of senescent cells with ageing.  
The gut is not only known to have a high proliferative capacity (Lee et al., 1998) but it is 
also known to accumulate cellular senescence and critically short telomeres with ageing, in 
zebrafish, in a telomerase-dependent manner (Carneiro et al., 2016; Henriques et al., 2013). 
However, accumulation of senescence in the aged zebrafish gut was never compared directly 
with the brain (i.e. in the same animals). Furthermore, determining whether accumulation of 
cellular senescence in the gut precedes the brain would be particularly interesting due to the 
recently discovered gut-brain axis (reviewed in Carabotti et al., 2015). If accumulation of 
senescence in the gut were to precede the brain, as expected, then it would be interesting to 
further explore whether this accumulation in the brain can somehow be influenced by the 
increased senescence in the gut, and which potential systemic mechanisms could be involved.  
Thus, in this Chapter I set out to test whether there is accumulation of cellular senescence 
with ageing in the zebrafish gut, and whether this is accelerated in the absence of TERT (tert-
/-). More specifically, I aimed to determine whether accumulation of cellular senescence in 
the zebrafish gut precedes the brain, a low proliferative tissue. In order to do so, several 
senescence-associated markers were assessed by IHC and RT-qPCR, throughout WT and tert-
/- zebrafish life-course. In order to make a directly comparison between high (i.e. gut) and low 
proliferative tissues (i.e. brain), cellular senescence in the gut was analysed in the same 
animals where I had assessed accumulation of senescence in the brain, in Chapter 4.  
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6.2 Assessing cellular senescence in the aged gut, in WT and tert-/- zebrafish  
First, I sought to confirm that, in the animals in which I detected senescence in the brain, 
there is also accumulation of cellular senescence in the ageing gut, and whether this is 
accelerated in the absence of telomerase. To test this, several senescence-associated markers 
were analysed in young and old fish, in the presence (WT) and absence of TERT (tert-/-). 
Here, I measured the same senescence-associated markers previously assessed in the 
brain (see Chapter 4). These included expression of SA-β-Gal, DNA damage foci, key 
downstream effectors of γH2AX (p53, p21, p16 and cyclin g1) and proliferation, all associated 
with cellular senescence (Campisi & d’Adda di Fagagna, 2007; Dimri et al., 1995; van Deursen, 
2014). Furthermore, relative telomere length was analysed in situ, to confirm that potential 
accumulation of cellular senescence in the gut is associated with telomere shortening and 
replicative cell exhaustion.  
 
6.2.1 Measuring SA-β-Gal and DNA damage expression 
In order to assess whether there is increased expression of SA-β-Gal in the ageing gut and 
whether this is accelerated in the absence of TERT, X-gal staining was performed in young (4-
6 months) and old (>30 months) WT fish and compared with young tert-/- (4-6 months) fish. 
X-gal staining was performed as described in section 2.4.2 and the percentage of blue areas 
was quantified as described in section 2.4.4.  
Similarly to what was previously shown in the brain (Chapter 4), the chromogenic staining 
in the gut was only observed when the slices were incubated with X-gal solution (Fig 6.1A). 
Therefore, the blue staining observed seems to reflect the presence of galactosidase, as this 
enzyme is responsible for cleavaged of X-gal, which results in the blue colouration.  
The results showed an increased percentage of SA-β-Gal-positive area in the gut with 
natural ageing (p=0.0002, Fig 6.1B, C). Moreover, in the tert-/- model there were already 
increased levels of blue staining in the gut at the young age of 4-6 months, in comparison to 
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Fig 6.1. SA-β-Gal expression in the zebrafish gut, with ageing, in the presence and absence of TERT. 
(A) Representative image of the gut stained with solutions A and B but no X-gal solution (negative 
control). (B) Representative images of the SA-β-Gal staining (after staining with X-gal solution) in 
the gut of young (4-6 months) WT and tert-/-, and old (>30 months) WT zebrafish. Scale bar: 20μm. 
(C) Quantifications of SA-β-Gal staining, in % of blue area, as described in section 2.4.4. Graphs: X-
axis, age in months; Y-axis, % of blue area. N=5 per group. Each dot represents one animal. Error 
bars represent SEM. Unpaired t-test: * p<0.05; ** p<0.01; *** p<0.001. 
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In order to test whether accumulation of SA-β-Gal is accompanied by increased levels of 
DNA damage, DNA damage foci were measured in young (5-6 months), middle aged (12-17 
months) and old (>30 months) WT fish, and compared with young (5-6 months) and old (12-
17 months) tert-/- fish. To do this, I assessed γH2AX foci expression, by IF, as described in 
section 2.3.2. The percentage of cells containing >5 γH2AX foci in the zebrafish gut was then 
counted as described in section 2.3.5. 
The results showed increased DNA damage with ageing in the WT gut (p<0.001), more 
specifically from 12-17 months onwards (5-6m vs 12-17m: p=0.0013; 5-6m vs >30m: p=0.039) 
(Fig 6.2A, B). Nonetheless, contrary to SA-β-Gal expression, no differences in DNA damage 






                                       B 
 
Fig 6.2. DNA damage foci in the ageing zebrafish gut, in the presence and absence of TERT. (A) 
Representative images of γH2AX staining by IF, in young (5-6 months) WT and tert-/-, middle aged 
WT (12-17m), and old WT (>30 months) and tert-/- (12-17m) zebrafish gut. Scale bar: 20μm. (C) 
Quantification of the percentage of yH2AX+ cells with ageing in the gut, as described in section 2.3.7. 
Graphs: X-axis, age in months; Y-axis, percentage of yH2AX+. N=5-9 per group. Each dot represents 
one animal. Bar errors represent the SEM. Kruskal-Wallis (WT over-time) or two-way ANOVA (WT 
versus tert-/- at 5-6 versus 12-17m): * <0.05; ** <0.01; *** <0.001. 
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6.2.2 Measuring downstream effectors of γH2AX (p53, p21, p16 and cyclin g1) 
Given that I confirmed accumulation of DNA damage in the naturally aged gut, I then set 
out to measure gene expression of p53, p21, p16 and cyclin g1, known to be key downstream 
effectors of γH2AX and markers associated with cellular senescence (Coppé et al., 2008; van 
Deursen, 2014). In order to determine whether there is differential expression of p53, p21, 
p16 and cyclin g1 with natural ageing, in the gut, and whether this is affected by TERT 
expression, the expression of these genes was measured in young (6-9 months) middle aged 
(22-24 months) and old (>30 months) WT fish, and compared with middle aged tert-/- (6-9 
months) fish. To do so, RNA was extracted from the whole gut and mRNA expression of these 
genes was analysed by RT-qPCR, as described in section 2.5.3.  
Similar to what was previously found in the brain (Chapter 4), no differences were detected 
in the expression of p53 (p=0.832), p21 (p=0.303), p16-like (p=0.629) and cyclin g1 (p=0.695) 
in the natural aged gut (Fig 6.3A-D). Moreover, no differences were identified in the gut 
between WT and tert-/- at 6-9 months in any of the genes analysed (p53: p=0.240; p21: 0.714; 














Fig 6.3. mRNA relative expression of key downstream effectors of γH2AX in the ageing gut of WT 
and tert-/- zebrafish. mRNA relative expression of (A) p53, (B) p21, (C) p16-like and (D) cyclin g1 
genes, in the young (6-9 months) WT and tert-/-, middle aged WT (22-24 months) and old WT (>30 
months) zebrafish. Graphs: X-axis, age in months; Y-axis, mRNA relative expression normalised to 
the WT 6-9 months of age, as described in section 2.5.3. N=3-6 per group. Each dot represents one 
animal. Bar errors represent the SEM. (A) One-way ANOVA test (WT over-time) and unpaired t-test 
test (6-9 months WT versus tert-/-);(B-D) Kruskal-Wallis and Mann-Whitney test (6-9 months WT 
versus tert-/-): * <0.05; ** <0.01; *** <0.001.  
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6.2.3 Measuring proliferation 
Senescent cells are characterised by being in a state of cell cycle arrest (Hayflick, 1965; 
Hayflick & Moorhead, 1961) and therefore proliferation activity was assessed as a marker of 
cellular senescence. In order to measure the percentage of cells proliferating, PCNA 
expression was assessed by IF, as described in section 2.3.2, in young (5-7 months), middle 
aged (12-17 months) and old (>22 months) WT fish, and compared with young (5-7 months) 
and old (12-17 months) tert-/- fish.  
The results showed decreased levels of proliferation in the gut with natural ageing 
(p=0.001), more specifically at 22 months of age (5-7 vs 22m: p=0.008; 12 vs 22m: p=0.001) 
(Fig 6.4A, B). Additionally, the tert-/- model already presented decreased levels of proliferation 
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Fig 6.4. Proliferation in the ageing zebrafish gut, in the presence and absence of TERT. (A) 
Representative images of PCNA staining by IF, in young (5-7 months) WT and tert-/-, middle aged 
WT (12-17m), and old WT (>22 months) and tert-/- (12-17m) zebrafish gut. (B) Quantifications of the 
percentage of PCNA-positive cells, counted as described in section 2.3.7. Graph: X-axis, age in 
months; Y-axis, % of PCNA-positive cells. N=5-7 per group. Each dot represents one animal. Bar 
errors represent the SEM. One-way ANOVA (WT over-time) and two-way ANOVA (WT versus tert-/- 




6.2.4 Measuring relative telomere length in situ 
Since I confirmed an accumulation of cellular senescence in the WT aged gut, characterised 
by increased levels of SA-β-Gal and DNA damage, and decreased levels of proliferation, I then 
sought to confirm whether this was due to replicative senescence. To do so, I tested whether 
there is telomere shortening in the gut with natural ageing and whether this is accelerated in 
the absence of TERT, as previously reported by TRF analysis in Southern blots (C. Carneiro et 
al., 2016; Henriques et al., 2013). I tested this by measuring relative telomere length in young 
(4-5 months), middle aged (14-17 months) and old (>22 months) WT fish, and comparing it 
with young (4-5 months) and old (14-17 months) tert-/- fish. Relative telomere length was 
assessed in situ, by telo-FISH, as described in section 2.3.3. Telo-FISH was the technique 
chosen to analyse telomere length in the gut in order to be consistent and comparable with 
the brain. 
The results showed no significant difference in telomere length with natural ageing (4-5 vs 
14-17m: p=0.925; 4-5 vs >22m: p=0.705) (Fig 6.5A-B; Fig 6.6). Furthermore, no differences in 
telomere length were detected between WT and tert-/- at 4-5 months (p=0.625) or 14-17 









Fig 6.5. Representative images of telomeres and centromeres in the gut of young and old WT and 
tert-/- zebrafish. (A) Representative images of centromeres (green) and telomeres (red), in the gut 
of young (4-5 months) WT and tert-/-, and old WT (>22 months) and tert-/- (12-17m) zebrafish. Grey 
dashed is delimiting the gut villi. line Scale bar: 20μm. (B) Amplification of the areas delimited by a 
yellow square in A. Yellow head arrows are pointing to the cell nuclei where longer telomeres are 






Fig 6.6. Telomere length in the ageing gut of WT and tert-/- zebrafish. Quantifications of 
telomere/centromere ratio, as described in section 2.3.3. Graph: X-axis, age in months; Y-axis, 
telomeres/centromeres ratio, expressed in mean Intensity value. N=3-4 per group. Each dot 




6.3 Analysis of inflammation in the aged gut, in WT and tert-/- zebrafish 
In some contexts, immune cells are known to be recruited to the sites of cellular 
senescence and clear them (Demaria et al., 2014; Krizhanovsky et al., 2008). Accordingly, even 
though I could not establish causality, I did observe increased inflammation in the brain at the 
same age as I observed increased senescence. Here, I set out to test whether accumulation 
of cellular senescence in the ageing gut is also accompanied by increased number of immune 
cells and immune activation. To test this, I counted the overall number of immune cells and 
measured chitotriosidase activity in the ageing gut, in the presence (WT) and absence of 
telomerase (tert-/-). 
If increased inflammation with ageing were to be a telomerase-dependent phenomenon, 
then removing telomerase would accelerate it and/or exacerbate it. I therefore counted the 
number of immune cells in the gut, throughout the zebrafish life-course, from young (4-7 
months), to middle aged (12-17 months) and old (>22 months) in WT fish, and compared with 
young (4-7 months) and old (12-17 months) tert-/- fish. Immune cells were detected by IF, 
using the pan-leukocyte marker LCP1 (L-plastin), as described in section 2.3.2, and previously 
performed in the brain (see Chapter 4). 
Contrary to what I observed in the brain, the results showed no differences in the number 
of immune cells in the naturally aged gut (4-7 vs >22m: p=0.248; 12-17 vs >22m: p=0.999) (Fig 
6.7). Furthermore, there were no differences in the percentage of immune cells between WT 
and tert-/- at 5-7 (p=0.112) or 12-17 months of age (p=0.999).  
Despite no differences in number, immune cells might become more activated with ageing. 
To test this hypothesis, I determined whether there is increased immune activation with 
natural ageing and whether this was accelerated in the absence of TERT. To do this, immune 
activation was assessed in young (4-6 months) and old (>23 months) WT fish and compared 
with young (4-6) tert-/- fish. Immune activation was assessed by measuring chitotriosidase 
activity in the whole gut, as described in section 2.7.3.  
The results showed no differences in chitotriosidase levels in the WT gut over-time 
(p=0.167) (Fig 6.8). In addition, no differences were detected between WT and tert-/- at 4-7 
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Fig 6.7. Percentage of immune cells with the ageing gut, in WT and tert-/- zebrafish. (A) 
Representative images of L-plastin staining in the gut of young (4-7 months) WT and tert-/-, middle 
aged WT (12-17 months), and old WT (>22 months) and tert-/- (12-17m) zebrafish. Scale bar: 20μm. 
(B) Quantifications of percentage of L-plastin-positive cells, counted as described in section 2.3.7. 
Graph: X-axis, age in months; Y-axis, % of L-plastin-positive cells. N=4-7 per group. Each dot 
represents one animal. Error bars represent the SEM. One-way ANOVA (WT over-time) and two-






Fig 6.8. Chitotriosidase activity in the ageing gut, in the presence and absence of telomerase. 
Graphs: X-axis, age in months; Y-axis, chitotriosidase activity in nmol/h/ml, analysed as described 
in section 2.7.3. N=3-6 per group. Each dot represents one animal. Bar errors represent the SEM. 
Unpaired t-tests: * <0.05; ** <0.01; *** <0.001. 
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6.4 Assessing gut permeability with ageing in WT and tert-/- zebrafish 
In order to test whether accumulation of cellular senescence in the gut was having any 
detrimental effect in the tissue, I sought to perform a functional assay. Gut permeability is 
known to increase with ageing, and it has been suggested to potentially contribute to a state 
of chronic inflammation with ageing. I therefore tested whether accumulation of cellular 
senescence in the gut, with natural ageing, is accompanied by increased gut permeability, and 
whether this is accelerated in the absence of telomerase. In order to do this, gut barrier 
permeability was assessed in young (3 months), middle aged (22 months) and old (>30 
months) WT fish, and compared with young (3 months) and old (22 months) tert-/- fish. This 
was performed using the ‘smurf’ assay, described in section 2.8.2. Briefly, fish were immersed 
in water containing blue food colourant for 30 min. After rinsing the fish in clear water to 
remove the excess of blue colouration, it was assessed whether the colourant remained in 
the gut (absence of blue colouration in the skin, indicative of no gut permeability) or whether 
it diffused all the way into the skin (indicative of gut permeability). 
The results showed increased blue colouration in the fish skin with natural ageing 
(p=0.0036), more specifically from 22 months of age onwards (p=0.021, Fig 6.9). Despite there 
was a mean difference of 11 units between young WT and tert-/- at the age of 3 months, 
suggesting that removing telomerase could accelerate this phenomenon, the differences 
between genotypes did not reach statistical significance at this time-point (p=0.189). No 









Fig 6.9. Gut barrier permeability in the ageing zebrafish, in the presence and absence of TERT. (A) 
Representative images of blue colouration in the skin of young (3 months) WT and tert-/-, middle 
aged WT (22 months), and old WT (>30 months) and tert-/- (22 months) zebrafish, after exposure to 
the ‘smurf’ assay. (B) Quantifications of the expression of blue colouration in the skin, measured as 
described in section 2.8.2. Graph: X-axis, age in months; Y-axis, % of expression of blue dye in the 
skin, in intensity value of the mean. N=3 per group. Each dot represents one animal. Error bars 
represent the SEM. Kruskal-Wallis test (WT over-time) and two-way ANOVA (WT vs tert-/- at 3 vs 




In this Chapter I aimed to test: (1) whether a high proliferative tissue, the gut, displayed 
exacerbated and/or accelerated accumulation of cellular senescence than a low proliferative 
tissue, the brain; and (2) whether accumulation of cellular senescence in the gut was 
associated with telomere shortening. This is because replicative senescence is more likely to 
accumulate in high turnover tissues, where there is rapid telomere erosion. To do this, I had 
to perform all assays in the guts of the same animals in which I studied the brain, in Chapter 
4. 
 
The role of TERT in accumulation of senescence in the zebrafish aged gut  
Firstly, to confirm whether there is accumulation of cellular senescence in the gut, with 
natural ageing, I assessed different markers of senescence in the WT zebrafish gut at different 
ages throughout their life course. I identified increased expression of SA-β-Gal (ca. 60%) and 
DNA damage (ca. 5-10%), accompanied by decreased levels of proliferation (ca. 20%) in the 
zebrafish gut at >30 months of age. These findings suggest that there is accumulation of 
cellular senescence in the zebrafish gut with natural ageing, in agreement with the literature. 
Indeed, Carneiro et al. (2016) had already shown increased expression of SA-β-Gal, 
accompanied by increased levels of γH2AX and decreased levels of proliferation, in the 
zebrafish gut, from 24 months of age onwards (Carneiro et al., 2016). Moreover, this does not 
seem to be a fish-specific phenotype as increased percentage of cells containing γH2AX foci 
had also been reported in the aged mice gut, at 42 months of age, particularly in epithelial 
cells near the crypts (Wang et al., 2009).  
Secondly, to confirm whether accumulation of senescence was accelerated in the absence 
of telomerase, I compared WT versus tert-/- guts, at different ages throughout the zebrafish 
lifespan. Compared to their WT counterpart, tert-/- fish displayed increased SA-β-Gal 
expression (~60%) and reduced levels of proliferation (~15%), at 4-6 months and at 12 months, 
respectively. These findings support the literature as it had already been reported that tert-/- 
zebrafish accumulates cellular senescence in the gut at an earlier age that their WT siblings, 
displaying increased levels of SA-β-Gal (ca. 2.5x) at the age of 12 months (Carneiro et al., 2016; 
Henriques et al., 2013), and decreased proliferation levels (ca. 40% in WT VS 20% in tert-/-) 
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from 6 months of age (Henriques et al., 2013). Again, this does not seem to be a unique 
characteristic of zebrafish, as the gut crypts of G4 TERT-/- mice model display increased levels 
of p53, one of the markers of senescence, when compared with TERT+/+ age-matched controls 
(Jaskelioff et al., 2011). Apart from increased SA-β-Gal and decreased proliferation, Henriques 
et al. (2013) and Carneiro et al. (2016) have observed an accelerated accumulation of DNA 
damage in the tert-/- model, compared with WT siblings  (ca. 10x of γH2AX+ cells) (Carneiro et 
al., 2016; Henriques et al., 2013). In contrast, the present study failed to identify differences 
in DNA damage between the genotypes. In the absence of increased levels of DNA damage in 
the tert-/- (versus WT), it is not possible to conclude whether the absence of telomerase 
contributes to an accelerated accumulation of cellular senescence in the zebrafish gut, as it 
was previously described (Carneiro et al., 2016; Henriques et al., 2013). However, none of 
these studies had compared the gut with the brain within the same animals, which was what 
I aimed to do. 
Despite partially going hand in hand with the literature, the results found in this study need 
to be interpreted with caution. This is because: (1) I observed a great discrepancy between 
percentage of cells expressing DNA damage and area of the tissue expressing SA-β-Gal 
staining, in both WT and tert-/- old guts; and (2) I did not identify accelerated accumulation of 
DNA damage response in the absence of telomerase, regardless of observing accelerated 
accumulation of SA-β-Gal and reduced proliferation activity.  
(1) On one hand, Carneiro et al. (2016) had identified 10-18% of cells expressing γH2AX foci 
in fish of >24 months of age (Carneiro et al., 2016), which is the double of the percentage I 
identified in this study (5-10%) in >30 months old fish. This difference might either be 
associated with an inter-laboratory variability, or with an undetermined technical issue that 
may have led to the labelling of fewer cells with the anti-γH2AX antibody. On the other hand, 
as mentioned in section 1.3.2, SA-β-Gal can also be detected, at least transitory, in non-
senescent cells, including in pro-inflammatory immune cells (Hall et al., 2017), quiescent and 
immortalised cells (Severino et al., 2000; Yang & Hu, 2005). Additionally, the SA-β-Gal staining 
is diffused throughout the tissue, and it is not cell specific, as observed in Fig 6.1A. This diffuse 
and non-specific staining can therefore lead to false-positives, which may be one of the 
reasons why I observed such a high percentage of the tissue expressing SA-β-Gal staining in 
the aged zebrafish gut. Further investigation would be required to determine this. More 
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specifically, it would be important to repeat the immuno-staining with anti-γH2AX, using a 
new batch of antibody, in order to test whether the few number of γH2AX-positive cells 
observed in this project is associated with a technical issue. Moreover, cells could be co-
labelled with SA-β-Gal and other markers of senescence, such as γH2AX (by immunostaining) 
or p21 (by in-situ hybridisation). Despite being technically challenging, this co-labelling could 
help detecting and excluding potential non-senescent cells expressing SA-β-Gal. 
(2) Regarding the lack of differences in the percentage of cells containing DNA damage 
observed between WT and tert-/- model, it remains unclear if this is real or if it reflects some 
experimental issues. It is reasonable to think that the lack of differences observed between 
genotypes may either be due to a possible technical problem during IF, as above mentioned, 
or due to the small sample size used in this study. Indeed, power calculations revealed that 
the γH2AX experiment would require a minimum of 22 animals per group in order to detect 
a 25% difference (with 90% power) between genotypes. This suggests that I would be likely 
to identify differences between WT and tert-/- if I were to expand the sample size of this 
experiment. Of note, accordingly to the power calculations, the number of fish required for 
these experiments are much higher than the ones reported in previous studies, where the 
sample size required was 3 to 6 animals per group (Carneiro et al., 2016; Henriques et al., 
2013). The higher variability found in this study could well be because, contrary to the 
previous studies, I did not use siblings as I did not have animals enough from each given time-
point to do so. Laboratory tert mutants are generated via the incross of heterogyzous fish 
(see section 2.2.2), and the parental telomere length influences the progeny telomere length. 
If, by chance, some tert+/- parents have longer telomeres, then their offspring will also have 
longer telomeres and will age slower. This is likely to contribute not only to a high inter-
individual variability (between non-siblings) but also to a high inter-laboratory variability. In 
fact, this is likely to have affected some of the results obtained in this project as the laboratory 
had many tert-/- fish living until the age of 22 months, which had not been reported to happen 
in the previous studies (Carneiro et al., 2016; Henriques et al., 2013). In the future, the lab 
will aim to characterise telomere length in the parents before establishing crosses. However, 
this is technically challenging and time consuming as it involves to measure absolute telomere 
length in every parent.  
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Therefore, in order to strengthen the data, in the future, it would be important to repeat 
the immunolabelling with the anti-γH2AX antibody using a larger sample size. Additionally, in 
order to test whether the SA-β-Gal staining is over-representing the number of senescent 
cells present in the tissue, it would be important to test: (a) whether SA-β-Gal staining is 
showing a great number of false-positive cells due to, for example, transient expression of SA-
β-Gal by activated immune cells (by determining if immune cells in the aged zebrafish gut are 
in a pro-inflammatory state and whether they express SA-β-Gal staining themselves); and (b) 
whether cells expressing γH2AX foci also express SA-β-Gal staining (by co-labelling cells with 
both staining at the same time). Moreover, apart from SA-β-Gal and DNA damage expression, 
it would be important to determine the presence of other markers of cellular senescence in 
the aged gut, such as, for example, the presence of SASP factors and p53 phosphorylation. 
The use of multiple markers would strengthen the confidence on whether there is 
telomerase-dependent accumulation of cellular senescence with ageing, in the zebrafish gut, 
as it was previously reported by others (Carneiro et al., 2016; Henriques et al., 2013). 
 
The role of TERT on telomere shortening in the ageing gut 
After testing whether there is accumulation of cellular senescence in the aged zebrafish 
gut, I aimed to determine whether this accumulation was associated with telomere 
shortening, a characteristic of replicative senescence  (Bodnar et al., 1998). In order to test 
this, I assessed relative telomere length over-time, in the zebrafish gut, by telo-FISH. Being a 
tissue with high cell turnover, where there is rapid telomere shortening (Bodnar et al., 1998; 
Lee et al., 1998), I would expect to see decreased telomere length over-time. Moreover, being 
telomerase the only enzyme known to be capable of elongating telomeres (Greider & 
Blackburn, 1985), I would expect that in its absence, telomere erosion was accelerated. 
Accordingly, telomere shortening had already been shown to occur with ageing in mice (Wang 
et al., 2009) and zebrafish gut (Carneiro et al., 2016; Henriques et al., 2013), in a telomerase-
dependent manner (i.e. accelerated in the absence of telomerase). Contrary to what was 
expected, and in opposition to the previous reports, the present study did not identify 
decreased telomere length in the zebrafish gut, with natural ageing, neither it identified 
shorter telomeres in the tert-/-, compared with the WT, at any time-point analysed. It is 
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unclear whether the lack of telomere shortening with ageing, or in the absence of telomerase, 
observed in this project, is real or it if reflects some technical issues.  
It is important to note that in this study I measured relative telomere length by telo-FISH 
whereas in the previous studies performed in zebrafish the authors performed TRF analysis 
by Southern blotting, the gold standard technique to measure telomere length (Carneiro et 
al., 2016; Henriques et al., 2013). Telo-FISH was the technique chosen in this study to assess 
telomere shortening with ageing because, contrary to Southern blotting, it allows the 
measurement of relative telomere length in different cell populations and in different regions 
of the tissue, which was one of the aims of the project, particularly in the brain. This is because 
southern blotting requires large amounts of DNA, which makes it really challenging to obtain 
sufficient amounts of DNA from brain macroareas or specific cell populations after sorting. 
Hence, telo-FISH was used to assess relative telomere length in both brain (Chapter 4) and 
gut in order to maintain consistency and to be possible to make a direct comparison between 
the tissues. Nonetheless, telo-FISH also has some disadvantages and it is not as sensitive as 
Southern blotting. Besides telo-FISH does not allow the measurement of absolute telomere 
length, it may not allow the detection of critically short telomeres (Lai et al., 2017; Lai et al., 
2018), and it is highly compromised by the amounts of background in the tissue. This is 
particularly relevant in a model species that has already naturally short, human-like size 
telomeres (~4-12kb) (Carneiro et al., 2016; Henriques et al., 2013). In mouse, this technique 
is highly use without such limitations because most of the mice strains used in laboratory 
present very long telomeres and thus their signal/background ratio is much higher and easy 
to detect. To overcome the challenge of detecting small differences in telomere length in 
zebrafish, over-time, after performing Southern blotting, in the previous studies, the authors 
used the median of telomere length (instead of mean) to assess telomere length, taking into 
consideration the critically short population of telomeres (Carneiro et al., 2016; Henriques et 
al., 2013). However, in this project, using telo-FISH, no differences were observed between 
analysis using the mean or the median (data not shown). It is therefore possible that telo-
FISH, used in this project, was not sensitive enough to detect small differences in telomere 
length with ageing in the zebrafish gut. Particularly, given that the biggest difference in 
telomere length in the gut can be attributed to a small population of cells, that have longer 
telomere length in the WT. Unpublished data from the lab now shows that these cells with 
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longer telomeres are immune cells, and it is the changes in telomere length in these cells that 
makes the biggest difference between WT and tert-/-. 
Furthermore, telomere shortening in the zebrafish gut has been shown to occur mainly in 
the first 3 months of life (~3-4Kb), from which there is a small decrease (~1Kb) or a 
maintenance in telomere length (Carneiro et al., 2016; Henriques et al., 2013). In this project, 
I assessed telomere length from 4-5 months of age onwards, where only a small decrease in 
telomere length is expected to occur. Thus, it is likely that I have missed the critical period 
where telomere shortening is more prominent, and that telo-FISH lacked sensitivity to detect 
slight changes in telomere length at later ages. Of note, on top of this, a great variability in 
telomere length was observed between animals, within each experimental group. In fact, 
power calculations revealed that I would need a minimum of 22 animals per group in order 
to identify differences in telomere length between experimental groups.  
So far, the results obtained in this project did not allow to confirm whether accumulation 
of senescence in the zebrafish gut, of the animals where I observed accumulation of 
senescence in the brain with natural ageing, is associated with telomere shortening. In the 
future, further investigation would be required to confirm this. In this regard, it would be 
crucial to repeat the experiment that aimed to measure telomere length by telo-FISH, 
increasing the sample size and adding earlier time-points than the ones analysed in this 
project (<4 months old fish). In parallel, it would be important to measure telomere length 
using an alternative technique, more specifically, TRF by Southern blotting. Apart from these 
experiments, it would be interesting to look at telomere-associated DNA damage foci or TAFs 
(i.e. DNA damage foci co-localising with telomeres), in order to detect DNA damage 
specifically at telomeres sites. Contrary to DNA damage that occur in non-telomeric regions, 
that is rapidly repaired and therefore is short-lived, TAFs are persistent, and therefore they 
are thought to contribute to the accumulation of DNA damage foci with ageing (Hewitt et al., 
2012). Hence, TAFs constitute another important marker of cellular senescence. However, it 
is technically challenging to assess TAFs in tissues of animals with short telomeres, where the 
short telomeres are already barely detectable by telo-FISH. Therefore, it is challenging to 





The role of TERT in inflammation, in the aged zebrafish gut 
In the second part of this Chapter, I aimed to test what are the consequences of 
accumulation of cellular senescence in the aged zebrafish gut, in terms of inflammation and 
tissue integrity. As immune cells are recruited to the sites of cellular senescence and are able 
to clear them, at least in some contexts (Demaria et al., 2014; Kang et al., 2011; Krizhanovsky 
et al., 2008), I would expect that accumulation of cellular senescence in the aged zebrafish 
gut to be associated with increased inflammation. Moreover, senescent cells are known to 
contribute to impairment of tissue homeostasis, due to their inability to proliferate, and to 
promote a chronic, low-level inflammation in the tissue, via releasing of SASP components 
(Franceschi & Campisi, 2014; Tchkonia et al. 2013; Freund et al. 2010; Campisi & d’Adda di 
Fagagna 2007). Together, this can lead to the loss of tissue integrity and contribute to disease 
(Ovadya & Krizhanovsky, 2014; van Deursen, 2014). Thus, I would expect that accumulation 
of cellular senescence in the aged zebrafish gut to be associated with increased inflammation 
and decreased tissue integrity. To test this, I determined whether cellular senescence was 
associated with increased number of immune cells and increased immune activation, as well 
as with increased gut-barrier permeability. 
Contrary to what was observed in the brain (Chapter 4), this study did not show any 
differences in the number of immune cells or chitotriosidase activity, with ageing, in the 
zebrafish gut. Additionally, no differences were identified between WT and tert-/- model (i.e. 
in the absence of telomerase) in any of these assays. Despite little being known about age-
associated alterations in the immune cells of the gut, it is thought that with advancing age, in 
mammals, there is decreased migration of immune cells from the Peyer’s patches 
(mammalian gut structures formed by an agglomerate of lymphocytes). Whilst greater 
numbers of lymphocytes accumulate in these structures, the mouse lamina propria was 
reported to display reduced number of immune cells with ageing (Schmucke et al., 2003; 
Saffrey, 2014). Although zebrafish do not present Peyer’s patches (Brugman, 2016), it is not 
known whether migration of immune cells is impaired in the aged zebrafish gut, preventing 
infiltration of immune cells from the bloodstream into the lamina propria, which could explain 
the results found in this project. Contrary to this hypothesis, Carneiro et al (2016) reported 
an infiltration of leukocytes in the lamina propria, with ageing, in the tert-/- (but not WT) 
zebrafish. This was assessed by haematoxylin/eosin (H&E) staining and qualitatively analysed 
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by a pathologist. However, the number of immune cells was not counted and the type of 
immune cells accumulating in this region with ageing was not analysed (Carnero et al., 2016). 
Therefore, further experiments should aim at confirming these results. Furthermore, it is 
important to note that this project only analysed the number of overall immune cells (L-
plastin-positive cells). Hence, it remains unknown whether, with ageing, there is a shift in the 
proportion of the different immune cell populations in the gut, with an increased number of 
a specific immune cell type.  
Independently of the number of immune cells, though, it may be that immune cells in the 
gut, with ageing, become more activated, expressing pro-inflammatory markers. For example, 
in humans, increased levels of IL6 were identified in the aged gut, specifically in dendritic cells 
(Man et al., 2015). In this project, I tested chitotriosidase activity as a marker of inflammation, 
but detected no differences with ageing, or in the absence of telomerase. Nonetheless, power 
calculations showed that it would be necessary a minimum of 16 animals per group in order 
to identify possible differences between the groups, and therefore these results remain 
inconclusive. In order to confirm these results, in the future it would be important to repeat 
the experiment with an increased sample size. Interestingly, Carneiro et al. (2016) reported 
decreased villi length and thickening of the gut lamina propria, accompanied by increased 
enteritis, with ageing, in the zebrafish gut (Carneiro et al., 2016; Henriques et al., 2013). This 
suggests that there may be inflammation in the aged zebrafish gut, associated with 
morphological changes in the tissue. Thus, it would also be important to use other methods 
to assess inflammation, such as measuring lamina propria width, localised infiltration of 
immune cells, and expression of pro-inflammatory signals such as IL6, IL1, TNFα or NFkB. It is 
important to note, though, that it remains a technical challenge to assess pro-inflammatory 
signals in the zebrafish gut due to the lack of specific antibodies available. Additionally, 
despite there are transgenic reporter lines available for IL6, IL1b, TNFα and NFkB, they do not 
enable an accurate quantitative assessment of the levels of expression of these molecules. 
This is because the reporter fluorescent proteins have different half-lives and because there 
is some uncertainty regarding the number of inserted copies of the transgene per animal 
(unpublished data from the lab). 
Finally, I tested whether gut permeability was associated with increased cellular 
senescence in the aged zebrafish gut. In agreement with previous reports in mice 
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(Thevaranjan et al., 2017) and  zebrafish (Dambroise et al., 2016; Martins et al., 2018), this 
study identified gut permeability in natural ageing. However, no differences were identified 
between WT and tert-/- model and therefore it is not clear whether gut permeability with 
ageing is accelerated in the absence of telomerase. Effect sizes showed that this experiment 
was underpowered and a minimum of 12 animals would be required to detect differences 
between genotypes. This suggests that I would be likely to detect differences between 
genotypes if I was to increase the sample size of the experiment. Hence, it would be important 
to repeat this experiment increasing the sample size.  
 
Conclusion 
Overall, this Chapter aimed to test whether a high proliferative tissue, the gut, accumulates 
cellular senescence with ageing, whether this occurs in a telomerase-dependent manner, and 
whether it anticipates accumulation of senescence in the brain, a low-proliferative tissue. 
Several technical issues, mainly driven by the small sample sizes used, did not allow to take 
any conclusions, apart from that there is accumulation of cellular senescence in the zebrafish 
gut, with natural ageing. Therefore, the data found in this Chapter could not confirm whether 
accumulation of senescence in the gut is accelerated in the absence of TERT and whether this 
occurs in a telomere-dependent manner. Due to the uncertainty of the results, in the end, the 
data did not allow to determine whether accumulation of senescence in the gut precedes the 
brain. Further investigation is required to address all these questions in the future.
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With ageing, the risk of developing chronic diseases increases dramatically. Age-related 
degenerative diseases affecting the CNS, including the retina and the brain, have an enormous 
negative impact on patient’s quality of life, as well as respective care takers. Thus, it is urgent 
to develop new models and techniques that may help to unravel mechanisms underlying age-
related diseases of CNS, aiming to identify therapeutic targets that promote healthy ageing.  
In this project I used the zebrafish model to address specific questions regarding the 
accumulation of senescence and inflammation with ageing in the CNS (retina and brain), and 
how telomerase, a key molecule involved in many age-related conditions, may play a part on 
it. 
In the first part of this project I tested whether the zebrafish retina undergoes 
degeneration with ageing and whether telomerase plays a role on it. This work showed that 
the zebrafish retina suffers several structural and morphological alterations over-time, 
resembling human retinal ageing. These include retina thinning, accompanied by increased 
cell death and reduced proliferation (Eriksson & Alm, 2009). In addition, there is loss of 
amacrine and bipolar neurons and disorganisation of the photoreceptors, which culminates 
in visual impairment (Marshall, 1987; Nian & Lo, 2019; Salvi et al., 2006). Reactivation of 
telomerase has been shown to ameliorate AMD in humans (Dow & Harley, 2016; Rowe-
Rendleman & Randolph, 2004), suggesting that telomerase is crucial for retinal health. 
Surprisingly, none of the age-associated retinal phenotypes described were accelerated in the 
tert-/- model (versus counterpart WT), suggesting that telomerase is unlikely to contribute to 
zebrafish retinal ageing, at least in the retinal areas I focused on, and associated visual defects. 
Importantly, despite MG maintaining their regenerative capacity in response to acute damage 
until old ages, MG fail to proliferate in response to chronic, age-associated 
neurodegeneration. Instead of a regenerative response, the aged zebrafish retina displays a 
gliotic-like response, like in humans. Furthermore, although telomerase is known to play an 
essential role in proliferation and regeneration (Bednarek et al., 2015; Lin et al., 2018), the 
absence of telomerase did not worsen retina degeneration with ageing. This suggests that 
telomerase is unlikely to be a limiting factor for age-associated retinal degeneration in 
zebrafish. Reduced proliferation with ageing, in the zebrafish retina, is thus unlikely to be the 




Together, this part of project shows that zebrafish display several cellular and molecular 
alterations with ageing that mimic what happens in the human retina during ageing and 
disease, making it a suitable model to study human retinal ageing. Importantly, here I show 
that there are key differences in MG and microglia response to chronic versus acute damage. 
Gliosis is one of the main differences between acute and chronic damage, and therefore it 
constitutes a key target to further explore regenerative mechanisms in the human retina, in 
the future. Furthermore, this study highlights the relevance of studying regenerative 
mechanisms in the context of ageing and points to zebrafish as a good model to do so.  
In the second part of this project I determined whether the zebrafish brain accumulates 
cellular senescence with ageing, in a TERT-dependent manner. The findings of this work 
suggested that there is accumulation of cellular senescence in the zebrafish brain, with ageing, 
specifically in the diencephalon and cerebellum. Importantly, accumulation of senescence 
was accelerated in the tert-/- fish model, suggesting that TERT exerts a protective effect 
against accumulation of senescence. In parallel, this project also suggested that there is 
increased inflammation in the aged zebrafish whole brain, as assessed by increased number 
of microglia/ macrophages and chitotriosidase activity. Once again, this was anticipated in the 
tert-/- fish model, suggesting that TERT plays a protective role against inflammation in the aged 
zebrafish brain. However, the macroareas where increased number of microglia/ 
macrophages were identified did not correlate with the macroareas where SA-β-Gal was 
observed. This particular inconsistency, together with the fact that some of these 
experiments were underpowered, makes it unclear whether inflammation in the aged brain 
is associated with accumulation of senescence.  
It is important to mention that power calculations made before the starting of the project, 
based on laboratory data as well as on published data, had shown that most of the 
experiments required sample sizes of 3 to 6 fish (Carneiro et al., 2016; Henriques et al., 2013). 
Regarding the experiments that were never performed before, effect sizes were not possible 
to calculate beforehand, due to lack of data available, and therefore I used sample sizes 
identical to the rest of the experiments. Despite this first analysis, in the end, some of the 
experiments were showed to be underpowered (larger sample sizes would be required to 
detect a 25% difference with 90% power and 5% significance level between groups, using a 
two-sided test). This could be, in part, because contrary to the previous studies I did not use 
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siblings, which is likely to contribute to an increased inter-individual variability (see section 
6.5.1). Nevertheless, it is important to note that the usage of non-siblings offers a better 
representation of the population, potentially presenting more meaningful results. 
Immune cells are known to be recruited to sites of cellular senescence, at least in some 
contexts (Demaria et al., 2014; Krizhanovsky et al., 2008). In addition, senescent cells are 
known to release pro-inflammatory factors (part of SASP), contributing to inflammation 
(Franceschi & Campisi, 2014; Campisi & d’Adda di Fagagna 2007). Therefore, it is likely that 
cellular senescence can lead to increased inflammation and vice-versa. Nonetheless, the data 
found in this project do not allow discerning what happens first.  
Curiously, within all the macroareas of the brain, the medulla oblongata was the one 
displaying the highest levels of SA-β-Gal from young ages. At the same time, this macroarea 
displayed the highest density of microglia/ macrophages from young ages, which became 
even more evident over-time. Nonetheless, there are some observations that should be 
confirmed in the future. Since DNA damage was not analysed in the medulla oblongata, due 
to a technical issue, and SA-β-Gal by itself cannot be used as a maker of senescence, it remains 
unclear whether the blue staining observed in this macroarea represents real cellular 
senescence. The main reason why SA-β-Gal staining is not considered a marker of senescence, 
per se, is that non-senescent cells can express it, in some contexts (Severino et al., 2000; Yang 
& Hu, 2005). For instance, macrophages have been shown to express SA-β-Gal, transiently, 
when activated (Hall et al., 2017). Given that the medulla oblongata was observed to have a 
considerable number of microglia/ macrophages from young ages, it is plausible to think that, 
at least part of the blue staining observed in this region, might be due to immune activation 
rather than senescence. Preliminary data suggested that most of the L-plastin+ cells are 
surrounding the blue staining and not co-localising with it. Nonetheless, some controls are 
required to confirm these results (see section 5.6.1).  Hence, it would be important to confirm 
whether the medulla oblongata displays high levels of senescence and whether this precedes 
accumulation of senescence in other macroareas of the brain.  
Therefore, future work should aim to confirm some of the findings identified in this project, 
including the following:  
(1) To confirm whether there is accumulation of cellular senescence in the medulla 
oblongata with ageing and whether this accumulation precedes other macroareas of 
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the brain. This could be tested by using a combination of markers of senescence, such 
as DNA damage and, particularly, DNA damage at telomeres (TAFs); γH2AX 
downstream effectors (for example, p21, p16 and p53); as well as the presence of SASP 
factors (for example, IL6, IL8, MCP-2, IGFBP, MMP-1, MMP-3). Since high expression of 
SA-β-Gal was already observed in 4-6 months old WT, it would be important to add an 
earlier time-point (less than 3 months of age) to the experiment. Nonetheless, it is 
important to note that these experiments are technically challenging. Firstly, because 
there is a lack of antibodies available in zebrafish to detect SASP components, and the 
transgenic reporter lines available are still limited and present several issues (see 
section 6.5.3). Secondly, since it is hard to detect short telomeres by telo-FISH, I would 
likely miss great part of the TAFs that accumulate in critically short telomeres (see 
section 6.5.2). After overcoming the technical challenges, these experiments would 
enable to confirm whether there is accumulation of senescence over-time, in the 
medulla oblongata, and whether it occurs earlier than in the other regions of the brain. 
This would be relevant because the medulla oblongata is a privileged bridge of contact 
between the brain and the periphery, as a great number of cranial nerves leave or enter 
the brain through this macroarea (Moens & Prince, 2002). Therefore, if it were to be 
confirmed that the medulla oblongata accumulates senescence in the brain before 
other macroareas, then it would be plausible to hypothesise that inflammation and/or 
senescence from peripheral tissues could contribute to the accumulation of 
senescence in this region of the brain. This could open an exciting new line of 
investigation on possible mechanisms driving accumulation of cellular senescence in 
the brain.  
 
(2) To test whether senescence in the brain causes inflammation or whether, instead, 
increased inflammation in the brain leads to accumulation of senescence. These two 
hypotheses could be tested by treating two groups of fish with a senolytic drug (to kill 
the senescent cells, group 1) or an anti-inflammatory (to reduce inflammation, group 
2) and observe whether this prevented and/or decreased inflammation or senescence, 
respectively. A low number of immune cells and reduced immune activation upon 
treatment with a senolytic (in group 1), would indicate that senescent cells contribute 
to inflammation in the aged brain. A reduced number of senescent cells upon 
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treatment with an anti-inflammatory (in group 2), would indicate that inflammation 
contribute to accumulation of cellular senescence in the brain. The findings of these 
experiments would enable to further explore mechanisms driving accumulation of 
cellular senescence in the ageing brain, aiming to uncover potential targets to prevent 
it. Nevertheless, it is important to note that before performing these experiments, it 
would be essential to test their feasibility, as so far it is not known whether senolytics 
cross the BBB. ABT-263 (Navitoclax) is a well-known senolytic that was previously 
administered in both mice and zebrafish (Bussian et al., 2018; Novoa et al., 2019). 
However, none of these studies looked at the brain and therefore it is unknown 
whether this drug crosses the zebrafish BBB and whether it exerts any effect on the 
brain. Despite it being reported that ABT-263 does not cross the BBB (Vogler et al., 
2011; Yamaguchi & Perkins, 2012), Bussian et al. reported that treating mice with ABT-
263, from weaning to 6 months of age, is enough to prevent the up-regulation of 
several senescent-associated genes in the brain (Bussian et al., 2018). Therefore, a pilot 
study would be crucial to test whether ABT-263 crosses the zebrafish BBB and to assess 
what is the best treatment to do it, by determining the dose and time of drug 
administration required.  
 
If these experiments (1 and 2) were to confirm that there is accumulation of cellular 
senescence in the zebrafish brain, with ageing, including in the medulla oblongata, then it 
would be important to further confirm whether this happens in a TERT-dependent manner. 
In this project this was tested by using the tert-/- model zebrafish, that lacks TERT protein 
activity in zebrafish (Anchelin et al., 2013; Henriques et al., 2013). Nonetheless, it would be 
important to confirm these findings, in the future, by restoring TERT expression in the tert-/- 
model and testing whether this is enough to prevent and/or delay accumulation of cellular 
senescence in the aged brain. This could be done by generating a transgenic line expressing 
TERT and using it in the tert-/- background, where TERT expression would be restored from 
birth (now on-going in the lab). Alternatively, this could be done by generating an inducible 
transgenic line where TERT expression would be restored in a time-specific manner. Despite 
being technically more challenging, an inducible transgenic model would have the advantage 
of allowing the re-expression of TERT in early adulthood, in order to test whether TERT can 
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prevent accumulation of senescence; or in late ages, in order to test whether TERT can rescue 
the phenotype already observed. 
Finally, exploratory experiments in this project also aimed at identifying potential 
mechanisms underlying the protective effect of TERT on accumulation of cellular senescence 
in the aged zebrafish brain. Within these experiments, it was observed that accumulation of 
TERT-dependent senescence not only occurs in proliferative areas of the brain, but also in 
non-proliferative ones, where it is unlikely to be due to replicative cell exhaustion. These 
findings hint that telomere-independent functions of telomerase (i.e. non-canonical functions 
of telomerase) may possibly be involved in this protective mechanism. Additionally, in a 
parallel experiment, I identified a set of tightly connected genes that are down-regulated with 
ageing in both WT and tert-/-. Interestingly, some of these genes have been shown to be 
associated with cellular senescence (bub1, aurkb, mad2 and plk1). Hence, these genes might 
potentially be key TERT-dependent mechanisms of brain ageing involved in accumulation of 
senescence. Although these are preliminary data and require further confirmation, these 
results point to specific mechanisms that may be involved in the protective role of telomerase 
in the aged zebrafish brain, encouraging further investigation. 
In conclusion, this study shows that zebrafish is a valuable model to study CNS ageing, in 
both the retina and brain. On one hand, thanks to its high regenerative capacity in the retina, 
at least in the context of acute injury, zebrafish was shown to be a unique model to explore 
new therapeutics aiming to prevent and/or delay degeneration of human retina. On the other 
hand, my data suggest that telomerase expression has a protective role against senescence 
accumulation in the aged zebrafish brain. This highlights the importance of investigating 
telomerase-dependent mechanisms of ageing in order to find potential therapeutic targets 
aiming to ameliorate brain health in ageing. Promisingly, this study opens new lines of 
investigation in both retina and brain ageing. 
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